	   SnapGene      ÚtagttattaatagtaatcaattacggggtcattagttcatagcccatatatggagttccgcgttacataacttacggtaaatggcccgcctggctgaccgcccaacgacccccgcccattgacgtcaataatgacgtatgttcccatagtaacgccaatagggactttccattgacgtcaatgggtggagtatttacggtaaactgcccacttggcagtacatcaagtgtatcatatgccaagtacgccccctattgacgtcaatgacggtaaatggcccgcctggcattatgcccagtacatgaccttatgggactttcctacttggcagtacatctacgtattagtcatcgctattaccatggtgatgcggttttggcagtacatcaatgggcgtggatagcggtttgactcacggggatttccaagtctccaccccattgacgtcaatgggagtttgttttggcaccaaaatcaacgggactttccaaaatgtcgtaacaactccgccccattgacgcaaatgggcggtaggcgtgtacggtgggaggtctatataagcagagctggtttagtgaaccgtcagatccGCTAGCGCTACCGGACTCAGATCTCGAGCTCCGAATTCGCGATCGCTGCAGTCGACGGTACCGCAAGCTTTAATACTTTCAGAGAATCCAGGAGTCCTGCCAAAGTGGCACCAAGTGGCTGGTGGAGACCCAGGTGAAGGCCAGGAGGCGGAAGAGAGGAGCACAGAAGGGCAGTGGATCCCCAACTCACAGCCTGAGCCAGAAGAGCACCCGGCTGTCTGGAGCCGCCCCTGCCCACTCAGCCGCAGACCCCTGGGAGAAGGAGCATCACCGCCTCTCTGTCCGGATGGGCTCACATGCCCACCCATTACGGCGATCAAGGCGGGAGGCTGCCTTCCGGAGCCCCTACTCCTCAACAGAGCCCCTCTGCTCTCCCAGGTAAGAACAACTGGATCCGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCTGTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAAATGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAGCAAGGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGTCTAGAGATATACTGAGTCATTAGGGACTTTCCAATGGGTTTTGCCCAGTACATAAGGTCAATAGGGGTGAATCAACAGGAAAGTCCCATTGGAGCCAAGTACACTGAGTCAATAGGGACTTTCCATTGGGTTTTGCCCAGTACAAAAGGTCAATAGGGGGTGAGTCAATGGGTTTTTCCCATTATTGGCACGTACATAAGGTCAATAGGGGTGAGTCATTGGGTTTTTCCAGCCAaTTTAATTAAAACGCCATGTACTTTCCCACCATTGACGTCAATGGGCTATTGAAACTAATGCAACGTGACCTTTAAACGGTACTTTCCCATAGCTGATTAATGGGAAAGTACCGTTCTCGAGCCAATACACGTCAATGGGAAGTGAAAGGGCAGCCAAAACGTAACACCGCCCCGGTTTTCCCCTGGAAATTCCATATTGGCACGCATTCTATTGGCTGAGCTGCGTTCTACGTGGGTATAAGAGGCGCGACCAGCGTCGGTACCGTCGCAGTCTTCGGTCTGACCACCGTAGAACGCAGATCaccggtcgccaccatggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagtaaagcggccgcgactctagatcataatcagccataccacatttgtagaggttttacttgctttaaaaaacctcccacacctccccctgaacctgaaacataaaatgaatgcaattgttgttgttaacttgtttattgcagcttataatggttacaaataaagcaatagcatcacaaatttcacaaataaagcatttttttcactgcattctagttgtggtttgtccaaactcatcaatgtatcttaaggcgtaaattgtaagcgttaatattttgttaaaattcgcgttaaatttttgttaaatcagctcattttttaaccaataggccgaaatcggcaaaatcccttataaatcaaaagaatagaccgagatagggttgagtgttgttccagtttggaacaagagtccactattaaagaacgtggactccaacgtcaaagggcgaaaaaccgtctatcagggcgatggcccactacgtgaaccatcaccctaatcaagttttttggggtcgaggtgccgtaaagcactaaatcggaaccctaaagggagcccccgatttagagcttgacggggaaagccggcgaacgtggcgagaaaggaagggaagaaagcgaaaggagcgggcgctagggcgctggcaagtgtagcggtcacgctgcgcgtaaccaccacacccgccgcgcttaatgcgccgctacagggcgcgtcaggtggcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaataatattgaaaaaggaagagtcctgaggcggaaagaaccagctgtggaatgtgtgtcagttagggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccaggtgtggaaagtccccaggctccccagcaggcagaagtatgcaaagcatgcatctcaattagtcagcaaccatagtcccgcccctaactccgcccatcccgcccctaactccgcccagttccgcccattctccgccccatggctgactaattttttttatttatgcagaggccgaggccgcctcggcctctgagctattccagaagtagtgaggaggcttttttggaggcctaggcttttgcaaagatcgatcaagagacaggatgaggatcgtttcgcatgattgaacaagatggattgcacgcaggttctccggccgcttgggtggagaggctattcggctatgactgggcacaacagacaatcggctgctctgatgccgccgtgttccggctgtcagcgcaggggcgcccggttctttttgtcaagaccgacctgtccggtgccctgaatgaactgcaagacgaggcagcgcggctatcgtggctggccacgacgggcgttccttgcgcagctgtgctcgacgttgtcactgaagcgggaagggactggctgctattgggcgaagtgccggggcaggatctcctgtcatctcaccttgctcctgccgagaaagtatccatcatggctgatgcaatgcggcggctgcatacgcttgatccggctacctgcccattcgaccaccaagcgaaacatcgcatcgagcgagcacgtactcggatggaagccggtcttgtcgatcaggatgatctggacgaagagcatcaggggctcgcgccagccgaactgttcgccaggctcaaggcgagcatgcccgacggcgaggatctcgtcgtgacccatggcgatgcctgcttgccgaatatcatggtggaaaatggccgcttttctggattcatcgactgtggccggctgggtgtggcggaccgctatcaggacatagcgttggctacccgtgatattgctgaagagcttggcggcgaatgggctgaccgcttcctcgtgctttacggtatcgccgctcccgattcgcagcgcatcgccttctatcgccttcttgacgagttcttctgagcgggactctggggttcgaaatgaccgaccaagcgacgcccaacctgccatcacgagatttcgattccaccgccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccggctggatgatcctccagcgcggggatctcatgctggagttcttcgcccaccctagggggaggctaactgaaacacggaaggagacaataccggaaggaacccgcgctatgacggcaataaaaagacagaataaaacgcacggtgttgggtcgtttgttcataaacgcggggttcggtcccagggctggcactctgtcgataccccaccgagaccccattggggccaatacgcccgcgtttcttccttttccccaccccaccccccaagttcgggtgaaggcccagggctcgcagccaacgtcggggcggcaggccctgccatagcctcaggttactcatatatactttagattgatttaaaacttcatttttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgcagcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaagcgccacgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgccatgcat  3µ   %         "   !                        '   !   %               '   !                                                
                                                $            +               !      -   !                                                 #            !                                                                                                          
      	                      !          $                           
         !               
                                                
                  9               !                  &                                          #                                    /   !         %   #                                 %   !   "         
                                             .   "      "   &   #               0      *        %   ‡ˆ‰Ž“¢£Ävwª ŸÉ
£ÅˆÅGijÚa[\]RST   7¡Ãß!L‘¤­ÅñM,O®	ñ*¤¤©½*Hk¼ö  ¶ Š�þZx„«·°!FÊ@ËÆÅÛB&^Þ"" ‡önÚ”ÏñZdj]~ ˆœ>FŒæz¹Æ‰bèObRU! 3 º Ä"¨ÉÝë*MS’ ¥5�«›	ò9]iÏUl‚v½é÷Y ã6]®(-P\æ&+¥±/FŽ¥[ñ~Ž’ãb �¢ýjÔ¨Æ¯	Ž”¯ËWpÁ6I°h@À ¡ 8àZ™òN:3�	¿	xªy$0¾++Ç · kÆÒ:w‹�Ìy¬"%QiêÑ–A‰ÌBî¿C·Y K Å †Ç±É|†ÌÓ s”8ÿ[…¸t 
d
©
G»&ÇÜ|\'_#€  %Øn¢Ûø1’	ËYbÆáNß' ˆà…Žº>_ekË^9	Ç
‰�?G�{º	¬¼Ô!X[cFÄV! Õ FyÐ¸÷•¼•[�z›:”¡â	º	M™^¦ç\Ç£ífÚ% [ Â"o•ÐòœRš`rÔÜ÷dm¯ûŠ¥<c2oéP�S R ØÛJ®Ï?	Õ	£28AlÃqøIjÃu‡’ #Þé“[¦¸bhO[Ž	þ	Ï06[^j’ÒZ¿mô ŸÊçNÞ�	@ æˆÐêñƒŽ¥¾ê 4 » Å©rèD|¯¬œ	Kc¯Vå' 3gì+T¡´6= 5v_	q	Ã	ó:HGK€¯R¹õo—wžìø7Z! ÕäóP7¯QˆîT{Ûƒ	',bªSŸ¦½\}O�Fºƒ¹ ^)ù.V€-
Œ"/5¦	 G�ì:òÌw§Àc n¡9
70Jå^² @ÌêlÞí,	'
]r¯ç²$¦N˜“ÑW{‰ä nkÇn �¬ ÿXq×7G ŽàBôFøÇž6A�Á £©%û¢°‹óù�”>¸ IavþˆÕíñöŠ	°	â	~‚•ÌktÂ:J±½i x „ ­  	ºƒè;A47‘		<	À	Ww“z¹¬Ý, 3 š²aÓQ	èŠð1…®È ¢ 9™á[÷óOø…Û	yâ«¿,2 _ j /ÌE0	¿à‚»ÄæE	x	¤	<59/Í%gÑÕÒý ¸ ‹¶ÀÇûŒ‘Í®#§
v—-DŒÍkïZ¾ l>Óz­T¹Rjë¢	­YËDD¸ãœE â xYMR46BŠ	À´ û%;&§ÎÓ	E	Ò«C�Àsd
 tçû	TV¶¼Ø  L ” Æ ñÈgDÎ	Ê
Ñ
×f0‡Ô ‡ ½ ä T²¾
Úe­ð}ÍÈ Ù ò )J}‡
=fšØ2Ê®È	Q C
F
¤
HO–9Â(  = I
e
×
â
î
ù
<}¿û:® t•ÇË9à \†¹u
Q
ª
XÂ¾™#Êç]a$ " 6 ‹ 7§R‹Wž	Rþ¼'~�±ÈXÎÝ>í`�¢ î€ÆÏù2ÌhÈÇõ^Oà;  { ° Z½EzêFo~£±ëI‚Z’8~Æ0™ÔùN ¬&&nÙÕÜÄ”c «fI-[h	“	®
eK“Ó>â« q’á�ÊÓ	<W¯b¢
"Y»EØdWLÅØWs t†½?`fl_:	ˆ	Ù	Šž3»8I­½Õ\Ûy ; ‰¥ÄWÌ	È
Õ
ì
d�|7÷.š9¬ R»!J†	@Hbx�Ž­ `…�“C™,™G«î$ Ö Gz0}øB–¹\ÒîÐñØ		)	X
[_£§-¸]‡È�Ug”›IÛ Œž	{œ;•s	=
q
 Ni‚±ÊyS¤>n Vdi½’q€ã»	w
Ž
œ
nr¶ºžB‚±•Õ Ñ¹î–Ž“ô#¢a	Üš´èM»îÛfð+ \ 5zÃ#–êÁ"�¢7 x¨G	J	˜	Å	J_*ønŠ°üLd3Rê7T� `NTóÞB†JÕÝe³ )=p›Pqò  �Õ

[
zûasÇÞüTku:Žr²ú ip¾Ñ	àS›û�á‹¦…QíJš -?ÛLÐ	¨	«	Ö	Ôuƒ39ÄÂç_•âù‚/e¹! ™ í °Ù=8ÂÓ?_üKq¼ûí	r‘¡éXpÄ­)jÐ W ^™òý'<BmÚš¤và
\vˆ“- ) S c q Í ö $ü06x£¶Üao(£©¯@	M	l	¤õØäíù"E'µà_Jkm! Ÿ õ¡ðLu©Yci\}E‡›ð)E‹?¨‡hçN»Ýõ Q §ÜêR\˜§'2Œ�	%8\�“ÊoÀ/�‘¯è $ÑÆ9vm¡Péÿ	Ð•ˆº{¶…Ë ×ß�”»¹Æ
Q]™¥17_kqÓ[¤«nHiÂEÃ 2žæè³Ý·ý	b /‡ÑQn–ë  òOËéÚÝ+	‚	6q!.#a©Rë±Ð¦¿ H`ßðõá	A}«ò�¼
�� ËD±Dw	;ç‰ï4V„­ü2 á =µ¿úSÒLQX¿³  “ ¼ Ø ñ (I|s	<e1­Í	d¬Uï  ! 5 ÆQŠV�	£
WÁ;ý°W=æ¾9 Y«ªé,E}°Ôg	dJ}’ÅÒ  ‘QÃV 	…	Ò	Ô
2;V_¡7H6’ºÚBöV˜Kx™ª×í8 /íU�¸ðó×(	`	r	p
v
�
ÛZm�¢µÉL�°“Úm 4h�!¡6~Ÿw§	Ä	Z
)I‰SpqŸù ( ,>¢µñ7Á>^Ú»ì	ô^”Wu¸l[# ÖôQŒ8 l X1|‹èÅ
†ï$(7§ª€�G®„DºÂ åÊ°¶CÜôv	5ap-"|†ª3U~P¬»	mÏ1 à ð ª´¾+;0RP‰UÌ	ÀPIc‘«T¾î< .Ž}žï¦Ö„	Ñ	o
Œ
Ó
Ú1l´ 6]Ù©Ö! ³*k/Wu	Ð	n
‹
4o…Ùî#06!Hk�³{í«­¨Á ÖéVjÎb


4
å
"3�Ž
ó©ª¶™¬ÖDEFGde N ×ê	W_�5
j
~
‡
Ì
æ
ñ
ü
#.á§ÊÔ÷ôÍ×¤ È äÏúcF
.
²
�;x·Ôš@Hf O � ³ „Àë
Xû�îÿ)L6
:
a
»
~¨ø1Kõ_Î  ~ œ •SµIr¦Bk
s
ˆ
Ú
8ËÕë æˆ¦³¥  o`ÅÊ‚?

Í
ç
ò
yÁ§  Ø¢ è	ý
$/¼âóÊØ2õ g – ÜÐdëGÁß~	s¸Õ[àX|gp ó°Í$i—¸ 	-	/
^§ì<yAå D É öÐû=²îL
³
ÞóO™s›w‰ÒŠ AåmT	
(
�°èh³î%„Ìä”IÄ 1 P ´ 5i…ÁlÖü‚ï*MÍ�	½	b
¡­ùYÒìö`` ‚ -Yì7
ä� àLrÏ8žÐ£ ‰ ìÖ¼
©Ø2  ë "ov¿È o
;
ùgp¯¸+ ³ØPHÓ 	 & ‘ � �¶Js§t
9CÐ4s7 B  ,Tž´æ	2
_
l
‰
,ìõ§´ÒÈBÂ - / é *áˆÈÛ
ÖçG„† –ãCð	Ì‰ùˆŸ¦æ‘ u ª ý ·akª2W’´åöŠ™@
U
Î
£±¶I‘    Vc€í�Ë&lzÂÊ ¿ ¤Æ÷	€
�
Ý
ó
üºÂ'ô•¡¨? p}‚ƒ”ž
è
ÐMØ+Œú¹ ]wfs‚	6	ã–ôh?D
—¡    Ý æ �ÙX‰î!òÊå‹	±	ã	é	y
¸
þ
0˜´½ƒöl„é,ìj Nb�(À
t¼Í×uÃK²Ë3 J£ÿÖ,š÷%Üèò;¾ÙöÏ±  I Ã 
žÝ„ƒ<HxÉ8’à
	=	xºz|¡½Y~ h ö5	Á	Xu{­ï4}ò y … ® R»˜éGe¬BÂt€«”O\á — ô Ñ�ì]¶Þ-¹Ö°hq ð
±›%¹‰‹í¯j—Éæ ôÎ³hNA¤°¶¿ÔþR	Ê	h
|
…
_é¨êñ†B @ Û +Ltœê˜	Ž	õ	0
Î=2äž
 ?Ejb.	
ozh„ Ê ÑøFåA™
ãPœ¬štòŠ¨‹	 ü>³"	X	i¨Þ E £ Ñ :Bâ˜ôPÚù†ï
M
œŠœÊ3 š÷\:©@´	Ü	´
zßôSÀð€xÓ- ` BW‰[4lÌäõ˜n¥	=‘6&hÒÿ‹ MÝ#=†ÅÍ  fÓ»âÀáÿ•¼ç%	%	U	ò	±il&…Í03ÖÓJSt¡Çþ 0
tÅ[	

)
:Ü#åè€“, k ²ÍF|æ1ƒ³¿áFd0	c	y	·éq´ïÎ@c•û05þ! µ 6†Â Km†�’¬ÃÎýYƒ¶ð+N¯žÈÊå¸aÄÄ  2 ¹ ŒÈü)Ó54~9ªš	¾	[w.E�h®ÎZxð5T*ua¿ j7Å×$0h‘	c
¨
í[$ Q Z Ô ExÏ·Á”Œ›­Î¢L˜lp®úÓ÷ ;WìŒ†‘ ZqçC{®Ÿ^	p	JåGZ‘¸äô��¤6 ?ÔøU‡íSkzì&
,
8
®¥IMžNvE¹V mì$ó¡ÿþsE9“ÆF· ^ w ƒ ¬ ÿ .˜¹/çß�ºÃ£	áÌf«ÐŸÑ1 ú¦
ª,35C‹ŒD½ ã ×Ç	ú	½
Ð
SÙµ× Š ÊB
E
H
P
á
ø
NQ½
œÁÍ`ú¡ í%eHmyZ­
7/=˜Ógôª
 pÉ¤a€¬„+« |c’Ï	<
W
›
hq°¹,x³R=eÔ ½ÀÔF	I	—		
úúŽ²àÝKtQ69ñIŽ™! Ì ì #¯5w˜ü&<`'p¢¨L	ÓDÁæ&´Ùáèod
 ž uïKt¨DD>pgµÁ Üèà	ü	:ÿŽ   
   ’ X<¢
|ÄÑW²½8 ' �P· u
U5t·Ù
 -ÉŸµÄ
Ò
CÕ M Ç ãUÍEÏ	
3
m
Š
Ë
ä
ð
û
-nØàíÉö¨µÓ˜«   € ”RÉþ(ç	`
Ù
»}¦É1ô C • òhK
gíÝòrßˆÃ 0 ˆ ê !4Õ×f®*ß�¢_ . )+â³Ç^
+…‡  ¾ ü Ub�‘õ‰˜T
Ü
k¹Á&L×µHÉ å É¿
—Ûgñè+~ Î°  H Â ó Q‚«wÈªy} ? Ú *K~>g›D@¯µÉ	g
ˆÍãƒ– A—¨äÙ
R‰§ eVˆ3Ëà$	Z	ñ	"?ŠúRs çý"<’Ì Ó DwÎ«3X“µ‹šZÇgÉ·:VÃ)t v « þ —¸.æ÷I¤ª’Å5 Élù	A
D
G
O
¥
¬
Ï
à
÷
P¼.—fÌ_C b_
V
w²ƒßàJ<c�˜
  W;îþ={Ã�À  “âÈÌ'
J
Ã
Ø
ã
ï
ú
m|—¥ªÞ   3�S
]
*À%)¯  > G Á d�
f
x~ü!;|Ë v–ÈÍ^ø	«
ß
ö
YÆ»fv-ËÄ^bBŒ— À :’áÇ

R

ý¿$(wŒ–¤©{9 uÌ]‡ˆº»v
‘
’
“
”
Þ
ô
õ
	ÃÄÅžÃÄ !"#cdeu+,þ$(¢£ÂÃè#$%&|}@Ayz‹– ¥ <¥äšMöR‰¼Üw�
•
ŸÅšÿõ% )é'~%¦ qØXŸ	é
 ›Ù,ž�Éö\Þ?êa& # ›SŒ×þ.ˆñ‚
–
ÑýÏž�Ì  ~ƒ8•¨û+Ÿ
Æ½( �§²µY!(¯£º! 7 Œ ¦ =¦åœ*N÷SŠ½Ýx„SÿNmû&$*î´ü‚§ ÇÙ7	¸	ä¡?ÚõUß@_Pá  e�õ;3Ytƒ	Í€‘-EiÊ÷ö< ï· 	—iÆÉq!ÈëbL ^rxgÐú	ê
œ@�Ÿ€Ž˜¢]Së' F^œ<ïTØê	ÿ
™“9Çm…-yú‘O&  | ± Þ ‚¾ÚŠ®"Gp¤ìJÿ/‰æò¹
1ƒ¾Òþw¿„1¨kÍ/  $ ç [{ë²�Ëä	¶
âÕ÷êNÐ‚ŸÎ œYróŒ	²	z
ƒ
—
µ[šÚíœ 'c»o„Ý�Eýv¶Âò)4Õï/» O'ÓÚ–©ÅÞ	 
•Çž	³° Öü),Á
)d¨³Z"z¤ ­caÀ9¶	u½	¾ÎØÄLÌ 8 ùKkg�×\øi	Ýáö À?'€Ð § §¯æ¤øT¾…¯
Tf|Oóü?ïý >¬«+JO-›”	€Ðãn<%¿ ¬÷ƒ¨ �  ÂB.‹Þy
 
&LU”�Ôé‡ã+Úµ²  ŸÞ�Ù­		=¢y£Ä¼)FÙA`%QZ! YâiŸå°V#}�g?ÆâX J Ä r“…ËsÈÚ÷X%Aa{¾àXMÒ# !„=I^yšÊ9“á	8	>	¹	Ô	@ÂÛöc»Z1¢eÙt f<4agNZu	€	Â	?Î5YéFJ®¾®ðó m‹4¼9|—ä]Ë‚zˆ¸ u‡m‰	Ÿú�jÖŠø÷5= i ‚ö¾@å÷6`„Ò	;	P	Ú	8v’.¸ÔÜ~ Š$­X¦¸Í	D	¡	u¬jÊCrâc› † Sð™fæCÉ
ÖeP/»Ç < ß6¦Ö
í
˜}•8"Éì­ z ¯ ¼DêHÅÎÃ�“‘Ç]ø:M : s¼I‡	Ø	ë
cw�®aŽD˜×-r ‹Ah‘Ñí"p�·†A�”ºTšHï _MSyéÝAI^y…ßÆû(j„šOì±/ V b p ˜ õ û/]ÒnûKú	k	§	ª	t‚×ãìø;!� �™£ß.^ß¬	(iÏ! ¦ÐÛÅ—º&šŠ”P\‡˜¤Œ¹Én†£.æMhzÊÜçÿP 1G_�ñC²ïÙ*	`¨.Qî°û•œ × 'H{~ùdÓÑf	V:ü % =ð
œÀ]ÂUÙòº		'	ë	Y
 (Y€¡È^ˆ“‘AVU’Jkp˜l# ß ï ©�½‹Ÿ:
O|� 0BŠ¥ÕçóË	`¿O…©2T5©Ø;lÎ0 Õè²iat	i
}
†
±
!2„Ój²zÕ?C£  } › ² ƒ¿´úHq€¥ÄíAK>
r
º
êÿxÀò‡¥ f Ûõ¯Ï#<–±·ÀÿS	}	~ƒËëãZvo ,hu¾Õë	Ì�	¼	ão·Ÿø²ÑëOÏŸÒ % , A � è �‡å	ï	1
Ï3Ñrƒå  t © ¶ j|ì1VŽ³ä“ö	�
�
Ï*
  Ü M\€We+Ž'r�™ä	5	x
·
³s»çÖõ>Cƒ	–ë �—F�õ\µtNî{¼¯ñ ï	sMé£¾ý�	ô	
{
„
négi� Ð 9?E@!	W	³	˜
h§Ý››ïñÉ% ±ÒºZ{ákãôþs”—²¾$c/	b	
¶kpÛ2þbÿ/4LÆÜ…+! Y 6Ä(JÒ4…Â}/8¬g�©™	Käo­wÃ4Së‹…�" ] ëpæB#žÞ€†Ây]	o	%
+
òFþH�ýMe·uóUŒ0¶ $dùGÆ	+<‹Ò›ó©Öù¼ Ë {®4—¼£‘¡H	K	–	š
`ùQ±å%Üçn*58ð	ª
 OÛß	¡
Cof´± QýºßìÈÜñqó û a(€Ôô—Æj–¸KÖÞf´*Ÿ
œ¡^ @PU§ªvÇß?´#	Y	©‡!>Qrâ‚• Ò C-
N
È‚ÞeßU©;s4 F 2\
Â
){Ý  ¤ ;ã‘™LõQÛ
�bt*ýv'‹Á"{xŠ•¥ ›ÿ)×Öúý*-‡ðülœ¦´[#��®Ë³û dô:¶	·	>�TŒÅpRêK ›];q­µ
áv¾Ù§Mx�Í.› `bº¿Òµ	Ý	DüÁñyÔî. ®øjªÁA

{Tœàõ
¿Ïâ†> X hžØrö]™¬	Á$@Ã`(0Œf$>Ñ läMÑ	O	>ù47è–·ã‰Ó�‡· CÞ#5Íå¥C	’ÕBºÆ. 9 U a o úLŠ.@\èmÜHoùj	¦	©	×	sv„ÞÖâë÷:Åú'iƒ —NÞÎ" &¥ÏÚÄ	c¿Á&	e	U'OX†— ûP’¢@åLTÿoþk e š î ¨Ôç±¼ù9Ã@`|	°
}4×â:YÔu¢" + s � ¨ gµÿ~0U�Ôã† *&4	î	²Îæô)Ðê	qÑ& Ï °8z>DàâýLr–±½è½ü 	V	ó	
g¦jms1ýaþ.3ðKÅÈ®*# X ­3I3|.…«Áfœ\	n	•	$
*
ñ;GÑä$Ûæmø„©µ ú ?¦PuÆ¹ë·Ûðneá�”] 1šþ(,K(�Ý›¥&ÀÜ!­w‰” _¬¹óµ

=Co=wé- T n Ýç"q¤ãGB	N	ørÕê#¶Aˆ– ¶0 * d r Ž Î %´þÎ7y}ÃC/bŒß)°3	d	{	
¥NW–Ÿåú(Ïá`äý-29Kn ù 2H¥¸2{„ª´Àem	#
'¸ê¶ðÚïFdlÛ´* l m ÷ ø ³ý1G¤· !pzâ1	2	A	z	!
"
ö÷µMV•žÙîü,1678ÿ³  ,r  qGACNNNNNNGTC,CCAGGCCTGG,GATCCGGATC,CCWGGTACCWGG,CCANNNNNTGG,CCAGGNNNTGG,CCANNNCCTGG,CCAGGNCCTGG,GCACNNNAACGTTNNNGTGC,CACNNNGTG,CCNNNNNNNGG,AACNAACRYGTGCGTGC,GCACGCACRYGTTNGTT,GCACNAACRYGTTNGTGC,AACGCACRYGTGCGTT,GACNNNNNGTC,GAANNNNNNNTTGG,CCAANNNNNNNTTC,CACNNNNGTG,AACACNNNNGTGC,GCACNNNNGTGTT,GCANNNNNNTGC,GAACNNNNNNTCC,GGANNNNNNGTTC,CAGNNNCTG,CCAGGNNCTG,CAGNNCCTGG,CCWGGGCCC,GGGCCCWGG,CCWGGGCCCWGG,AACNNNNNNGTGCACNNNNNNGTT,GACNNNGTC,GAANNNNTTC,CCWGGTACC,GGTACCWGG,CCWGGWCCWGG,ACNNNNGTAYC,GRTACNNNNGT,CCWGGYRCCWGG,GAAGNNNNNNTAC,GTANNNNNNCTTC,AACGGCNNNGTGC,GCACNNNGCCGTT,GCACGGCNNNGTT,AACNNNGCCGTGC,CGANNNNNNTGC,GCANNNNNNTCG,CGATCNNNNTGC,GCANNNNGATCG,TGANNNNNNTCA,TGATCNNNNTCA,TGANNNNGATCA,TGATCNNGATCA,AACCTGCNNGTGC,GCACNNGCAGGTT,GCACCTGCNNGTT,AACNNGCAGGTGC,GCCNNNNNGGC,AACNNNNNNGTGCMC,GKGCACNNNNNNGTT,CCWGGNCCWGG,AACTGGGNNGTGC,GCACNNCCCAGTT,GCACTGGGNNGTT,AACNNCCCAGTGC,GACNNNNGTC,GAGNNNNNCTC,CCWGGTCTC,GAGACCWGG,GATNNNNATC,GATCNNNATC,GATNNNGATC,GATCNNGATC,CCWGGCGCCWGG,ACNNNNNCTCC,GGAGNNNNNGT,AACNNNNNNGTGCAG,CTGCACNNNNNNGTT,GATCATGATC,CCWGGNNCCWGG,AACTGGNNNGTGC,GCACNNNCCAGTT,GCACTGGNNNGTT,AACNNNCCAGTGC,AACNAACCGGTGCGTGC,GCACGCACCGGTTNGTT,GCACNAACCGGTTNGTGC,AACGCACCGGTGCGTT,GCANNNNNTGC,GCACNNNNNNGTTCGAACNNNNNNGTGC,CCTNNNNNAGG,GCNNNNNNNGC,CCANNNNNNTGG,CCAGGNNCCTGG,CCTGGCCAGG,CAANNNNNGTGG,CCACNNNNNTTG,TTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAA,GCACNNNNNNGTTTAAACNNNNNNGTGC,CCAGGNCCY,RGGNCCTGG,CCWGGGNCCTGG,CCAGGNCCCWGG,AAGNNNNNCTT,GAYNNNNNVTC,GABNNNNNRTC,GAYNNNNNRTC,GATCNNNNVTC,GABNNNNGATC,GAYNNNNGATC,GATCNNNNRTC,GATCNNNGATC,GTYAACNNNNNNGTGC,GCACNNNNNNGTTRAC,GCACNNNNNNGTTAACNNNNNNGTGC,GATCNGATC,TAACTATAACGGTCCTAAGGTAGCGA,TCGCTACCTTAGGACCGTTATAGTTA,CTCTCTTAAGGTAGC,GCTACCTTAAGAGAG,TAGGGATAACAGGGTAAT,ATTACCCTGTTATCCCTA,GTTAACNNNNNNGTGC,GCACNNNNNNGTTAAC,AACNAACGCGTGCGTGC,GCACGCACGCGTTNGTT,GCACNAACGCGTTNGTGC,AACGCACGCGTGCGTT,TCCAACNNNNNNGTGC,GCACNNNNNNGTTGGA,CAYNNNNRTG,AACAYNNNNGTGC,GCACNNNNRTGTT,GTTTAAACNNNNNNGTGC,GCACNNNNNNGTTTAAAC,CCWGGCGCC,GGCGCCWGG,CCWGGNNCC,GGNNCCWGG,GATCGCGATC,AACNAACATGTGCGTGC,GCACGCACATGTTNGTT,GCACNAACATGTTNGTGC,AACGCACATGTGCGTT,TGGCAAACAGCTATTATGGGTATTATGGGT,ACCCATAATACCCATAATAGCTGTTTGCCA,ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGG,CCATTTCATTACCTCTTTCTCCGCACCCGACATAGAT,AACNNGCACGTGCNNGTT,GAACNNNNNCTC,GAGNNNNNGTTC,CCAGGWCCY,RGGWCCTGG,CCWGGGWCCTGG,CCAGGWCCCWGG,CCAGGWCCTGG,TTATAACNNNNNNGTGC,GCACNNNNNNGTTATAA,GCACNNNNNNGTTATAACNNNNNNGTGC,GAACNNNNNNTAC,GTANNNNNNGTTC,GGCCNNNNNGGCC,AACNNACTAGTGC,GCACTAGTNNGTT,AACTAGTNNGTGC,GCACNNACTAGTT,AACNAACTAGTGCGTGC,GCACGCACTAGTTNGTT,GCACNAACTAGTTNGTGC,AACGCACTAGTGCGTT,AACNNNAACGTGCNNGTGC,GCACNNGCACGTTNNNGTT,GCACCCANNNGTT,AACNNNTGGGTGC,TTAACNNNNNNGTGC,GCACNNNNNNGTTAA,CACNNNNNNTCC,GGANNNNNNGTG,CACNNNNGATCC,GGATCNNNNGTG,GATCTAGATC,CCANNNNNNNNNTGG,CCAGGCCT,AGGCCTGG,CCTCGAGG,GATCCGGA,TCCGGATC,GGCGCGCC,GCGATCGC,CCWGGWCC,GGWCCWGG,GATCGATC,GATCATGA,TCATGATC,GCGGCCGC,CCTGGCCR,YGGCCAGG,CCWGGNCC,GGNCCWGG,GGCCGGCC,RTGCGCAY,GATCNNGA,TCNNGATC,CGCGCGCG,CCTGGCCA,TGGCCAGG,CGCCGGCG,GTTTAAAC,GATCGCGA,TCGCGATC,TTAATTAA,VCTCGAGB,CCTGCAGG,CRCCGGYG,CGTCGACG,ATTTAAAT,GCCCGGGC,GATCTAGA,TCTAGATC,CACCTGC,GCAGGTG,CCTNAGG,GATCGAT,ATCGATC,CCTCAGC,GCTGAGG,GCTNAGC,CCTNAGC,GCTNAGG,GCTCTTC,GAAGAGC,GGTNACC,CGGWCCG,ACCWGGT,RGGNCCY,CCTGGAG,CTCCAGG,GGTGATC,GATCACC,GATCNGA,TCNGATC,GGGWCCC,GAAGATC,GATCTTC,CCCWGGG,TCCNGGA,TCCWGGA,RGGWCCY,TTATAA,AGGCCT,GACGTC,GTMKAC,TCCGGA,TGCGCA,ACCTGC,GCAGGT,GGTACC,AGTACT,GGYRCC,CCGCTC,GAGCGG,AACGTT,YGGCCR,RAATTY,CTGAAG,CTTCAG,CACGTG,GRCGYC,AGCGCT,CTTAAG,ACRYGT,ACCGGT,ACTAGT,CACGTC,GACGTG,GWGCWC,GTGCAC,CYCGRG,GGGCCC,ATTAAT,CCTAGG,TTCGAA,GCTAGC,GKGCMC,TGGCCA,GGATCC,GRGCYC,ATCGAT,CACGAG,CTCGTG,GGCGCC,GAAGAC,GTCTTC,GCATGC,GTATCC,GGATAC,TGATCA,ACTGGG,CCCAGT,CTRYAG,RGCGCY,AGATCT,GGNNCC,CTGGAG,CTCCAG,CTTGAG,CTCAAG,CGATCG,GGTCTC,GAGACC,YACGTR,CCNNGG,GAATGC,GCATTC,WCCGGW,GCAATG,CATTGC,RCCGGY,GCGCGC,GAGGAG,CTCCTC,CGGCCG,CCCAGC,GCTGGG,GTGCAG,CTGCAC,CGRYCG,CGTACG,CGTCTC,GAGACG,CCATGG,TCGCGA,GDGCHC,TGTACA,TCATGA,ACATGT,GTATAC,CCWWGG,CTCTTC,GAAGAG,GCNNGC,CCRYGG,GTTAAC,RCATGY,TACGTA,RGATCY,GCGATG,CATCGC,GCAGTG,CACTGC,CCCGGG,CCGCGG,TTTAAA,GGCGGA,TCCGCC,GAGCTC,GATATC,CTGRAG,CTYCAG,CAGCAG,CTGCTG,GAATTC,ATGCAT,CATATG,GTYRAC,AAGCTT,GTNNAC,TCNNGA,CAATTG,ACGCGT,TCCRAC,GTYGGA,GCCGGC,CMGCKG,GCCGAG,CTCGGC,CTCGAG,CTGCAG,CAGCTG,GTCGAC,CTYRAG,AATATT,GATCGA,TCGATC,GACCGA,CACCCA,TCGGTC,TGGGTG,WGTACW,TARCCA,TGGYTA,TCTAGA,GGATC,GATCC,CCWGG,GTCTC,GAGAC,GCWGC,GGNCC,CCSGG,GGTGA,TCACC,GGWCC,GCAGC,GCTGC,CCATC,GATGG,ACGGC,GCCGT,GCNGC,CCNGG,GCATC,GATGC,ACTGG,CCAGT,GGATG,CATCC,CTCAG,CTGAG,GGGAC,GTCCC,ACNGT,CTNAG,CAGTG,CACTG,GACGC,GCGTC,CCCGC,GCGGG,GANTC,CGWCG,TCNGA,CCTTC,GAAGG,GTNAC,GAAGA,TCTTC,GAGTC,GACTC,GTSAC,GAWTC,GCSGC,CASTG,ATGAA,TTCAT,ACGGA,TCCGT,CGCG,CCGC,GCGG,GTAC,AGCT,GCGC,CTAG,GATC,GGCC,CCGG,CATG,RGCY,YATR,ACGT,TGCA,AATT,CCTC,GAGG,TTAA,ASST,TCGA                                                                                                                                                                                                                                                                                                                                                            )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          	                                                                                        	                                                                                                                                                                           &                                                                                                                                                    
            
                     	            
                  ,                                                       
                        	                     	                   .               
               p   E                     S                                                                                                                                                                       )                                                                                                                                                                                                                                                                                          	                                	                                                               &                                                    
    
       	    
      ,                   
        	       	       .     
     p E       S   hA  iW  iy  i¯  m™  qÏ  w#y52º§* ÏÚŒ¥H¦	>„'@`aä9:YºÑw‰)þ²c_§rh “gFS Í °9¿6¹â	�â	�ti±gS Í í q‰t°-6†Á»W“ ÌÕ3Nxzi±ä39e|‚Õà›g.j¼ƒè]ñÛ	ÌrñÛ	ÌêñÛ	ÌñÌÛ	Û	ñÌhFþ²cäÑO—á€rOå8¼t~Ó	«Ia‚ktiròÞ	àrÈÞ	w~�\	n	}O#…iñF^ºHäK¤'¤]
*kx ­  ºè€g�„#å¸†ÉÐ†¸:É%ÑBÞƒ:¹IÎÔ	Âp÷n�~
æ
ñ
†y�MÖ�x ­  ºèÝ,QÂ
EžõFgì_	�Kddd:Ú &neÉNÚ&§ æCdpýÔgn¡´ÚÏó‰Oîñ¶p¯Õ½n¶±ÚðÍìã%bd	ú{‡Ö•Q?Gª`Ð†¸ý* ÔÚ:5É%?	Ñæò±RšB’áY€(©™	S>4§.uÊQ—«ªNgÎHIÃ2p{ ªMeœN–4=nÃÐeäåKLþ9
’œ
Wg�õ?‹=Ðõ˜_/é[ªÔ	ÂWŸnÁÎ	‘u÷Ô	ÂMg Ðrgìn¡´ÚÏ&§ _	óæC�K‰OdÇ	âÎžg nÐeä}OS NŒ¹½Ž{œÌ		<J[n£¶´nI‹‘­±ÚÞ/êQg:j�g ÐI
t½n¶±žQH`ýÔõËÁI°¼lžÕ\e>–øÐ˜
á
–©à!ÄVùøi	áö g(†y©™	�MSÖ>�'	Y¡’H	–	5np¸Óè €I
ŽÆ >€=DjëI
ev­dcr'g�Ú9·ò 	Þ	âO„1mvÉ-‡¨íÎkÍ/µ>
|(à/è(ˆUJL3ç·	>d:{(ˆ€d:Â
§.4Ú
~€i<5Ñ{b	Ùßµ ÊØ (I|	<e×­Ç	gc
;ÚÞ	ýÔ¯	”ËÁI°hIþÕö:½X ¥ÏÚIÄ3|.«fœO†—¢åLþ„¬Êæˆƒz–\¢ ñ		G	J	X
_ø]‡°�U7IR ÚÛ®?	’	£$áIjØq¬	#Ã($kÒy¬QiêC·YóµÚ’	$á\ñ		X
]‡�UIz–¢ G	J	_ø°7*&4	²æôêk ¬Xƒ<HxÉ8’à
	=	º¡Ô¹z-?–\¢ Ûñ		G	J	¨	Ó	Ö	X
_uƒ9Äø]b‡°
ùY‚�Ud7IØsX ¥ÏÚIÄØ3q|.«fœ¬	O†—#Ã¢(åL$þ„Vdq€ãw
rºB‚•nÇn ÿ×GÑã¬Š&ce	UûÿjÆŽWp6+™ç];xpæBž]	o	F·óŒ  7ßñM©½*-K“ÓâI Ã 
B„øF4Ìä‘šz½¨~Å];pæBž]	o	F·xóŒùÑ E@˜
›ñÝ,Ä�÷9T n çGrÕê–�<¢»EØ™[¡©èD|¯Û	cy‹¿ù,¸‚ÅÎ@6;	v’¸ÇÜ]:F^kœoÝäEýU¶ú€á/šþ(›¥­ÕóP7{'¦�Fƒ¹= ” ñg¹¢	e
Zf™Ë}‡û:ä¯Û,}OºÖü),³Z"©èD|¯c™[Û	y¿,¹¢	Z™Ë¡‹ù¸-?Û¨	Ó	Ö	uƒ9Äb
ùY‚dØsùE@Ñ˜
›ñ ì7
L# ŒÏž|: s¼I‡	Ø	ë
cw�®aŽD˜×-r9 U a o úLŠ.@\èmÜHoùj	¦	©	×	sv„ÞÖâë÷:Åú'iƒ —NÞÎq’á�ÊÓ	<W¯b¢
"Y»EØdWLÅØWsÙ ò )J}‡
=fšØ2Ê®È	Q4h�!¡6~Ÿw§	Ä	Z
)I‰SpqŸùR»!J†	@Hbx�Ž­ `…�“C™,™G«îOÛß	¡
Cof´±IavþˆÕíñöŠ	°	â	~‚•ÌktÂ:J±½iR ØÛJ®Ï?	Õ	£28AlÃqøIjÃu‡’X hžØrö]™¬	Á$@Ã`(0Œf$>Ñ,hu¾Õë	Ì�	¼	ão·Ÿø²ÑëOÏŸÒ( R [ 4h�ÂØ",>o•¢µÛñÐ7Áò!>^œ¡6J~Ÿ®Úw§»Ï	?	Ä	Õ	ì	Z
£ô)Rš28AI`lrÃÔÜ÷dmq‰¯û^Š”¥ø<Sc2oéIPWjup�¸ÃSlqŸù[u‡’% , . 0 A ˆ � è ê !,4h)+u¾Õâ�Õ‡³ë	ÇÌ�	¼	å	ï	1
^
+×ãfo®·Ï*Ÿßø²Ñë3O�Ñrƒ…‡Ïå¢_ŸÒy … ® R»˜éGe¬BÂt€«”O\á|c’Ï	<
W
›
hq°¹,x³R=eÔ o`ÅÊ‚?

Í
ç
ò
yÁ§_¬¹óµ

=Co=wé-#Þé“[¦¸bhO[Ž	þ	Ï06[^j’ÒZ¿mô “âÈÌ'
J
Ã
Ø
ã
ï
ú
m|—¥ªÞy … ® 0R»$4h�ÑÆ9vm˜¡é
!Ge¡¬6Bt~ŸÅPw§Âé	[	Ä	ÿ	

)
Z
t€«Ð•)ˆIº:‰”Ü#OSå\{¶áp…èq€“ŸËù,e�õ;3Ytƒ	Í€‘-EiÊ÷ö<  ð   ,  Þ  Í        Í’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:–z´E½¾=Rõ à�Ð…ADtP4�¿×·O„ôQ7ðâàO?ã÷´óGþmóîâð`;v?iÃPÀC�¯ÿžû]þã»ôð?*Wó†Óìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÖ¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒskšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      M  º  º  é  Ì  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  N<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="æ­£å�‘çŽ¯åŒ–ä»‹å¯¼åº�åˆ—" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="661-672" color="#a6acb3" type="standard"/></Feature><Feature recentID="13" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4759-4806" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3235-3339" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2625-2746" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3549-3684" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3341-3698" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2753-3208" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5135-5723" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1783-1785" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1786-1788" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1789-2502" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3733-4527" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1006-1230" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1245-1768" color="#ffffff" type="standard"/></Feature><Feature recentID="0" name="FAM64A(human)-circRNA" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="673-968" color="#a6acb3" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ?<Notes>
<UUID>02537702-210a-4747-99aa-f42abd87fa35</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="16:0:0">2018.5.29</Created>
<LastModified UTC="0:43:3">2026.1.30</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
   «<StrandColors><TopStrand><ColorRange range="660..671" colors="black"/></TopStrand><BottomStrand><ColorRange range="660..671" colors="black"/></BottomStrand></StrandColors>  q   +  Û  Á        Á’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:E½¾=Rõ à�Ð…ADtP4�¿×·O„ôQ7ðâàO?ã÷´óGþmóîâð`;v?iÃPÀC�¯ÿžû]þã»ôð?*Wó†Óìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÖ¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒskšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      M  ®  ®  Ý  À  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  �<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4747-4794" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3223-3327" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2613-2734" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3537-3672" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3329-3686" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2741-3196" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5123-5711" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1771-1773" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1774-1776" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1777-2490" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="3" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3721-4515" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="994-1218" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1233-1756" color="#ffffff" type="standard"/></Feature><Feature recentID="0" name="FAM64A(human)-circRNA" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="661-956" color="#a6acb3" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  @<Notes>
<UUID>02537702-210a-4747-99aa-f42abd87fa35</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="16:0:0">2018.5.29</Created>
<LastModified UTC="0:42:52">2026.1.30</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
      *  £  ä        ä’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OZ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½šÍ®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      M  Ñ  Ñ     ã  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  è<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1012-1535" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="773-997" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3500-4294" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1550-1552" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1553-1555" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1556-2269" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4902-5490" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2520-2975" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3108-3465" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3316-3451" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2392-2513" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3002-3106" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4526-4573" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="732" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  @<Notes>
<UUID>e72dd4e9-52bd-4a1a-80ea-946c0e8778c2</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="16:0:0">2018.5.29</Created>
<LastModified UTC="0:38:20">2026.1.30</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  i=   )  £  ä        ä’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OZ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      M  Ñ  Ñ     ã  I      I®ZTR

SMP4      C™>c  xÁIÏ¯[zäß½Özúîß¾ÍÞûô§Ê…±]å²!åŠÁ16ÆŠˆâÈFHh‰X0L�˜ #&hIð%ø	e)RÁ!ö9uÎÙýÛüûæi×Z÷ÍuÑŸüSÀþ)DØDqžæE\E*Kã"�‹ä¦¼ÉoæŸ½X}ñåÝg_ÞÜ|ýõú7¾¾ùÉ¯ñ³—?ýÑ§¿þÕ¯ò[¿‰ßýÝŸÿÚücû{øCû‡øçÿìŸÿê¯ÿÙ÷ßü‹¿ùá›ñ/ÿæ_}óæÝû‡¿þæoÞýê‡ç×»íÓÓ¯v�‡ïÜùrl¯ç®k»ar“ÌB„?ÀöDXCGZkæQ�ZXÙ„½sl¥Á%!2Jyp‘Š „ "¥80ÊØx¥½Ò	kž™C`D™&5Šó	eˆˆ °0Cc Â.
Âæ!VQnœr¥ÎOQš@ÙB~Dd²Ds½ŠÈhÒJÙ{°ŸX#Í´¢I¦L«LàVÙß€xï”ŽSR¡ƒ6J«ÈFðâ(É–…êûëåz6y‘²ÿ˜G2¨(õSë{_˜ˆŒbû3AœêŒ©MÊ®{'F%^‘ý1„„0ÉdÒ²q2tç-¦(IA†ì‚ŸÇ¹�wÃJÈ�� ¡VË2y8/T”e¬XÛß†„GLiUÕ‘\vÛ³¨D™ ˆí¿!phÉgÕ*ËÞ�ŸwÐñbV$¸öW´qžA±ý	‰›ÂP¯:\Ÿ7\Di”€Øþ}AÂˆP•QýéÒ«,ÖŠíO  ùZ½¼�é¼}}ÌÊUª'û#ˆ}‹8Ÿ5ÞÛƒ4U©„ˆØ~!!ž<Ò¼1~lO�dQÅI“—Ôh­±ý5	‰¿bjî^Vá¼» jr#€ˆýC@az®_Véþø!p\¦  b›B âÉñTÝ¦íñ8®%”€x5)]H4ŽÞ‹ÒEUÖ˜Î—s¯SdEš·—ãn–�’ ˜ÀÃàÜúeÕ?¿ÿîCµ¾-C�Øbî�²nŽhO­²B³Û÷að‹Û2:=?�âf�Xû;k Š^~~{|üáõ¦¾›5	Cl
±~ì\òªÁîøp Y5W`á1DY]ê©mˆ’zF›óî¹)M«2+ºîªº$ÑŠ‚b¢Ð�W^¾ªðôþM‡õz‘y&²)„„Øµ”çM’vçý¡Ê3Œ�Ø
@îyþe‰§Í¯Øäw•	Øy$E{º´È£„	l_B¬�sÓ4ûd�vÿa¼d³ž±9DB7ŒÉË¯£ýáãÇ¨¬—‘‡�À3%i¡œï'·Í4žŽ›¸¬ bk@ž¯£¾‘¹ç§o¯‹å}B ±9D2].Óâ'ŸãòÍÿûÕ¢™980Èf`‘Ö�šû/^tß}PßG:8b!›C„ˆÿ”_Îðþý¿~ÆÝªŠØ	‚oS)3Ý»Ó¹<ÍšUÚW¨Y®l_@ HçÏqõ2¿<ïß0¢J# ¶€@H\èŠO>óíÛŽ‡rÙ˜Ñif²ÿ¢‚:]ÇÙK=ŒÏ»>7Q3›•ýy»§yUØ·×g‰ÊTé bÿCˆ0ô‡üöG_ {ÿÿ�øüe¡ØÙÐåË”U{9õºÒÆk°ýˆ(pçúøæ¥èíó\ÎÏDdÿˆ(„a˜Ôí§Ä¿zz$ÿb¦DdB8§MµÀn¸<¡/
M¶w ŽÏªjhÛ~Ÿ—©+°Øÿb¦0ÑìÅÜÇí)RóLl"
Ü�£Yß*|¿ÿá9JÊf]ç�§Ã¨³&Sl	ßQ’4EÛ·¦$ÓÊØþ�ž’ù¬Àõ¸ëâ*N'û?A
�ßÊÍ§	?|ø¦ïÒ´)K7ŒûÝ¤Ê2Ä·ƒª>íŸÛk¢êbVÁN[�¤¬ªaÜÛ�èl1+£Óîi¬r&±DÒõWuûUq>½}7âvÃ)†Ø!áëñ½ø»çïß?Åw«æ.ê§ÃfRTÖF¿Ù\-Ä~	:Žª¦VSwâ)O)v€Ø¯Á
âýˆòWÓæô!T³ZÀ€Ø?…@@~ê†èþÞìŸ_¿ÞßÞÝ•< 6…XƒpÎùÝ�êíæé#–M{"²¿1FP–¯ÊÍpÜøš"öK„0�~Ì_féóãîŒUYC;†Ø+DB?8³\™óéý™çE©= bˆqçÎÕí—·éëßž²ÛÛH»ÞEËudÂaÊ¼Œá±@èašYMr¸îsÉ£ªÆþÒîÛ”2­‚ÛŸAˆI¨—Qn^eÕfû¶Ï—·±´B ÙBLðW?¥ë{Ú¾ú>JïæÃØþ&åÇq×|ý£üúÍë×{¼¨o_Þ»öùÃ1zU-I˜|rÒMÍÝ�êýþ¡ÛÏ›*ö¤a2M5áÔ?GÞ­oV|=¾Û»U\GLãi¬_Í°y÷þCó"5>�Ù��³fUy·=mó$� XÄÞB H��Ìju¶û³)3‰ýˆhôÏCúõWÀ·¯ÿø|^&ž bÿ°‚p7xóâðÃÇýnæJb�¨€¶í›Ï>Ï¶×oÏhê4ÀKÛýýW�>ýðð•/
‚ö)adÆê~6ô»wçñv™�„£T³2åvw ä)b!qÆÕíí4mŸÝ0[%Ñ@ìÄx7Œùíræ7ï/OóõL!±k ï„«UÓ—ã.Ã<‰Y„Ä¦€8\¸‹ï’›ówž¦åjf„{!VÞ]CWÝÜÅØïß\Ê¬Ñ,ûw  æ^$^”æ¹ÝïÜX7é¢ë7›€¤,!ûO  Æ(£_ÝTãÇÃN˜–™5±Dd˜N®ù´Âùám+Íº¤ÀÄ�Ñ‹y@¿ßª2Ê"" nÀ”~²ŒNÛ§ñÐèbQÞÓnœTÕ"öK@^¦�7sûóá’"›­òl8ž»¨Ì*�@HäêÏüÉž><ì¤¹‰ƒ†Ø¿6cBnQÜW�÷ƒ/ª»Z®ÝŒU<ÓÆ› bS@¡¯O›í1•¤XD¦ïöG¢Üè‰ ÈÈ>i–ÓÙm·µª2	‰Í!¢Éw­þôób÷öÝÛ¸Éî>+ãÓåñ±�Lº¸+³ãîùIébxûoB@,½(×y´ßì}ÍR	‰ýBšdœŠår¹}:|8§q]zŽ½ˆ]AÆ)‰êjµ?_¶ýÀñj�uÇýî`fÙLÃ+°M!$$¾uc2»+†Ãîõ>^ÌK°(â0@eå¬ Ãå�:Žµ×`{E¡Ú°|µÄöáõ£ZÌ=	ˆí’	ç³e{86’¸f¾,ÍØí&©²Ô)xN]ùòSLÛw,n–YäX�íh
Õ�Âé°½^"Sj	‰ý;�8Õ‹€i»ó±N
ZHì_AHHx,—w|¾È¼¨bEl3HÂÎ¼~q‹n÷Ø9ÝT±&ÓÄqºìNíµ}EÅ:ÏÜu»Á˜Tõ*Ï7×ý¸&™­çNö‡7W•å$û„p¸™ÏôexÞy*×ÍBd¸žvi]VAñ8žûôågéxyÿª›»@ Ù?†€X÷zXÜ®¦ËñiTy
Bb—‚ð|nVÅÕ´ç«ÅËÜm{È£¢`€ˆí?†8ônLV«2½öç1]e†ÛbzîûâóÛç7§nz¹Z¶�•°ýM�}+¾œW	_Ï@XÄ»„€˜\ðç¸~‘^®Û7NåI{Ã $T­ÆÄ®Ï&Ÿ•Z1�¼ºÈXÝ.k}Þ=8•èEÓ:¶gšÕë‘Àös	É`F¥y÷›m;b¹œ'z¸´û(Dy¬‚�ð8†òåýêrù°9éò®2"žÄþB¢¼¾„/oîxzúèú¨l4œ"ˆ]BzViÕä¡¿\™&SÅöŸ@,£xµX¼L†Ëã‡(K !¶+A$ôà¢,‹q¼v�!ÃúŠøô âºÉÍDšEìÁÄÙìvÉ—ÝÇÍÁ'ÅM“ó°»ì€¢ Lb#Ä={*oÓ_ûMŸeËE|½ž»�S>¯?¶ýÃä}1»™—ç§ñ,ÕN;�ØÏ �’¼œáàÎç�çPöBàišB¾X®ºóîáEE™ãíŸ@aš\¨—³’»ÃáXR™ÅÞx[��—5óJ›ýå9ñQé ˆí„Àcp.¬noópx¼Ã¼Éˆ<‘ýBð®Cbê\x<m„T3_8:N;JU)±ý%Ê™A¤¬æÝiÜ»#¼I´q±c²k±ëÜ¤æu’Çã›“—U�4\º]§cš/–Ì]{Ùp(ŠÈ²Dà<‚Ä+µû�—k/š�CµÇK”d%ö¢‚qNë¢Éiw~<žò¢i\ä.ûíÁ$EªJØ~aßÊHÅº€	û§}ÈÒZ²¿ÁÄaÊf³$Û\ŸŸ:Wó<ŸäâNG¯ª›y}8·[Ï^‘ØÏ!Ö€[nyvßhÙoÞí®«¨6ÖbÿÂ“plÊ(÷mß]ƒpJyÇŽ£¼œEOÝó½ÉÓX„tˆÉ~
Q!†ïItZ¬Qž÷×±‘™ÉX3!˜àA‚ 2btiºnêK÷üÑéy²¨¼Ú´—Ó!F‘šˆ‰ìb�g„4ªËãù²5œÕI\8w½˜:©’ˆ†~ì�(¦HH3È¦ß#LÕr9ÛÓ£"OH„ì
!xÏ*‹Ö·‰´û�3¦Ê"Q¤dW~JÌ,Š0¶Ã)
MÕ\Ë¾/-Åy¤IOÞIZ®šôpÜ½GJM©„!a„Oã¢öª;o‚‰ŠTƒˆØ~…àmÒ¢4š»öÒ¶q^Ô>öÃ8x'œJ,Šì—
	ûÁ„,.òòy¸v—Tåó$•©ŽN+£#&Ò²KûÑ)]Wõ€}¿ëÏF5Ó·CÛoFQùŒÒ]ßžÚž³8BÙO! (ø+s^MtîwÛ£SUNŠìB~:Mª~:îúÞ”M–„¾ÑTåyAâúaìCZÌ(}N§áŒ8UQˆØÞ"¸Vq–W3ŒçÃö"y=«n�ñ|jûHÇÚˆBð­AQÅÐ·×ÃàLœ(²o!"�0ù QY›ÁŸïâùrÌÆ±ÝŸ/©äežn§Ö·=m”ñ¢ˆ”²/!ï'�Be^õ\!eXÂÈÆ$yËÐºkÒ(�%ÊþÂ~òJë¢H•»´ÇV›BD²KˆOð	§uI{º	q”�Ä¾€ƒœé%y™¤a:ôG/Ub”íAö ™X©(›eÅsw<áªâL�Œý/ QBAQY.ÊAN›í©òM‰�@Ù?„ˆ Q*‰r&ç;�‡H‘‚’€IEå*RC\/&�ã‘§ÑQ”©X4D$A%f‘gèÏç€1ŠS¥ƒ@šÄþ,ÄÂA‹*MÚã~ï4²" 
Š`0ƒFçY¦¦éÚõ!N­@ û A„Ä©ÉÄydÂtZ§&†æ (Eöï�Á,!ŒÚGIšÃÙùŒb-`ˆ‚"û€DHDìï@XÀ*H.©fuqèŸúN×e’xí"V¤Â¥(0ªÈÓÀ�›&«Ø	‘}		�0y�èªÆy¼öŒPi‹¬“dÖ®Û?¦èf¶Ìwýñxñ!R…hCi²1DB˜ $®âÄ»k¸ Q¤5	Á“VusÓäîpi©æ<×­�ÖJ|$ÁŠT‘d�nl;$:#`Èþ9Äˆ øQOIRÆÌ£›&]è(bò1ˆ‰0&r‘’©ë0e‰‰5“±²¿b%Á�@^U�c·Ïú$Ž�'F)# H~TCå™¡¯NÅu”Å½?÷ç %QÄ`Ù¯Áf"ñWÅY±Xæúz|wŠB�çaì|ð‰Î|ÄÄ÷0Q1¯»ÝÓUÊf©U?L]”›D)²ÿD H˜(¢,2*8Ž…´!%Êþ„%8$NL?ºÑ§0Ú0ÙŸ@B²Ç±Bh‰E#Ö¢ÈÞ‚ÅCG*%ç�‚R²ÿ-„À~âXç±‚»rÇªÌ2%ãµo§4�%ö¶†¼ëMU‰„a”‹:ÑÐd¿„ˆ÷ÑTdËtžú–Ê&KÜÐâ8Ò¬! XUYmüx¹´.7Q±½ƒx"é"îÆ�§,‰`È„‘QdU�CŠ¤Ì4 Øq’(¯rÇíyòMÑÌ4º~ç¸J#6Dl_@Æ â¢ÊÂÐ�/L(!ˆj
ùM’N‡ëCœTY"¢ˆíWûž¢¼,gnØ4ÒBâ	€�ø+Æl¶¬Ñm6˜åiæ�0‰½‡8ôBU]“´ç-»(Ê
‚ïe*ªZÚétÚ«Ú33¸ñx±)¥=‰ýmH»©lfÚÝó%Jã„˜Äˆ¦4mš—íIŠ(5$Dlï!$ÄC 4_.í.$Q­uP „ÄM¤«U�^/‡G�y®	Bb+	É(bâeIc{¥ub{I'Æò¾æýóó“Yå¥	¬À¶€��LÌi=+ÎÓõ|2I–)Ö`ûc€p•,oÅµ�ª¨4óyHOûs›š²
"–ž(«çÎûÓ¡ˆ³Ø+%lï Ö g`µX´oŽ�Pz¦£ …ÄÞBHH&Gq=k.¸†DW‘	Z ñ =-ï<>>í]³JU Dì�! Æ4i³¼)é°Ýwe<3q ˆÍ!ÖÀ—7…�ÏÏq™z"ˆØŸBˆ•wm‹U˜vÏ-Í‘%õ¢iÇóÁ›(I@AÄþ’à¥Uì§ýÆ˜<Mœ"öÿ„€Î‘Y,^„i÷|ÈÓ8aDì�  Æ¦j�éi»h‹"¶ + ´®/>‹/ßNÑl™*/±% 0õ½[Ýéöíùy’Ù< 6‡ ÆQx¾*Ñ>Žœ–Ú‚Øÿ"šýàÇr¹Îüéð�ÑT@Äþ"Šœ}ºžÃåý³Y%XAÄþ7`	ÝÀåÍ�„íö£ª›Õ½2¯ŸßDÅm•†@€Ø <.�¾t‡Ã“I—ë{:>¿ïºYœ.¾D×>~<øÅ<&ˆØÿ Q�{Ï¯nbÿæñ2YDËõ]ÜmŸ/í,1ÙmÄøöãæU•8ˆúÉÏ–wÀù]‹rÖè‰ bç©î3r›óÉu0 6‡ �ÁyZ/—ãeó ) ³Oçøpúøƒ,Ö30üyºä/?MºÇo÷;õÉÂHO±9D…žC2_6ýñé¬fy¥bVï|ŸÝ2íöÚÆçÉý�9mÞý æ÷7p±9D”`j/®ú²ˆº÷ßû—ëy€…ì/!Ö`£,WU'û¥ËåZ_Þ�ÃË¥!†Ø¬ Þ…©\­Óö°ãXiäó—éØ~øþc¼X¦ð`ˆÍ ’q¼¨Õ'µß<ý0Œw÷±
Âû� $!a›BDÁ¹Ñ%/nüi·½0BVÜ¼�éÛ·û]Y¤åý+lŸß>\ò,š¯_ªÓoÎ]ñrs 0ˆÂåÔãËÏ›aûæû�^ÆÍâ¾V›§-ÖªX-h|~Þ=Ts*×«šÝÃ.‹‹û›¬{~ÿƒÃ¬Êœö,do! …a‚ž5A®Û‡S>©ìþ.vÇï\RÌ#Å›ƒ•(º/?_to¾	tÏ«Êœxÿî\•&O@ö@aå:EØ?r6"�Ý$—×ÛÇn4*]×§�GÄe,�(€ìEÞO]±¸7ûëãÃÅ”q}kþîiãB>S �Ç8†Õš§~»h6�uÐ`V�1œ®‹O¾äÓ¿|ýfZÏŠbÞèðîáôTR”.kžß‹¤ˆ”g â&‰šåÚŒçý)3óX	AÄÞ�àùêÌí+�ÓÇÝ¦J«lþêV·›÷!4·À€Ø„Ð‡¯_ÜOû‡_=a©uhÔöøVI2Sq ˆý×€Â4��sÝyw�ë<AÄæñÐvôÉË—�ï¶®œÅ`‚Q£‹¡Óf�D*Äþb¼ï8~qÃÃö°Á:oà™XÈþ÷Qà.\ÕÍ}´{ýôîˆlñÄBv…0ö-­>‰pü¸{òi�±xb�ý…ió»å¬ßÜŒ‹EmFíYÈþS ï ëå\üét€‰�a‚Ø¯  ¤ƒ”óYå¯Ï»0O3£"6‡ Æiªê™	ýv3ÅIÅJ b?@ âÑMÉ²a¿‘2ÏR†™ìoB òè†¢^E|~~‚�j!�ˆ½… 4©!Í–I3œ»ýE1‰Ûˆ1R j� ‡ÝYeIæAû€|`¡Ù¢î.ÏU�•‰ÓAÄþ>@èœ¯g‹ÔNÏ9æ“‡�ÀM—.UÑõÃûÍšY‚@€Ø_@ ×_Ûô“Wjú›‡óY&ÍLö¿„��ø«¨ìvYñ~wÖ³9Ìˆý)B˜†Kˆ>»Ã´y8áÅ²6pš™ìŸAHˆÝ©—«•7Oã¸^TP»† ÄÓÔ¹ô“»ìrÙ¾Cs;[¦«öq·ýày�‰žlÿâÐ
Õ«&×‡ÍO%Ï×ëâzxþÕˆE¶¼[UÃéýMÞF±ŸC@\?…õMãN»§-°H¢A+aûÇ€8tÓ­î5ŸžÞ�u4‚†ˆý+ˆ5àÓù4ÿä¦ÄÓ»wÇô¦*³Q{›B â>ªî
wÜ<H«„‚†ˆýG�„ÞXÞ|†ëãÇ�7«ÛÙüÒmŽ§£«f÷s¨Ëîû¡ž/*rû'K'7¹îŸ&ÄEõÉ‹|ì>~ßâåªÖJØþ:„„Ä·¾ÕËEì6»Ç1,ê b8ƒ©ogúýîéç«$I	Ûß‚€˜œÇbùÊàÝãû©ªnã@ÄöÏ ñ¸z}·š�nsx<Ï“JÃ+°]CHˆ{	·/îi»yâlžÝøÝqû¡�gµñJ„í_Bì[™/ô!Ú>ïœÃí‹:u×í÷—}5{u›x÷øæ�Ü­q$$ö3ˆ¥g`v‹p9�™7¥r¤„íAHHF?õå‹þû�o6óU‘ $ö‡��CÏ«Orõ¼ß¢.f¤<	‰ýï „Îíhn_šôùáõ‡!yµºYóðþ²=ŽAr_¦÷t:¹E“jÇDlÿBà0L]TÔçVSGlaÇ)_/’ÃÇ>º­í•Û„À¡÷æËÊ§Ó!ÒI¥…AlÿBžFöÅê&Þ¼=Õ:SLDlÿ
BÝ¹ÏoRGÏß¶>ª+±ýKDFL}:¿+ÒÍöñ€òvþò¾JºÃiÛS^Vb3‰Áåå¢D|Ø]\’U«dží÷Ûª¢ÈÈþ¯
&•Ý¬šáéòº�“y–z(�“’f¶J�¿<}nf7e�íæÉq“)yìoADœ“©*s÷§@uÆŠ‚½…@|ï/˜¯¾d¼yz¸Œe±¸YjœŽÏ×.¿]Þçùõôñâ*3/H€à[Rù¬6Çqß?õlSØuh¢$‘bû#´aÌšÛPŒ‡óóÐ¤IÆDb‰¿JÐ³»Y8öï‘-êÔLÚÛ¿QÁ¸É![WÆýfr¡Éã@Êþ„òC³œÕS·ÛL“I"±ý)$ŒnÊ²Õ,™Î‡'@šLëI‘Í `vqÔ4Óq<�qªÒ`²_CØw‚<i
Út§ÝÉÔXÎu§NÇÀ®(aRl		¾×:Ëêr�ûã>¦¹‰e¿ CœS¨šEH¯‡ãã”ÆUÎfÒb×!Gã¤òjÿpÝœŽ®š­š.9Ûã4êÙúE1¾oÎOqœD¢!ö+ß“N³ºâhÚï$¦Y¢“ý¿ Â,zÍeYGtçË6ã¸^¢ïÎ§Mlâ,×Ê+²7bæAiUúÃå«,5Dâ}iU–Y1í9öU‹a&°­  „8Z™´¬æz¸¶Oì£ù†ó¹wq–d
D DÈÞ@H ×‚Š²žk>Ÿw¡D•i(ƒÖ³¦Î¶§�ËË4æØ‘Í –)ˆ‹›Y?ž®QÐº`eÿˆ„‰Yi“íøÚŸOÞ¨\�ÙfÇPI•û~4-š²V|¾>%>Ò±Ö^ÙÏ ~YS²»ÃT›L!bû
BB`	<’h,gùE®ýä‘DZ”°Œ†tV&™Ÿö»©Kòz•W8Ÿ½.Ò,õ$âCì‹¤N3.Û=FÕÍõ2nü¨òºH!]>ª–•§ËõtòƒÎ“L
&û;p¡T\f)íù`¨H
£”w#;eY"4�Ãt1y‘&äÜx�âTëØ'“ý‡`0û1Pœ6ÕbÞwçÇ.5ëYÓáÒu�ã<V”ýcXÄ�@””‰á¡í;–Ôd¬	˜àT<›eÉ®;�q
“j€(L,º.Šú(íõŠÑ:†be—a´ReÙ”×ã©ÝI¬ÓÜˆ&"�ý„Cè5Åuœ?^†~*U¦d¿„ ˆ©žU£/ûCš¤Q¢¤l
F¯z­T�•…kû“šr•‘Û$@|`âr6ôåòtQ%±E
DÖ€EXœH¦ê"Õãx=^¦*JH‰‚ˆý? ,�B4¦y=¸á†‚%šÀa0”æ³(›®îŒ	qŠ8hÙ,Â M^$zœú�I±Èçä¯®!CÄZ,$€Ø‡.Ò<Íãõä•&&b%qÂ’ªyuw�k{èG©óñ(" »‚€¡„à¼“1‰«æzé÷u]Þx7Úvòq”ˆR
`�i<¼P7³Œ®×íÖIJ‰5vMu”`ð×nð…N$†Ù�ÄOAë<™'7nèCÜ§*G¢@JXHH$.DQR§	u×þ¨BjRe‚a‘Í Ö@|'¢M“ýÐ_ƒò™Ž#ÑBD±�™Ä�›"+"žöÛó€¦ªOáz½Ž�"Š…4�Ã`´iîÏWt:žgó0^ü	œ™”���Ø,ÂF¥T^hæ¡ï=ÊBÂJH&(ŸF¥Æxm»‰M¤�(!€ìC Pq–ÝÔ‘ªLlX“ðIM‘eÇËÁuq]”Ñ4œû~Œ%Ž4H1@¶„€E',YV/iêŽ»É¹:5*D,ì6I^&ñ8/—,™Í�g×¶*‹�Qá‘€´LSí†îØfº,ËX¹ýidŠS­�@dÿDXÄìGYªœºj¯)1‰(%"ûˆ€”
ºOØ¤QD¡‡�¯1�ìï‚‚"T‡4Îàü¹?±N£ˆˆ Ddÿ0‚TÄÄ| V¬´VJÂD.õ&Î5y7œÚ�™<RädP^GqbÅ˜+5%&�c/½š "­•6¢ì�!œf§ˆ‚÷¤"VÆ(²"!xŠŒ!öA“‚ï]j"LäS-P6…ûIÈ$yª¸?O×Ž³¤ÈRã§î8ùL¥JÙO!>8MI¬tptÆZ)E`8ÓeŠ8Å8v×‰L¢E)û	D	²¸4ÊO­;si£ØÞƒƒS.5Y¤'ç00Úûk?eeb†ñzì|žh(!¶wönB§i`ç†.Ó1™  @pWeê²¸&ýá¼(ÒLö·\«£¼*j¯Ã9¡¤ª,Õá<^Nœ%PÄöça¢8ÊbÅaœ¢H"ŠÀöw!ñÊ’Â«qÀ€$ŠHCa"—'eBnè‡N'qÌZ±ý1„&Q:Íbò=_©Œ#!¶¿!°£QÇIÆÞMÊE”(„ Â=(/f©ûö<D:VJˆí=„À¾‡©æÍçÃ‘)J"ÅDlK	É@N–+5ùÝñ¡[d�öZ„m!0ë:+¼?^†e"¶5„ÀaäX—¹çéÒM!‹5±- $ÄS×úùýÂ‡ÇÓ‡v®nVž6G�•ö¤„í×€x'·óÌÐùàÂ2Ê…IHì-„„zŸ¤·©à|êdQÆšIHìÏ! 	£‡ÎµÎû±Ê“4ˆb(	Î•Ío©=·'e¢L±  0´�«_-ºÃó‡‡þE³ˆCDìŸCHˆÝUÇY“vCÛŸE)	ÛŸA@7}µ¼ïÝîpìã¸6Ž bkˆ}\1_þxþ˜9#>«nkÝ?¢Ñí�0„Àþ*HÖ³ù¡Û<i O`ûAH(p ¢jºç~Æh²Ä%lZß'Ë»Ê�>^d^ÌH1DìÏ!$tQ¥é0ûA%9ˆíß‡�¨@®/Ò8õ~ðý0
ª»™ì¶›Ý1�–PŽHØ– û´®k™Ž;Yê‚E ¶„ˆ�]‡ù§5¿yxs­nVµq[@@Œ�¸*ëªNÇk(²¬Àök		Ègy†ýÉè"3A ¢�úi~+Ùùð1$Í* ñèz,o)ûÃ9%-TºÆããÇÇðr¶Š�'@ìW`ák?%7_TøöÃ[_«ÈGó»UÛ}|û¨“X¥Í�
íÓãShå{�iýâÕ:Ú=o6ÅÍ²`Dì„¼s!}U'§ÍódnêB;Ä– Ü9'Ë›å&<¼?¡(“)�ýbúÐbõ*KÛçïvi5ËØƒ!ök	±»F¦Ì
ïŽ—‘šŠÀö"ŒþVw·ñÓ»7­ªîR€!B‚Þ]õÍ«¼}ýôÃûæåMJ^bÿBB2qÍ:2ÇÓé¹ŒÊ*AÄQíÐEŸ®ÖaûîIµJ0)†Ø5 /ý�77Åx}zì—³Zyûû@ÈOÝ˜¿¸×ÜÑ¼šEƒb�Í BÀ8\õâëŽßüõwøl5?b˜È® �öÐ?~Ñà›þÖã×Ë“0CìV¹öS¼ºÇu÷ðú¨‹8€)d.´áŠõzæ¿y8£¤1A¼žÙ?‡ˆ¢	½ÏV·àíæ¬³²‚v€Øß‚ˆOÝ9®¾øÊ]þÕ÷É_VÆçqŠ¡o}˜Å‘Ø@»dò‰jŠÌÇ3Ò—·tyxú.F:a°(á~ºêù�>]Ï4›—$Û¿„�€<w£úä>3?ì_û2]Æ¬œb&ûC ÊS×Òêêº}ê¢Öì!�a,ë
ç§g$Ž0¿ÿ§ã›w>Z4"ŽXÈþ&˜”øîz‰o~=jõæ½Z,šx€ƒì€ÂètÜ”¥ëvgpU*0Ä~±~l¯ÕËO’éo>œâû¦1`!{V¢œ¸1]¿�ÝùÃ›Ó¬™	3L^ÒÙ"†œ>^Ò,7ÆÄækà¦Nšûy;=NB¿|Qn~õöéËY"Âp9{?�õË»r¿x·›eó8Äþ�kà§qŠ_.—o¸ú)Ëâù‹L>¾{>EÆÔóÚøãöAjIÍúÓuÏï�¾IËÙÍÍéqópjkÔõ]6ì·Ï­oríùLàF‡æ6ê§ÍÇkäÑ¼Î4ŸqWif†v:LI2+9évgp•x<)?v×øæ³f||ÿp-nS4M:�¶W‰c�åed.íE;_PÖä³±oÏ‘ÊSR›A âÉ±_.]7O‡¡±øt±pïÞ?»Oæ·{I‘]BD�§ëÞå?úÓ»ïŸ9[-‚Š!vô”Œ>+ò„†öt5,Õ�N®—Í‡s©ÓTçY.íyè;¥£¬ÎÊ®mOW­%‹«Ýyc¤É4G"A�'/hæw:wý4:ZÞ}ZŽß=½“y½4Á�È.! …¡ïýê“—Ü=6‹43eYèázÚ{hÎÊF�‡ý³bS³ˆØP‡�–‹y{=~ÐˆKCž ö 2�ŽnnSã~µ�ªu®Xbs^õ’gµ6×þ|¹0¢Ù*uÝîõ>«nu4*Q!&»€‘ø³›’ûlq|øáÂÈVq`ˆÍ (ï†Î|•¯üû·®o³,_Wf¿Ý¿CQ§e}—^x÷Ö3©¬\Í]Ø<µÍrU)8@lVBÒ�­Ü|–úÍÇ×}<¿)ô‚¸¸YÎÍñzÞ…tŠÕòN%o6\ž‰ÍB4NçSþõ�î¶?|èËE“T/çv÷þriT^¬	ÇýóG™Ç�@Äþ _ÛÃüÅç÷tz÷·Oé­‰ªe–o?¼½ìP¯4œf&û„„<‚N±r}wJ}‘°†�„^0k*Æát³´ $ö� BÄÃ¸õ�WEûö›o`æëI÷A!Œc«–7Ëþ¸{ÏÑËºtˆØ_BÁ9•¤M†¡o�¸ŽÑíç/ÓíÃ7û3ševsW\�[SÜ×i"ö?��€Â$¨KËƒªo—îðôtöÎš<�¸?íz¯MT•yë.§¶7…I¼û9*ÄÔ³—›»Eò¸Û³ÜL¢EÄ~‰Ÿº./—YôÝñé2Kóˆ™ öß‡„�Pœ¥Æ¹ÞÃeˆo>›Ó·O¿ê¨¹© ^l!­ÔÍ‹Š·�¯Ÿ.µ*æŸÎvo?tCgË&Eûðî©_×uµžáxzÜ³Š*CÞøT±›B7¿_Š½_dµÛ!!¦K´º½C¿ù¸�ÉgÍ§õÍôüÝ›/™rL,dWc`•/²´Ý?m�y!¶´K†©Åâv1~Ø<ù¡Œ“TÇ±„Á_B¥S²21'õ¼}AÆ°û9$Á9.ÒÎÃiï"U¤Ð"l!V~rùz­ºÓöãµ6Yî“ÈäB[,ïpÙ?žƒÉóLÄö—‚Q¥;�zÉó¹‡Ã:ª³
½Ï,*Q‘WBbÿ+‰òæ:´ñâ&½¼¾|ï»¥)«4Gp§SÛ"ŠË2ÅØvý5¥R"bû9ÐSvÆÅê.j¯×k¥9 $l?ƒ€ÄO-óÍ¬jŸ¶‡>’êÿ/Nv­ÛÎ³ ¿ß(f=çªöÚ{ÿÿ)íc[>1…±!)E‘E$$$ I C“>â"FŸàÒ¥I+
IŽOñ»Xõ,Gñ}<O��¸!ŠÊÇ¬®J+ã<_®>{x»£—Ûó+¶]SÍfa»_Bˆ¢‰ÑdUV²OÃ2†XÛ¼žýËËPæU¶Ye›0\Ïg¤zÕ´Lýé|Q‹­VµžÃåô"¶ÍŒ øeàî­‘Óòô»Ô”e@ÌËrNùÛÏ,½~øp•Ý¦‘!q?…�@æt‹Ýýn³¼þê}­òv5#Æåp›FjÊÎ–ðÃ0¨3¥ˆ�ƒ�¨`.SZïöàñõêºÍ,Ô4§­5Dìv‚ðç¸zxC·ËÓÓAÕÅ*ób÷'B6kÄ¦Ãmíösc†Ã»§°zhK•’»_BHÀâUªŠ*O²Ì—©Wy¾…Ÿ^ŽOLÕno[§çYS×uÂÙt~‘‚L	2$ˆ¼jµïÎ/ïz•WµP8ÌØ>ìËáüþÛí�1ž”°û)„ âS
Åz“ÃAi¥ÛÚV {?ú ëªÌTœ¯aæRg6¹!á)-Ò>l8^ŽïæÚ˜»ÿ!&o}*ËM«–ñzH¹iu2N ÷9„�dTïºu7Œç�SŽmQ0‰û_bâ1Å|µ^õýåò’L�åš5‹¸A
½Rm».•¿¼\Ç´ÊÊ�'!q¿¡”sZ<âjóFåï>ÎE‡ÍºÜ�ã°,¦,ò2§0†~ñ¥ÉóY‘ûDÀˆžVûÇz9ß�ý�j2J @ÜŸBˆ)ÒœPíït:]Þ…)Ó�1‹†b�ûB)‹H±Ë·Íøz;OVÖ¶Â<h6»"úÃËP6ë"+B¹ÿ!QLU¯e’Óíu ¬º¢�1Ý†«¯´±šAî‚yÖ:/ª&Óùõ¶Hc2!-®‚KŒlŠjs/Ùp}]’mT‘‘¸!fÀsòÅ®S�¯ïûKÅ]WF-iˆ—”£*”P	ª c2¹G0O ÓÕËípQe%�÷9,iöŠÛõÝÚ_O—ƒZ•y®I¹_@‚Mf»¬d¦Y$ÓŠ‹xÑbkb¸ÉY«J[EÊý1§II™w«¬Ž=ÏÊ4)‹&	¹Ÿ‚)Y/Ú•]ö:žÞ›œmg²$àI”Ea´˜…L+dXÄYÄD”•«JÅ¡ïã­j²Œ $ÉÌ�Õv«Òw·gµµ+“+¹„˜)kleXÍa™|Ù4M>…ñ<žXg+eB"eYh±QÈ`
•m³æù|•"¬2²¬Üƒ	A‚m;ä§Ûók_s[Z"MšÈý3ˆ#ù›·«©:/C2fm­Z	‘ûNq‚)óu§p9Ÿl§óÍ}¡øÚŸÅdy‘sÆ¤ˆÜ¿G"fÄ UY®›êê¶³M@'ÁF!÷? ÄÌq4©©ëÆð8\Ï™®óš•¤àmÊŒÒFÙ rwI>(ªªu§x<^ƒæ&ÏaX»ÿ¡dy¶ÉTe—7ãr¢ÓYRì³E2"¥¬°‰B.C<|Ò«õÆëårJ�ÙBƒÇ™¬­³Ë�Îd3c•Rär	! °)Êû¢J§—'®TÛB@²@*½U5û>Þ]ØL)!÷kˆ  ³²°‰{^Ä™M"�*[´ÒàoSÊmiI$ÀCrÉLiØÆ>KF6*èr_ƒ{#&7
<« -Ê"D×yÑØè‡ž‡ªÝ´uÆ—ãë¡B–• C"K3S·��§¥Ï�eZ+ˆpHºTmgMºŽ·Y²JgÉh÷D8Î*UYS”>MóÔçÊ-Pœâ T¹nïzs™ÏµÊ•‚V WA¢‡]ä&É˜n~AU·»§Ëñâ93ç¢¹ÏáŒ0‡¨¥ªÚ•Šþµ'FžY"Ò
äJH
äµÉl.˜j¥²¤‘+!ÂiÑ‹Ím9Œ€Ì¨ŠÈý",ÈØŒ ïÏyQ¶­öã¼,Úä,Dna‘8)ŠºÜÖóí0Ü ­Ö¬@J)÷÷�„E/¬²¬Y[}»Ù£È�)W‚“D«s@Í
RAkRŠ‰ÜIÂ+U¬êâ8{AQh¥A)—Cõ¢#•%2½WÊ*�û%„%	Ø³¡¶¬š×p;ÌXlÓaŠSÆ´T&C–¤��� ’â’2”yab¸32*D“4)qÿ�sbæ…9¯ÛMaÎÇ³¿e»j—[îÇ~¸Å¼(¡I±`É#MS^âxº`0­-Á$ñj.lU+
³¿,±T¦€Väv $¬¢ºÌ­_Îç8a·º«—ùòz)ºú¾–~šç…É´€Å›H¶2D1*2…V6*0�½ñy–ø8û±«ºíÕŒsÆœ«Ò°!sÈtI†dVJe*)f "h¢)Žz»Ý­°¼SÔºÉ@ úÿÕ/Ïî-DXCkHERJ•PÁ:2‘2rw`NKìL”ÒŠ$Ny�¬$¢'¥s*l¦T
�µJ"÷Ï!E´.J…ÅÏÓbr£2QäZˆ�ØæÈBm†ªÐÄ©_ªueó} •Á�+ â�Ï²Ò˜”<A'­2&÷kp
*Ù\é(ƒ¡,S†4¹¯ <knÌfÍÒŸŽ—ÌÚFˆÝO LRÕµFèÓ’Ê¬Mä~!°'_é672_®£¶ÆhRî_Aœf…ªÙLÃI�º±Š@ì~IHaQ»‡Ç|~y:Ûf-1€zS•ëLæñ¤=2c#» !pš�¼ëük8�N&¯*ˆÝ@’Â@UÙÖû¥ÇŒlµm0Æ�Ï7è���¸_@H@^–ÅnÞ0¿¼|wªïª
€�¸7�¤ØÃ«ÎûëtðºÉ+b÷{³�™m‹,�ó©*¬0‰û#�£—Ìe�‰•AžÜ�€$ù…Õî±ó·óÇQÛE½�æt~¾Të.'��¸¿!AôÆÖÛò´ã!3U¡DƒÝˆÓ$zµªB¸ÍWC›‚´»ÿ(0ëæ®]§“mm˜ØýB›ª-eº-7©
ÍFH\!|ˆf¿‹¼\¯³^[Ø¶S~¼^½ª
«˜ ¡ ’ÖëÝ.·Ihg-XHÜ×‰Ÿ\yW-÷­ºÛ® �XÈ•€x	sÜì:}‡*_ç`÷ Y|Äæ“»áûÃœïª,”@î÷ $”�LÙtÂÓ0�º´V±û—€’ŸfêÞÔË·ç'´em f!÷@¼„€»ŽÕtz¡¼(sNqÿP€OÍ®+žn××�Ö¥„Äý!^úk|ø²Þ}ÿ·a\½)t€@ÜŸC@½GÖ5a<ö!—\ºÍWr~>.�Îên—óòzžó¼È�4Øý;°‚ð‚Úï¿b[n‘˜XÈ•I¼\Sýé¾y÷þå	ûU«âþ Q‰½ } õ/Ï´«VJ÷ ™Ó,�»vzø@«ªÓ B
žŠj3ÏÓùx)l¥•'°{„@TŠþ–­Ì%<{‰Ðåêí®Z>¼¿øÇûµŠ„"NÓ¶[Ý²ëùÕ”Bq5 4‡`Û­ŸûãÇTAºý§w8~üë9Ü¯
áˆû3ˆ(Á<Ï¸ÿÔâòý»q[vyJŠ¤>õúíÎ�OË°¯W‰%¿µY7çÓùôšEñvƒÛáyÁã]eB"B„¹ÛÞs?–
RµûM˜./‹Þ Xï·Ëëù�WÍ¾ ÷5B2§Q?ìváõã^e�æH÷‡ <Cu«ïÇó�t[Ø=‚$�s°ûO¾{¹Y¥Úûòîv}ÿÍb¾X—�ˆ«À
’†4eû;uº<÷£Jzýð¹‡wßïë;�D€¸ŸCDAFa»ß¯ú�/ïz½j4" î! †Oº¬›Ln§[/mMŠÀîkˆ(ð²ÜÔý›·úéé›0|Q—	÷s„àç©/>ÝúÛËûQµ«ÊxCHd7«vo/—ÔUuØÕ@(úÑÛO·Íùéå	y•m>ý¢¤o÷í8U][¿YgOOß<åoî+3ÄUÑ&IÛvsÓ—ñUS]�	â*ˆ(ÄzµÞ}>y`eL$ˆûÄøÒý†FýüÑ×yUÍ,äþ@–)åûûÍðÍñýmY™ìÍî^Þ¿û?t_Ô5<	Äí!Î ú4TûåÇãë“­¶-t Ä}1@WÛZ¦ëa„÷jóv×Ì‡¿ùŸm¶%'ˆQ@°åfu™‡þ²P•™¨âDÕw�§p9œ¥ÎK‚¸G€4IZ­:{½ÇšW™�¸ žRª·ëb¸žß7ÜF  “J¦Ûf‡áõuÁº…Šv%ÄLð¸»Û‡Ã÷‹'­ÊÏ>•çß}|7í·ÍIÀDHc´ízKýëx0XW@‚ 2†¨Öoè?\}[•ùþþnùþåw?,›}Ç" J~¦¶ÙÙãp< šºð
"î7 iÐ¦ÙåzûË\f9%v?� �‘Ð­·¶?÷ÇRš`!q÷ Àc
õnß¤Ãå{iSl7Ýåo?þ�Öy—…H”@î¿B ÈÌºXuõ2½ÕnÕ*í	ìþâBˆÜî[{zù8Lõ¶RQAÄUg½ÐÝö!¤×Ë“Ùu+)a÷5X�Ê»‡O§Ë²­ËÒ+ˆ¸¯  ÏTµ•ñáÜ_¹.¬€Ø}q>.²{³¦×Ç÷Rd+›@Bœ$ØÍº:õ¯ÏLU�3‘âÄ\n¶ëþúúý„ª¶‰XÄÕ�aSnÊ<Ìý%š2W¢ Žó‚|_ŽoãsÔu—t±ûÄ,,óîÓ­Ü^¿ªÔ®$ <…Á¶Ÿ¨Ô¿>¯ªV ®„ˆæ8-ÑÞíÖóéøí­«Ã÷Ía`ÓÝ?úá|~-ê.W”ì
@iƒß½} Ï?x¥uµ¿¿·ÓËwïr»ëD±�û5D4ó´Œxü¼Ã‡o®E…í÷õíôÃÿ=ûÚl>ù¼?¼ÿËEÝ¯›J î	}”îþ1áúÃ»áN¯LP,â  ™—b³+âøòSØÍgŸ•·ßù!ü²ÒÏÇ§�‚½ÝÒµ—áÝ«½‚°@Ü¯  aÏb²»m7ó5+MM$qwÑœ†t²ëO­><?G{—‘ "îÇó¨U³Î+å_.M©Än!!ñÉûnÿIùtºY¾j!PÂîkˆÅÏs¶ÝvÇiÊÂÖBâî  qð�ÛOî„Ÿ®ß÷›ºÑ)*°ûïËoêq·¯ÇCÒõºÓ^±ûBÔ7cÚ»½�·ëËh�5»U§ÃILÝ“DÜ„€é¶,íÃ§›ëøtéó¬U*i°ûb–›~x[•ÏïßŸ±Ý6”ˆEÜ=ÄHWÍù~ÓÒåå�–¦¶†±»ƒ€sšýnßq<úå~Ýª%ìþ1*i¿èªiß^²¨÷+Ëów¯Ï±·yþ˜ºâxy¾Í¦aè(âî $j±7)º¦~}Ÿ‚Ízß5ãñü[·6)a·‡€$ù…õên[—ë;îËî³‡U<ÿð×ß½˜ÇÏÞ´áz:|û2µíÛÏJsº=ÿeÌÞì;pÄý
’ä#×åŽÌ|;ž%kr- v¿…��¯ôfÛZ>÷/à¦Î’Qìö�Äy™±Ý!Œ¯ï|Ä¶%�vÿ’8‡EU{o×Ë¹Êš†!q{ ªÙwq8ü0DìrH±ÛA ‰ËÄùÝj¯Ï�ÛÜr îBb/)Ïª
Ò�×ë¨ºÕÎ#»õÏ«îA×0·ñ½±zý¸j�êÏOàlõ †Ü®cÕU†™Üç(%Sl…1�O¶�õf³Šé|}—«¬Ì” HË"±~@Ç—±W¦{ÛA?þnPÕ¾U‰•°û„ {Äí¦�¦þõ°¬²¼Hb·ƒ„ã­�åîS‹áý‡Án«Î‚±û„ "vÕžâü|îSQXÅäî!N#¤©w¥=§ÉcUeI	±û9„ iñ³_=æÍÜì§•-s@ˆÝ=„g/aý¸mn×�ï¥²ëB± ˆ³`3çiPëÆêqìyÐ¦Úm¤ËÉ÷[Û(­¢ˆ{€’ÎlSä!^/ÇIšu�²0<?IQ×wMËqzºJßl×I§óøBÕên—•˜�çSHuea£ˆû»‚ ÄîSÀäMÊiÝ=Þ×#l{·Ò8¿¾÷²]›Ñ0÷G±¨mFq%„àu¯(ëJ
·ø|ƒÏ6›²ý‡£ïL›‹ò vÿBBb—Aiñèî±$ÿáo']uy$OÚÞmPÝž_<t®˜\!$�e³ê›a<žT�Í¾²Wx7Û˜m»}>|ÎÏE–e¹e²�Éý„°¨ Êº³Ö�óñ¢b»Þ¶�Ÿ^^‡µZ×$
ÂîKA8öbšÍ¶.¯K®šZ™ Ý#$Í wÛ6Ñp:\²¦m2ÑÉýBˆÞû”¯ï¶j>œÎÃJ¯r¥X	� ³_ÝU‡ÛËK¼5jÿfkÕáòÍ8ªMYGQâ~!ö^”î¶Ûi:?€lžC1¹Â3Ètû6÷ýíÃØÐº´ å~I>’­ÚÕDÃxMD]¥LPä~!ŠØ¬­Àþ|¥‘êUUcèoÓ¡÷&ëÊÖøe¾ÌãJW¡œHÜ¯ dumMšÆqF®*ˆ&W@ˆ•ÝdEì§Ó‹¯šnÛf¸1­óvmJÕ�WœL‘ÐLËÀä!!Åsˆ©}Ü®—þõC
Í]¡� " W@ 0!1OâQîŠyx=Äªu¡’"g B@ÄllµîJš†ë¨­ö«ä/çÇ¥­ë‚`ˆ3!‡[tU#ñ:ÜnUWh#,$î�!‚Hc,²Ug†wýmÉ2kJ�²�³ $�¸„X"yBVZ#©_ÆEª|SÄü2�GOUf”†§E!++«‚Ü$+Œ‚AîO!OžM·ê4Î§ÍÒÕb ä~á…ªjUÓóp|½[–š  ·…0R!eÝ®‡×ÛËë¨¤Ës†q¿�°¤Y¨2Ûf£/·é¨¸ÊKQDîÿ@xÑè:ñ~ì�c´ÖfÑ²û7!V ³$EŠ á$"¤IÌ‘ŠˆDXˆ‰Ü
B,Â1,¹*rÉ—Ð‡¦.�¦ër¾QÖ•&É-Ý–%/6eŽ%Œ£P§3CPÍ WC D €€!x‘X•û.·—£.ËÂ*ÑI‰�¸¿!f$Os®«R™eñã"mµ²…OÃmò…µY2
¢#ÈÕ—�=KªÊÕzš§Óó¤ª”‰¤$ R™—uYúËéÙ(�ÝÅ"Í§ù´°èÂ)�¸ß‚ÁœePæÊ.|�×%®ëº4ÁŸæžÉæJC	Iô m[˜4³
Je)c%ˆj±¡ÕÑ2†yà¬Îk›üoŒÕ¤DH\!&°0/Êçºèò»×éúYž)‰¹·‘DI¢pÓîê0½ö7@VE¦„”(ˆ[AD’‡([çeâñxSi×îLZ†é<†¢Ö9“’äÉWªk
úeœc§+ÖP ¹D$	1)«2“R?>Y£ˆÜ=D8†YÇÜÔà0û~Ì­6¤”@�6ÕE¥Ó°œ§E¡5‘rRZIÖX2Ó²Œ0•²J‘ˆÜI,AûÂ49i?±Ì¹2J“@î8+¬ò¼ËÁãÌ#tžkhQ r¿R
€Êl#æÔ“.tF–!\çeU„0œ³í¶e.·Só(2k "»J@³	e^(`’)ÙB™"*‚ªò&7aéo#å¥ÎØ(�¹ß‚S\ÈªÖØ„YæÙæ*Ó¬”ûs0$�IÒØnÛÏ ®ç÷³µM‘P‘k ¢„†¸OÀ KP‹¢ª4zŽK±6*#@�ÈÕ!!I˜ÈÝAÀ
¢,qD„!	‚\w…•e^n~)ŒÊ �ÈY0	8†�T¥óÈéT¦´2J¹¿ ƒ…Ã¨®Òù4O×AUºÍÄ)Š²&š¯—þ?Ž"2BASE      @  xÁA 0„°:Ì>0€-MÞ¹aŠ£pˆK+0ÙlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØl[M[²±ÂÒØ´¹±‘&Ô	Â²º* mBPOS      J  xÁQŽ4 E±A­Úi®OòÄ’øa[,ûßÿþùëëëëëøµŸß?n¿Þ~Ò¾ûöç\öýû‡ýÝöœóÎè�]uŸwr<ÒÝ½ãªU·ÕçÜùœÞñ>gºÚýtV}Îç¼ã”7{û¬>çe�tMÞ¤·w¬ÝÏöæ¶·ñ9o÷ŽêâS˜ê�gSwîîyçº�wö¢½ÝÎÍà¼“k®ÝÃ]×4ì{çÍÕq)-iwiw´F»CDP­H­†²,ÈÜ¥6iÒšÕÌ,íÎš4°µ„aÚ€†)4cÃd5X›å®aÒÀ´dËÌPÐ0c¦¡™Æ�1
ŒYƒaXk44¶F44kÀ¢	LÈ°†h1Æ,@AƒekbXvahŠe*-Y4’Õ"‹ˆ ¦!sGZ[¹ÛåÜÎ]þúÄ1•CNF4      µd  xÁÁnUÀrn÷tü2²=‘•Qö(_ÁÜ¯gÁ‚5$“/ÃISõðñ…þé�×ýûçŸ_ï_¿<|ûÓ×ªÆ·7ï¿½ýã¯÷×Ï¿üpûp_÷ñ;¶ûzµžUf/öÛÅùzQ¤WÁÕZ¹ãn\?¾é“ÛÙõ"uíÕ»og·ÕØÝ9ùÂ¥T*ÓV2í.¸±²1ö�±Q½HeÚnžíC\CJzq»³.þ»cŒ}ôI&Û�ç(B!W*½¸9÷ª‚bg°ïŒ­7žSý"éE%(Aõ“(Ò«êGéEõ"½(¢z‘
%TJ”ô¢Ò«êMTPA‰êU(©Þ„ê“(¤z‘Jõ“TzQ%}RH‰êU()RH/ª/¢úE(¢„ê“TªßI/JQ%ªE‘
ªWQ¢R½J¥ú$JŠ ¢ú,“�Jõ"ª‡˜CÊÎˆæV¡Rá×S¤WÓH¿U)™6%½˜ŒT¦Í4Â´)aºŸM6ÓÖ‹Ù«�ÉÖ/¦±o®÷qçbÚ¦±�ÝÆÍyn½ú�WÛdþ97Þ.û¿÷¡}èCúÐ‡>ô¡}èCò?”6ëÈTEXT       Ø  xÁAnÂ0Ð9Ê [ß®#eá$E@ˆ’µ+$*$6,JÏß÷dÈÇ"rÈCÊ¼Û’›�ÞªU×p“°Ú6!nâjiX…$ó˜;	kok•>/E–ûK™t¾=¡&j@	RºÜ_Ê¤óí©°¬+S‚”écè… ‘˜<¨S‚Dbò0°2é¿Ê(ûöbÑpOc¼´ýògþçq•cîÞå³˜Û�G„ä,\tfLt€ÉñÔÄ¢AÚ.dßúë÷SÎe
²ö�s™(ûVƒ§È?gÜ8ìCLIP       	            <AlignableSequences><Sequence name="95_CMV-F_TSS20220928-027-10413_H02" ID="0" isTrace="1" sortOrder="2"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  è<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="732" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="12" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4526-4573" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3002-3106" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2392-2513" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3316-3451" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3108-3465" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2520-2975" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4902-5490" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1550-1552" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1553-1555" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1556-2269" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="2" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3500-4294" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="1" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="773-997" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1012-1535" color="#ffffff" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  @<Notes>
<UUID>e72dd4e9-52bd-4a1a-80ea-946c0e8778c2</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<Created UTC="16:0:0">2018.5.29</Created>
<LastModified UTC="1:51:20">2022.9.29</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  "i   (  ›  ã        ã’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      M  ÿ  â  A      8®ZTR

BASE      "Q  xÁA  ƒ°Yãx` þµ,9µª’�$rµ�h“˜æÈZ8‰9#§ÁfÆÌ%Í°†&ä†ÙÂ!ÊÂZlˆÉBf8„ba,„Å´RÛ¨¹˜¤3\K7G[JÊ\[ÛR�ª-Ýtuµ§âšnÓÁ lÉL¶æ¢Qk²96WU«Z•’PÅVA#)Y®Še­rŽÕc¸h²Qá6…UÛ–JC5aT-˜ 4•­H¡!.š0*Ü¦lÕ¶¥Ò &ŒªMXµmSÙØJlÈ &ŒªE“­Ú¶))lƒÀ”5Ü¦¢laV9¶ K°…n¬á6•‘‹VmsF
ClÂ*h•¤ 6Mµ¶MulÊØJL6ÇV.rÙæ°Uce†’ÍÚLš›5Š6“˜hÍeµH¨Œ"×&ZµZ*ÓÕŒ\a6ÀR„6ÉÖ´ŒÊ¨Œ¥è°„\¨Úd.Q´„\jK]©¨³…¢.tX¶¤å&iÕPdA’nnBÓ”¥å°)E&ÊÜÜ„Â°‡j¦QÚŒÊuµ@“¹ ’nBQX‚LW%B®hAR›cLVB–L¨nBLS™QX’-É™†âP’@Te–a©¶\.5Å¡‹D¥iê"�P#ÈŒ‰¬¦Ëm¶Ð4­˜8gÉ
#×�¥Î“Á$e(²­µm¸å6 Ð©ˆNÕº À‚%lmmmàÖ6¶$ðKùü   b<AlignableSequences><Sequence name="Copied Sequence 2" ID="0" sortOrder="1"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  ù<?xml version="1.0"?><Features recycledIDs="1" nextValidID="15"><Feature recentID="0" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" cleavageArrows="732" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4525-4572" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3001-3105" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2391-2512" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3315-3450" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3107-3464" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2519-2974" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4901-5489" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1549-1551" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1552-1554" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1555-2268" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3499-4293" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="773-997" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1012-1534" color="#ffffff" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  S<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-CTNNA2 V3</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.30</Created>
<LastModified>2020.5.18</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  $F   '  <  &        &’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßcÑÅYºø¬�×í°¦?‹¬öÚº¹ëcøãÿ·¾úçã´Ãã�Î¬`w8ìÎémA
€=Žc‡Î;ßb>(-~ã‰þ÷8®½[M„¨ƒÒÞ7ït® ¼CHD·Q†Ç¢ððŽ°nyß±Žâ·èˆàºç�¾çâ½«¸@~¤ î +Á€û€·�ý³èáK;m2Ûß†Ü<ü×`ãøÓGÌõQÌ‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  W    !  B  %  A      8®ZTR

BASE      "Q  xÁA  ƒ°Yãx` þµ,9µª’�$rµ�h“˜æÈZ8‰9#§ÁfÆÌ%Í°†&ä†ÙÂ!ÊÂZlˆÉBf8„ba,„Å´RÛ¨¹˜¤3\K7G[JÊ\[ÛR�ª-Ýtuµ§âšnÓÁ lÉL¶æ¢Qk²96WU«Z•’PÅVA#)Y®Še­rŽÕc¸h²Qá6…UÛ–JC5aT-˜ 4•­H¡!.š0*Ü¦lÕ¶¥Ò &ŒªMXµmSÙØJlÈ &ŒªE“­Ú¶))lƒÀ”5Ü¦¢laV9¶ K°…n¬á6•‘‹VmsF
ClÂ*h•¤ 6Mµ¶MulÊØJL6ÇV.rÙæ°Uce†’ÍÚLš›5Š6“˜hÍeµH¨Œ"×&ZµZ*ÓÕŒ\a6ÀR„6ÉÖ´ŒÊ¨Œ¥è°„\¨Úd.Q´„\jK]©¨³…¢.tX¶¤å&iÕPdA’nnBÓ”¥å°)E&ÊÜÜ„Â°‡j¦QÚŒÊuµ@“¹ ’nBQX‚LW%B®hAR›cLVB–L¨nBLS™QX’-É™†âP’@Te–a©¶\.5Å¡‹D¥iê"�P#ÈŒ‰¬¦Ëm¶Ð4­˜8gÉ
#×�¥Î“Á$e(²­µm¸å6 Ð©ˆNÕº À‚%lmmmàÖ6¶$ðKùü   `<AlignableSequences><Sequence name="Copied Sequence" ID="0" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  7<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5104-5151" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3580-3684" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2970-3091" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3894-4029" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3686-4043" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3098-3553" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5480-6068" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2128-2130" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2131-2133" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2134-2847" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4078-4872" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1352-1576" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1591-2113" color="#ffffff" type="standard"/></Feature><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1314" maxFusedRunOn="1314" detectionMode="exactProteinMatch"><Segment range="1246-1311" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="CDIPT" directionality="1" translationMW="23539.46" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1314" maxFusedRunOn="1314"><Segment range="601-1239" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  S<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-CTNNA2 V3</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.30</Created>
<LastModified>2020.5.18</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  !‹   &  4          ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ß×í°¦?‹¬öÚº¹ëcøãÿ·¾úçã´Ãã�Î¬`w8ìÎémA
€=Žc‡Î;ßb>(-~ã‰þ÷8®½[M„¨ƒÒÞ7ït® ¼CHD·Q†Ç¢ððŽ°nyß±Žâ·èˆàºç�¾çâ½«¸@~¤ î +Á€û€·�ý³èáK;m2Ûß†Ü<ü×`ãøÓGÌõQÌ‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  W  ÿ    "    !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  /<?xml version="1.0"?><Features recycledIDs="1" nextValidID="16"><Feature recentID="0" name="CDIPT" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1215" maxFusedRunOn="1215"><Segment range="601-1207" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="15" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1282" maxFusedRunOn="1282" detectionMode="exactProteinMatch"><Segment range="1214-1279" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1559-2081" color="#ffffff" type="standard"/></Feature><Feature recentID="13" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1320-1544" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4046-4840" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="11" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2096-2098" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2099-2101" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2102-2815" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5448-6036" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3066-3521" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3654-4011" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3862-3997" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2938-3059" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3548-3652" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5072-5119" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  S<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-CTNNA2 V3</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.12.1</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  @»   %  g   Ò         Ò’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßaëzß›k…`õR Vðs—H(ÞŠwBw¢×u5ÕÛ‚UE@BÕ?by8û‰SÞÑjø@…Ñ³”-FíQD ƒŽ$AˆÍ]BÆ0lûï£Fèì°•3ö	ÀÃP:Žï0‡s§¶ø0v¶ê›öáVˆCøâÕXçVQú5|ªTJ€TFW¥æ$ÓQG]áA¾Þ,ƒO?áE=Ö8�ÃîÔÚ»ÏF,óœDõñb+WRôöÏ»Ö8íN~ÏÞSÔwl188ÃºXJ‡YF›àØr´Ä=
ðòþM¶ÓÓ8`ñï¾71|3È0H×<Œ43½ã´Ä�…–xPFûµÚ1¡”aåu¹A:ÁSH`mÙ¸{«àWÖ+ê9+¶„8ÕaT…E˜ýJ¯!6=ux$B�Zƒâ½»×XQ@!ZJÁƒOF‡Oˆ¿Ð¶Ö<îàãð÷DÕ(í]�Ë­Qô€E4/(tCÈvß´�‡¯»‹´U·n�!u"!“ûÔ@Æ w¸� öÐNÄ¶wmµŽ�˜S€*g„PŠ9Õhêá]!�s¬áu$B�hSøHõÊû_*E„­±�»>˜`ÊÀvÑPâ8a´ôQya®¡4i†#$Ðu"´xA‡Ó¶�DÍÀöØ3^|ÐA5VNBf½µTÔàcE õ`tÃXfÚ'ƒÔÑˆ˜m†aÑëuÕÚYÛ†-¥Ž=EZ<SB»V“²8ƒ†Ò/†´Ø”Ðji>~µÅ£èš=´éfãMB4R4[€A¶ˆ´A+DÞ­çê˜BFˆbÙ Ð9-z¹ýûõøŽ¼l�M!¯½ŽH÷lé½9UøacŠ/·TÛæ û_V}.`4â×·âˆºPïDQOú!DESáE¯Gq+B»EÝ«>'C©HZÕ5�¯­Ì‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  ‚  Ë  Í  î   Ñ  T      K®ZTR

BASE      5/  xÁA  ƒ°Yãx` þµ,9n–à&:&›X…*@Û
˜æ@ZåÚŠ·6Djá·&ˆ� P*s5 *j©¬áÈ¥s�HHqlÓ@µ@bæ ˆ&Äœ@mµr¹Fk™€P‹0–ÅL§Óh[uËÙ¬™%ÊjXYBå¶œÓ¬…˜N¦+YI¬É"Ü6¦2ÀÖ
¢Ôäš ,‡À"!tK@Û6 ÚV«¸�c�$!AŠ\PL'®Y±ˆ•¤©Qå\K–kˆ¥sB²ÍiŠJ¬™æ0"�ØXkšR”2Ó’9…årB�©¸0H¡RÄJf¹rYÎmaÓª,l“ŒRjÓÒ¦®(¢\Éd’e’¹Xi8�.1#-3¢˜­,Z‚iË’2§ºœd4dÁ`¸‚ ˆéœ [ÆƒX8@ˆ˜ƒ"$7HZ¬˜È˜ç6]
kÓm9ÚœlQ.�È@AÆR¡mÓÉRp5¢¶¶•®M™SUØh³XIŠJl!éZS¥&–æ\ˆ+—ZŠDm9)²Âæ&J«’šFk‰ÒV,d¢“V,ÜtÎ5'LdnE±­µ©SˆÊX+Ä¹B—T)“*­$g4"“	ËE¬rUÛ.‚Z[A¶Üæ¤ÅRÌÍ\ 4¢¶”-H]´lÓ	Ú¶(‚E›ÌX:gºZc±²Í
™”k¹XL
U‚ÀÅbsá¶H
bc±–�¤Z›„‹b¡ädK*‰L¬”ÉÊ‡&E” Œ\$µ"Æ¦Lˆ rÅ’ •«0$KXŒÉÖp¥�ÄZc1Y¬€…„›Q¥²À�¹X“–K!€-’ÚœÁ
��œ-×ÊÅ¤5]l’¬ARlc#º	[º5¶”In0æ’„ZP´$˜«("'[kR!E›Dâ6qè¶±¨[‹5±ª¤r4Ám�
º–‹ŠœÆ¬hI‹M§,WHK‘™SJr èbÁrmM'Ö’éX+� ÀP‚šc’äšàD×Öš[A,(§D¤ºµ "€tA°)!F›aÔæ$Ùfº†”Û ›@ÂŠM7GÝWk       ü®ZTR

BASE      æ
  xÁA  ƒ°Yãx` þµ,9n–à&:&›X…*@Û
˜æ@ZåÚŠ·6Djá·&ˆ� P*s5 *j©¬áÈ¥s�HHqlÓ@µ@bæ ˆ&Äœ@mµr¹Fk™€P‹0–ÅL§Óh[uËÙ¬™%ÊjXYBå¶œÓ¬…˜N¦+YI¬É"Ü6¦2ÀÖ
¢Ôäš ,‡À"!tK@Û6 ÚV«¸�c�$!AŠ\PL'®Y±ˆ•¤©Qå\K–kˆ¥sB²ÍiŠJ¬™æ0"�ØXkšR”2Ó’9…årB�©¸0H¡RÄJf¹rYÎmaÓª,l“ŒRjÓÒ¦®(¢\Éd’e’¹Xi8�.1#-3¢˜­,Z‚iË’2§ºœd4dÁ`¸‚ ˆéœ [ÆƒX8@ˆ˜ƒ"$7HZ¬˜È˜ç6]
kÓm9ÚœlQ.�È@AÆR¡mÓÉRp5¢¶¶•®M™SUØh³XIŠJl!éZS¥&–æ\ˆ+—ZŠDm9)²Âæ&J«’šFk‰ÒV,d¢“V,ÜtÎ5'LdnE±­µ©SˆÊX+Ä¹B—T)“*­$g4"“	ËE¬rUÛ.‚Z[A¶Üæ¤ÅRÌÍ\ 4¢¶”-H]´lÓ	Ú¶(‚E›ÌX:gºZc±²Í
™”k¹XL
U‚ÀÅbsá¶H
bc±–�¤Z›„‹b¡ädK*‰L¬”ÉÊ‡&E” Œ\$µ"Æ¦Lˆ rÅ’ •«0$KXŒÉÖp¥�ÄZc1Y¬€…„›Q¥²À�¹X“–K!€-’ÚœÁ
��œ-×ÊÅ$WHK‘™SJr èbÁrmM'Ö’éX+� ÀP‚šc’äšàD×Öš[A,(§D¤ºµ "€tA°)!F›aÔæ$Ùfº†”Û ›@ÂŠM7Gl\ÌÇ  È<AlignableSequences><Sequence name="ATGACTTCGGCAACTTCACCTATCATTCTGAAATGGGACCCCAAAAGTTTGGAAATCCGGACGCTAACAGTGGAAAGGCTGTTGGAGCCACTTGTTACACAGGTGACTACACTTGTCAACACAAGCAACAAAGGCCCATCTGGTAAAAAGAAAGGGAGGTCAAAGAAAGCCCATGTACTAGCTGCCTCTGTAGAGCAAGCCACTCAGAATTTCCTGGAAAAGGGTGAACAGATCGCTAAGGAGAGTCAAGATCTCAAAGAAGAGTTGGTGGCTGCTGTAGAGGATGTGCGCAAACAAGGTGAGACGATGCGGATCGCCTCCTCCGAGTTTGCAGATGACCCTTGCTCGTCGGTAAAGCGCGGCACCATGGTACGGGCGGCAAGGGCTTTGCTCTCCGCGGTGACACGCTTACTCATCCTGGCGGACATGGCAGATGTCATGAGACTTTTATCCCATCTGAAAATTGTGGAAGAGGCCCTGGAAGCTGTCAAAAATGCTACAAATGAGCAAGACCTTGCAAACCGTTTTAAAGAGTTTGGGAAAGAGATGGTGAAACTTAACTATGTAGCAGCAAGAAGACAACAGGAGCTGAAGGATCCTCACTGTCGGGATGAGATGGCAGCCGCCCGAGGGGCTCTGAAGAAGAATGCCACAATGCTGTACACGGCCTCTCAAGCATTTCTCCGCCACCCAGATGTCGCCGCTACGAGAGCCAACCGAGATTATGTGTTCAAACAAGTCCAGGAGGCCATCGCCGGCATCTCCAATGCTGCTCAAGCTACCTCGCCCACTGACGAAGCCAAGGGCCACACGGGCATCGGCGAGCTGGCTGCGGCTCTTAATGAGTTTGACAATAAGATTATCCTGGACCCCATGACGTTCAGCGAGGCCAGGTTCCGGCCGTCCCTGGAGGAGAGGCTGGAGAGCATCATCAGCGGCGCAGCGCTGATGGCCGACTCCTCCTGCACGCGAGACGACCGGCGCGAGAGGATCGTGGCGGAGTGCAACGCCGTGCGGCAGGCGCTCCAGGACCTGCTCAGCGAGTACATGAATAATACTGGAAGGAAAGAAAAAGGAGATCCTCTCAACATTGCGATTGATAAGATGACTAAGAAAACAAGAGATCTAAGGAGACAGCTTCGGAAAGCAGTGATGGATCACATATCTGACTCTTTCCTGGAAACCAATGTTCCTTTGCTAGTTCTCATTGAGGCTGCAAAGAGCGGAAATGAAAAGGAAGTGAAAGAATATGCCCAAGTTTTCCGTGAGCATGCCAACAAACTGGTAGAGGTTGCCAATTTGGCCTGTTCCATCTCCAACAATGAAGAAGGGGTGAAATTAGTTCGGATGGCAGCCACCCAGATTGACAGCCTGTGTCCCCAGGTCATCAATGCCGCTCTGACACTGGCTGCCCGGCCACAGAGCAAAGTTGCTCAGGATAACATGGACGTCTTCAAAGACCAGTGGGAGAAGCAGGTCCGAGTGTTGACAGAGGCCGTGGATGACATCACCTCAGTGGATGACTTCCTCTCTGTCTCAGAAAATCACATCTTGGAGGATGTGAACAAGTGTGTGATAGCCCTCCAAGAGGGCGATGTGGACACTCTGGACCGGACTGCAGGGGCCATCAGGGGCCGGGCAGCTCGAGTCATACACATCATCAATGCTGAGATGGAGAACTATGAAGCTGGGGTTTATACTGAGAAGGTGTTGGAAGCTACAAAATTGCTTTCTGAAACAGTGATGCCACGCTTCGCTGAACAAGTAGAGGTTGCCATTGAAGCCCTGAGTGCCAACGTTCCTCAACCGTTTGAGGAGAATGAGTTCATCGATGCCTCTCGCCTGGTGTATGATGGCGTTCGGGACATCAGAAAGGCTGTGCTGATGATCAGGACCCCAGAAGAACTAGAGGATGATTCTGACTTTGAGCAGGAAGATTATGATGTGCGTAGCAGGACAAGTGTTCAGACTGAGGATGACCAGCTCATTGCAGGGCAGAGCGCACGGGCCATCATGGCGCAACTACCGCAGGAGGAGAAGGCAAAAATAGCTGAGCAGGTGGAGATATTCCATCAAGAGAAAAGCAAGCTGGATGCAGAAGTGGCCAAATGGGACGACAGCGGCAATGATATCATTGTACTGGCCAAGCAGATGTGTATGATCATGATGGAAATGACAGACTTCACAAGAGGCAAAGGCCCATTGAAAAATACATCTGATGTCATTAATGCTGCCAAGAAAATTGCCGAAGCAGGTTCTCGAATGGACAAATTAGCTCGTGCTGTGGCTGATCAGTGTCCTGATTCAGCATGTAAGCAGGATTTATTAGCCTACCTTCAACGAATTGCCTTGTATTGCCATCAGCTTAATATCTGCAGCAAGGTGAAGGCAGAAGTGCAGAATCTGGGAGGAGAGCTCATTGTGTCAGGGACAGGAGTTCAGAGCACTTTCACTACCTTTTATGAGGTAGATTGTGATGTCATAGATGGGGGCAGGGCTAGTCAACTTTCTACCCACCTCCCAACCTGTGCTGAGGGAGCTCCGATCGGGAGTGGAAGCAGTGATTCCTCCATGCTGGACAGTGCCACATCGCTTATCCAGGCAGCTAAAAACCTGATGAATGCTGTTGTCCTCACGGTGAAAGCATCCTATGTGGCCTCAACCAAATACCAGAAGGTCTATGGGACAGCAGCTGTCAACTCACCTGTTGTGTCTTGGAAGATGAAGGCTCCAGAGAAGAAGCCCCTTGTGAAGAGAGAAAAGCCTGAAGAATTCCAGACACGAGTTCGACGAGGTTCTCAGAAGAAACACATTTCGCCTGTACAGGCTTTAAGTGAATTCAAAGCAATGGATTCCTTCTAG&#10;" ID="0" sortOrder="0"/><Sequence name="ATGACTTCGGCAACTTCACCTATCATTCTGAAATGGGACCCCAAAAGTTTGGAAATCCGGACGCTAACAGTGGAAAGGCTGTTGGAGCCACTTGTTACACAGGTGACTACACTTGTCAACACAAGCAACAAAGGCCCATCTGGTAAAAAGAAAGGGAGGTCAAAGAAAGCCCATGTACTAGCTGCCTCTGTAGAGCAAGCCACTCAGAATTTCCTGGAAAAGGGTGAACAGATCGCTAAGGAGAGTCAAGATCTCAAAGAAGAGTTGGTGGCTGCTGTAGAGGATGTGCGCAAACAAGGTGAGACGATGCGGATCGCCTCCTCCGAGTTTGCAGATGACCCTTGCTCGTCGGTAAAGCGCGGCACCATGGTACGGGCGGCAAGGGCTTTGCTCTCCGCGGTGACACGCTTACTCATCCTGGCGGACATGGCAGATGTCATGAGACTTTTATCCCATCTGAAAATTGTGGAAGAGGCCCTGGAAGCTGTCAAAAATGCTACAAATGAGCAAGACCTTGCAAACCGTTTTAAAGAGTTTGGGAAAGAGATGGTGAAACTTAACTATGTAGCAGCAAGAAGACAACAGGAGCTGAAGGATCCTCACTGTCGGGATGAGATGGCAGCCGCCCGAGGGGCTCTGAAGAAGAATGCCACAATGCTGTACACGGCCTCTCAAGCATTTCTCCGCCACCCAGATGTCGCCGCTACGAGAGCCAACCGAGATTATGTGTTCAAACAAGTCCAGGAGGCCATCGCCGGCATCTCCAATGCTGCTCAAGCTACCTCGCCCACTGACGAAGCCAAGGGCCACACGGGCATCGGCGAGCTGGCTGCGGCTCTTAATGAGTTTGACAATAAGATTATCCTGGACCCCATGACGTTCAGCGAGGCCAGGTTCCGGCCGTCCCTGGAGGAGAGGCTGGAGAGCATCATCAGCGGCGCAGCGCTGATGGCCGACTCCTCCTGCACGCGAGACGACCGGCGCGAGAGGATCGTGGCGGAGTGCAACGCCGTGCGGCAGGCGCTCCAGGACCTGCTCAGCGAGTACATGAATAATACTGGAAGGAAAGAAAAAGGAGATCCTCTCAACATTGCGATTGATAAGATGACTAAGAAAACAAGAGATCTAAGGAGACAGCTTCGGAAAGCAGTGATGGATCACATATCTGACTCTTTCCTGGAAACCAATGTTCCTTTGCTAGTTCTCATTGAGGCTGCAAAGAGCGGAAATGAAAAGGAAGTGAAAGAATATGCCCAAGTTTTCCGTGAGCATGCCAACAAACTGGTAGAGGTTGCCAATTTGGCCTGTTCCATCTCCAACAATGAAGAAGGGGTGAAATTAGTTCGGATGGCAGCCACCCAGATTGACAGCCTGTGTCCCCAGGTCATCAATGCCGCTCTGACACTGGCTGCCCGGCCACAGAGCAAAGTTGCTCAGGATAACATGGACGTCTTCAAAGACCAGTGGGAGAAGCAGGTCCGAGTGTTGACAGAGGCCGTGGATGACATCACCTCAGTGGATGACTTCCTCTCTGTCTCAGAAAATCACATCTTGGAGGATGTGAACAAGTGTGTGATAGCCCTCCAAGAGGGCGATGTGGACACTCTGGACCGGACTGCAGGGGCCATCAGGGGCCGGGCAGCTCGAGTCATACACATCATCAATGCTGAGATGGAGAACTATGAAGCTGGGGTTTATACTGAGAAGGTGTTGGAAGCTACAAAATTGCTTTCTGAAACAGTGATGCCACGCTTCGCTGAACAAGTAGAGGTTGCCATTGAAGCCCTGAGTGCCAACGTTCCTCAACCGTTTGAGGAGAATGAGTTCATCGATGCCTCTCGCCTGGTGTATGATGGCGTTCGGGACATCAGAAAGGCTGTGCTGATGATCAGGACCCCAGAAGAACTAGAGGATGATTCTGACTTTGAGCAGGAAGATTATGATGTGCGTAGCAGGACAAGTGTTCAGACTGAGGATGACCAGCTCATTGCAGGGCAGAGCGCACGGGCCATCATGGCGCAACTACCGCAGGAGGAGAAGGCAAAAATAGCTGAGCAGGTGGAGATATTCCATCAAGAGAAAAGCAAGCTGGATGCAGAAGTGGCCAAATGGGACGACAGCGGCAATGATATCATTGTACTGGCCAAGCAGATGTGTATGATCATGATGGAAATGACAGACTTCACAAGAGGCAAAGGCCCATTGAAAAATACATCTGATGTCATTAATGCTGCCAAGAAAATTGCCGAAGCAGGTTCTCGAATGGACAAATTAGCTCGTGCTGTGGCTGATCAGCTGGACAGTGCCACATCGCTTATCCAGGCAGCTAAAAACCTGATGAATGCTGTTGTCCTCACGGTGAAAGCATCCTATGTGGCCTCAACCAAATACCAGAAGGTCTATGGGACAGCAGCTGTCAACTCACCTGTTGTGTCTTGGAAGATGAAGGCTCCAGAGAAGAAGCCCCTTGTGAAGAGAGAAAAGCCTGAAGAATTCCAGACACGAGTTCGACGAGGTTCTCAGAAGAAACACATTTCGCCTGTACAGGCTTTAAGTGAATTCAAAGCAATGGATTCCTTCTAG&#10;" ID="1" sortOrder="1"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  ü<?xml version="1.0"?><Features nextValidID="16"><Feature recentID="15" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="3534" maxFusedRunOn="3534" detectionMode="exactProteinMatch"><Segment range="3466-3531" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3811-4333" color="#ffffff" type="standard"/></Feature><Feature recentID="13" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3572-3796" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="6298-7092" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="11" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="4348-4350" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="4351-4353" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="4354-5067" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7700-8288" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5318-5773" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5906-6263" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6114-6249" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5190-5311" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5800-5904" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7324-7371" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="CTNNA2 V3" directionality="1" translationMW="105316.41" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="3534" maxFusedRunOn="3534"><Segment range="601-3459" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="Feature 16" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2895-3173" color="#a6acb3" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  S<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-CTNNA2 V3</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.12.1</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  #†   $  C   B         B’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßaëzß›k…`õR Vðs—H(ÞŠwBw¢×u5ÕÛ‚UE@BÕ?by8û‰SÞÑjø@…Ñ³”-FíQD ƒŽ$AˆÍ]BÆ0lûï£Fèì°•3ö	ÀÃP:Žï0‡s§¶ø0v¶ê›öáVˆCøâÕXçVQú5|ªTJ€TFW¥æ$ÓQG]áA¾Þ,ƒO?áE=Ö8�ÃîÔÚ»ÏF,óœDõñb+WRôöÏ»Ö8íN~ÏÞSÔwl188ÃºXJ‡YF›àØr´Ä=
ðòþM¶ÓÓ8`ñï¾71|3È0H×<Œ43½ã´Ä�…–xPFûµÚ1¡”aåu¹A:ÁSH`mÙ¸{«àWÖ+ê9+¶„8ÕaT…E˜ýJ¯!6=ux$B�Zƒâ½»×XQ@!ZJÁƒOF‡Oˆ¿Ð¶Ö<îàãð÷DÕ(í]�Ë­Qô€E4/(tCÈvß´�‡¯»‹´U·n�!u"!“ûÔ@Æ w¸� öÐNÄ¶wmµŽ�˜S€*g„PŠ9Õhêá]!�s¬áu$B�hSøHõÊû_*E„­±�»>˜`ÊÀvÑPâ8a´ôQya®¡4i†#$Ðu"´xA‡Ó¶�DÍÀöØ3^|ÐA5VNBf½µTÔàcE õ`tÃXfÚ'ƒÔÑˆ˜m†aÑëuÕÚYÛ†-¥Ž=EZ<SB»V“²8ƒ†Ò/†´Ø”Ðji>~µÅ£èš=´éfãMB4R4[€A¶ˆ´H÷lé½9UøacŠ/·TÛæ û_V}.`4â×·âˆºPïDQOú!DESáE¯Gq+B»EÝ«>'C©HZÕ5�¯­Ì‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  W  ;  =  ^   A  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  <?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7180-7227" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5656-5760" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5046-5167" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5970-6105" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5762-6119" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5174-5629" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="6" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="7556-8144" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="5" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="4204-4206" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="4207-4209" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="4210-4923" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="6154-6948" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3428-3652" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3667-4189" color="#ffffff" type="standard"/></Feature><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="3390" maxFusedRunOn="3390" detectionMode="exactProteinMatch"><Segment range="3322-3387" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="0" name="CTNNA2" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="3390" maxFusedRunOn="3390"><Segment range="601-3315" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  O<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-CTNNA2</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.8.8</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  5Ü   #  Q  y        y’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ß`ãpNƒôÐñÃðãXîÂÃä:¸Íñ8±ø�<W	ÿà€ÞÎÀãŽ8«Žœ80èÏüÕSóüÔÀA0ò<<Ãÿ~£…ïÄEQ|W‹ÄSõ}X(R!N+~Õ"]5M=ôF‡QU…RÕYEµKF9SHÕt­Ïa�PR†àåZKtDW4É\†PŽà­ k^oàgÛt§ß^�|Ûjø ¯QE•k¶åbµ)5êVàUk�ëB®´~Þ-`A…RâUîûtm#BE ^ò­øë�DxOn>µàF9gVQà H|­f«ƒhž8OJ»KŸzá¦ÒŠO%µþfÆX.•‚âëŽõî�ôÑD€5 $qEDëzåKôÖ¾mT.Ñ†QT@Në×€VõTUUQE5Q—¹ãtÑE¤UDiGëÒ~å_ËÕtSª¾…e7’ÓÅ'²ÕY=>mGº÷ãž¹ñ=¸–éµT†¸uºýHóÖyÔGFVõ-Yõ5Y">úÝRá^Nný]YUETôqÇ2uGØp†™Q¶±çPaÆHA¼Ê•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      N  T  	)  	r  	t  •  x  A      8®ZTR

BASE      "’  xÁA  ƒ°YãúÀ þµ,9Ýnn”µ¹‰Š2œê–Î¥s™›+œnn,EÆÚÖ6·¶©­-�N§˜è’áTaKE¶­Ímm›Ót8Ý¤mÓµéœ¨L7'9×tK´Ø¦Ût[mÍÕ¶&‹ÚXÎÖæÜ6��¶œØ¶–LEI—cŠK‡2qé6º‰¢®é6]Nr­iÓ-tÕrŽM\êÖdKu)nÓØ6]jÒ–¦Ž¥s®©ËårY-—º˜.usºrnº¶9 œ¢¸ÍmsàT�N7sÓÍé¶M&[º•KZ›âDa‚ l
Ë6Ül@ê”e	¦KÔ—5al0ƒá ‡"%H   � Ð ’p˜Ö˜I
(X’ ¸¥ °1D&Ãá˜I ¹dI-­QJmK%ˆ�Æ°ØØÄÁŠÁæhT[–Ö‚ I­Ñ²V-P¤c5´Z¥„ØË)Š.…°e km�!sh¢¦°6«±åj9\âFË-Å2–"¹ ¤ ²TA±“ÍDÕÒQj‹å7¬Ö°ÅÆjIÑ0•,Ül‹h’$¤-µ€´e«å’¶ÁZR
96‚˜ê Ô�	âj¬`ÛPØ ¶$i Ú’$¨ˆŠkµÁR�6   Ap 	¬ÅreA(@¤A¶Ú0!¶À6Û †àªÚJ��À±0iÃM0Öl „nÑ@ÖjcËÅj±‰-ƒV4 LjÉ@\«m`nn‹�È�€6°±�3·¶C6°%°p©ÐÚ À™Ìªª¶„RFfå€±²• E.+rT&ŒŒ!V°AU XN�B° "�Ñ†CˆXÃ$+°U!„I+¨@ˆ¢-­`0ÌmY1Ræ¶h�–ÃM”ZRˆZn1¤0pP[)­È1„•±Q	-«ÈÐ s•4 G°åF´Š•¥á 2
hÌ`£¢QYÁ–�´ÂŠAU X+€Xä°d¬ÌHW$XT%a+F±Ê`#ª€LXDFe1*Ð²F@�‹²"©X5t mP1ªÚVÛÂA±ªÚp5X«b•%« H QcÀª4"I€…Ø�á*(eƒ±µaÑPˆQU±Ü
¶s†9T+A‘Y�P52(ÊA™6 P˜Õ–+�"J* ÉL$«±Q5t,3¨E,­2X„9r72Æ2 Ü*6`f%e#(�&”I€  n$5É¤teUd:7&lYÁpl�Æ’m´A–�"*Y¦5F9Ë†,p�Va•K�¥[Q�2\µ‘¢`U44FËj(ŒtY1²!XeµH£Z@ÉÊ
¨á   €f  ç<AlignableSequences><Sequence name="GGCCCAAGCCGCCATTGTTCCGCCGAGGGAGGACAGCGGGGCCTGGCGCTGGCGCCGAGACGCCGCTTAGCGGCCGCCACTGGAGACACTCCCTCCCGCCTCCCGGGTCTCCTGGCGGCGGCGGAGTGAGGCTGACAGCGGGGAACCTGGGAGACCCCTCCGCCCTCCCCGCGGTGGCAGCGGCCGATCCCCGGCTCCGGCGCGAGGGACGGCCGCGATGCGCTCGGCCTGAGGTTACCCGGCCCGGCCCTTCCTCGCTTCCCTCGACTATTCCACTGCGTCTCCGCGCCCCGGCGTCATCCTGCGAGTCCCTCTGACGGGAGGGAAGATGGCTGCACGGAGCTGGCAGGACGAGCTGGCCCAGCAGGCCGAGGAGGGCTCGGCCCGGCTGCGGGAAATGCTCTCGGTCGGCCTAGGCTTTCTGCGCACCGAGCTGGGCCTCGACCTGGGGCTGGAGCCGAAACGGTACCCCGGCTGGGTGATCCTGGTGGGCACTGGCGCGCTCGGGCTGCTGCTGCTGTTTCTGCTGGGCTACGGCTGGGCCGCGGCTTGCGCCGGCTCCCGCAAAAAGCGGAGGAGCCCGCCCCGCAAGCGGGAGGAGGCGGCGGCCGTGCCGGCCGCGGCCCCCGACGACCTGGCCTTGCTGAAGAATCTCCGGAGCGAGGAACAGAAGAAGAAGAACCGGAAGAAACTGTCCGAGAAGCCCAAACCAAATGGGCGGACTGTTGAAGTGGCTGAGGGTGAAGCTGTTCGAACACCTCAAAGTGTAACAGCAAAGCAGCCACCAGAGATTGACAAGAAAAATGAAAAGTCAAAGAAAAATAAGAAGAAATCAAAGTCAGATGCTAAAGCAGTGCAAAACAGTTCACGCCATGATGGAAAGGAAGTTGATGAAGGAGCCTGGGAAACTAAAATTAGTCACAGAGAGAAACGACAGCAGCGTAAACGTGATAAGGTGCTGACTGATTCTGGTTCATTGGATTCAACTATCCCTGGGATAGAAAATACCATCACAGTTACCACCGAGCAACTTACAACCGCATCATTTCCTGTTGGTTCCAAGAAGAATAAAGGTGATTCTCATCTAAATGTTCAAGTTAGCAACTTTAAATCTGGAAAAGGAGATTCTACACTTCAGGTTTCTTCAGGATTGAATGAAAACCTCACTGTCAATGGAGGAGGCTGGAATGAAAAGTCTGTAAAACTCTCCTCACAGATCAGTGCAGGTGAGGAGAAGTGGAACTCCGTTTCACCTGCTTCTGCAGGAAAGAGGAAAGCTGAGCCATCTGCCTGGAGTCAAGACACTGGAGATGCTAATACAAATGGAAAAGACTGGGGAAGGAGTTGGAGTGACCGTTCAATATTTTCTGGCATTGGGTCTACTGCTGAGCCAGTTTCTCAGTCTACCACTTCTGATTATCAGTGGGATGTTAGCCGTAATCAACCCTATATCGATGATGAATGGTCTGGGTTAAATGGTCTGTCTTCTGCTGATCCCAACTCTGATTGGAATGCACCAGCAGAAGAGTGGGGCAATTGGGTAGACGAAGAAAGAGCTTCACTTCTAAAGTCCCAGGAACCAATTCCTGATGATCAAAAGGTCTCAGATGATGATAAAGAAAAGGGAGAGGGAGCTCTTCCAACTGGGAAATCCAAAAAGAAAAAAAAGAAAAAGAAGAAGCAAGGTGAAGATAACTCTACTGCACAGGACACAGAAGAATTAGAAAAAGAGATTAGAGAAGACCTTCCAGTGAATACCTCTAAAACCCGTCCAAAACAGGAAAAAGCTTTTTCCTTGAAGACCATAAGCACTAGTGATCCAGCCGAAGTACTCGTCAAAAATAGCCAGCCTATCAAGACTCTTCCACCTGCTACTTCTACCGAGCCATCTGTAATCTTATCAAAAAGTGATTCTGACAAGAGCTCTTCCCAAGTGCCGCCAATACTACAAGAGACAGATAAATCCAAGTCAAATACCAAGCAAAATAGTGTGCCTCCTTCACAGACCAAGTCTGAAACTAGCTGGGAATCTCCCAAACAAATAAAAAAGAAGAAAAAAGCCAGACGAGAAACGTGAAATTTTTTTTCCTGAATTGGACATGTGTTTGCAAACACTTGTCTTGAAGATTATGCTGTTTATGCAATAATTTGTGAACATGTACAGAGTTTTATATAAATTTAAACCAATTTTTAAAACAAAACTGCGGACACCACCATAAAAATGGAATCAAAAGAAAGTTAATTTATGAAATTAAGAGGTCAGCAGAATATACTCAGTGATGGAAGACACTTGGGAAAGTCTTTTTAATAGAACAAGAACGATCTTAATTTAAGAATATTATCCTGGTTTAACAACAGTGCCCTGTTTACAACAGATTGTGCCCTATCTCATCTGCAGCCGAGGAATAAAGGATTCTGATTAGAAAGAGGGTTGCCTACAGATTAGTAAGCAATTCCTTGGATCTTATGCACAGAACTTGTACCATTTGAATCTGTTTTATGCTTAAATCAAAGTGCTTTGATCAAATGCATAACCTGCCATATCTTTACATATTTGTTGGTAGCAATTTGTATTAAAGAAATCACAAGTGCAAATAAAAAGTCATTTATCATTTGTTTAACTAAACTGTCATGGTTTAGTTTACAATTTTTAAAAAGTTCTTAAAATACTGAAAATGCAGTTGACACTTGTGTATGGCTTATGAAGTTATTTTTGATAGTCTTACATTACTTGAATTGTTCAAAGTACAGTATATTTTAAATTAAGAAAAGTGAACTATATGTATTTGTTTTATACATTTAAGGCTTAGACTCATAAATAATGCTATTGTTTATGATTTGAAAACTTTCAGGCAAAATCCAATTTACATTTTTCCCTTCCCTAGCAATTACTTTTTTCCAGCTTCAACTCTTCTTAGTTACTAATACTTTGTTGACTTTAAAAATGAAATCATTCACAAACTTTTGGTATATGATGGAGAATGAAAAACTAGAGTCAGACAGCTTTAATTGACATTGTCAACACCTCCAGTTATCAGGAATACATTTTTTTACTGCCTTAACCTGTAGTGCGTAGAATATGCATCAATTTCTTGAAGGAGATTCATGTTTTTATAAGAATTTTCATGTAATTATTGCAATTGTGGTCAAATAAGGAACGTTTCCTGCTTGAAATTATATTGATTTAAATGATGTGTGAGATGTTTCACCATTTTCAGGCACTGTGTAATTCTATTGTAATAAACTGGCAGGTATCTTTGTAACTATAAATAGTGCATGCTCAGCCATGTACACTGTAAATAGCCTTTACCAAACGTGTTTGACAAGGACCATAATTAACATCACTTAGTGAATTGTGATAAAGAAAAAAAAGCCATGATTTATTCGATGTGATTGGCTTGTTTTTATGTGGCGCCAAGAACGAACCTGTTTAACAGCTGTAACCAATGGTACTGATCTATCCATCCAATGTTGTCATTATATTTGACTGTGGTTCAACAGTATTGCGTTGTCAGACTAGGAAAGCTAAACGAACAAAATGGTTTTAGTTTTGCTGAAGACTGGCCTTATTAATGGACAGCTTTCCTAACAAGAGATTATTAACTTTTATCAGGTGTTAACATCTGTTTCAGGAACATGGCAGTATGTTTACATGTCAGAAGTTTTGTTTAATTCTATGGTATTTCTAAATTGACTTGTTTAAATAAATTCAGCAAAAAAAAAAAAAAA&#10;" ID="0" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  6<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2421" maxFusedRunOn="2421" detectionMode="exactProteinMatch"><Segment range="2353-2418" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2698-3220" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2459-2683" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="5185-5979" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="3235-3237" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="3238-3240" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="3241-3954" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6587-7175" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4205-4660" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4793-5150" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5001-5136" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4077-4198" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4687-4791" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6211-6258" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="MTDH" directionality="1" translationMW="63838.51" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="2421" maxFusedRunOn="2421"><Segment range="601-2346" color="#ff0000" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  N<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-MTDH</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.1.18</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  'ý   "    “        “’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßa‚‘L©VA�¶�}A­Ó«ã„aç!Q™$�u�Fde8`«hnEf‚‰ÓØ`xa=T´LDÒ¢„«”_!€Q�ÔGÕúþÑæcD4SÐß‚æÑõ]AƒS§ÔFÊI‡¦¢ƒOCÝ >’pØa+s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  T  C  Œ  Ž  ¯  ’  >      5®ZTR

BASE      µ  xÁA  „°Y%÷À þ³öHÙr2¬VdnÙ¶Ì1Ü*·lc (›£‘¸5\Ãd 5I®!VI‘l$¹ÕJÍ%�­’†KÆ† â@]) e` !éd L­l,S× YJ•c Î¥TL”q2LAu$[ƒD™nÍjKE1 7¶˜.f’´!mI’RÁ"`H’"‰S´H‡”ÙåÆŠb�áª-Ç¶D1’ÅH@"c(0HA"$rIZ�’‚QšŒŒáF’
±$qCH�!NÄae‰ÕTa3II(ˆl€,¥­¶5d‘4rˆÁ[Ú"¡!À@I®Ø@Q¤Y20’•¥ÃÝR¥Šn…1Ib-y~Ö  D<AlignableSequences><Sequence name="atgga cctgcgacag tttcttatgt gcctgtccct&#10;      121 gtgcacagcc tttgccttga gcaaacccac agaaaagaag gaccgtgtac atcatgagcc&#10;      181 tcagctcagt gacaaggttc acaatgatgc tcagagtttt gattatgacc atgatgcctt&#10;      241 cttgggtgct gaagaagcaa agacctttga tcagctgaca ccagaagaga gcaaggaaag&#10;      301 gcttggaaag attgtaagta aaatagatgg cgacaaggac gggtttgtca ctgtggatga&#10;      361 gctcaaagac tggattaaat ttgcacaaaa gcgctggatt tacgaggatg tagagcgaca&#10;      421 gtggaagggg catgacctca atgaggacgg cctcgtttcc tgggaggagt ataaaaatgc&#10;      481 cacctacggc tacgttttag atgatccaga tcctgatgat ggatttaact ataaacagat&#10;      541 gatggttaga gatgagcgga ggtttaaaat ggcagacaag gatggagacc tcattgccac&#10;      601 caaggaggag ttcacagctt tcctgcaccc tgaggagtat gactacatga aagatatagt&#10;      661 agtacaggaa acaatggaag atatagataa gaatgctgat ggtttcattg atctagaaga&#10;      721 gtatattggt gacatgtaca gccatgatgg gaatactgat gagccagaat gggtaaagac&#10;      781 agagcgagag cagtttgttg agtttcggga taagaaccgt gatgggaaga tggacaagga&#10;      841 agagaccaaa gactggatcc ttccctcaga ctatgatcat gcagaggcag aagccaggca&#10;      901 cctggtctat gaatcagacc aaaacaagga tggcaagctt accaaggagg agatcgttga&#10;      961 caagtatgac ttatttgttg gcagccaggc cacagatttt ggggaggcct tagtacggca&#10;     1021 tgatgagttc tga" ID="0" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  6<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4957-5004" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3433-3537" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2823-2944" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3747-3882" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3539-3896" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2951-3406" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5333-5921" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1981-1983" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1984-1986" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1987-2700" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3931-4725" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1205-1429" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1444-1966" color="#ffffff" type="standard"/></Feature><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1167" maxFusedRunOn="1167" detectionMode="exactProteinMatch"><Segment range="1099-1164" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="CALU" directionality="1" translationMW="19409.61" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1167" maxFusedRunOn="1167"><Segment range="601-1092" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  O<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-ACMSD</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.1.18</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  b	   !    –        –’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßa‚‘L©VA�¶�}A­Ó«ã„aç!Q™$�u�Fde8`«hnEf‚‰ÓØ`xa=T´LDÒ¢„«”_!€Q�ÔGÕúþÑæcD4SÐß‚æÑõ]AƒS§ÔFÊI‡¦¢ƒOCÝ >’pØa+…Ì‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  F  �  ‘  ²  •  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  
<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="0" name="CALU" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="601-1095" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1170" maxFusedRunOn="1170" detectionMode="exactProteinMatch"><Segment range="1102-1167" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1447-1969" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1208-1432" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3934-4728" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1984-1986" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1987-1989" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1990-2703" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5336-5924" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2954-3409" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3542-3899" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3750-3885" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2826-2947" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3436-3540" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4960-5007" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  O<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-ACMSD</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.1.18</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  b�      ˜  —        —’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßaV‡od¶kŸUFåU¨9Á4ï]÷M@E5J(T`.´H#Ž½¬šDVÕPIt�Oê÷Jø¶*NxWáz•ø�N©]qú=7Ê!9ÿA
È€£ö4?á80µ`Lâ!Q8¯À/Vƒr×ø\Íî¯‹˜ÃOŠþ+#oà�X=Yàïè:$=4Gßdö£½†ØjJ¿W…HŠ³v �¯úÝ [¿`kMŒýˆ�ÐuÿaV~‚¾©Ýê
Øo¸¿µ8¥Ñ‹dT¶¨ñ§þ¯yNøydKØZ†WTY^Õ<5�àÚ¨¡WZ…s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  T  G  �  ’  	³  –  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  <?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1683" maxFusedRunOn="1683" detectionMode="exactProteinMatch"><Segment range="1615-1680" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1960-2482" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1721-1945" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4447-5241" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2497-2499" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2500-2502" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2503-3216" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5849-6437" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3467-3922" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4055-4412" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4263-4398" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3339-3460" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3949-4053" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5473-5520" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="ACMSD" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1683" maxFusedRunOn="1683"><Segment range="601-1608" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  O<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-ACMSD</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.1.10</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  bû     Û  ¢        ¢’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ßbÓ]EPˆEEÊšaúEÕ~Qf¿átÚæØF@õXaEYívýQT¨xUJ»¹‘vÝ£‘	æKXóV=.ºB `âkdM<?â£“…‹%øX8†x�U·baúøÕf-½ž$Y= öi`¯ÝAGèÕ£™[náNÈTU—oJ6¯ãn×Cj`êýq>8ÒÚ?µßiA`èõßaÚ®"ë¤R‡­VçUEXXJ«¼‘ÆYaEAŠ…EÑ„\/DMR QXMÔcFµÞ-â?ã­CJx•Qª5A…Y§U!Htm®#!õoÆQ×XVUhWE³Dí™�]^­µ}Eò M}†½¥ÑÔQU!U;ÐÄß�càHPïH~EYïBøc@7Q…1AuE`^UÌ‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  T  R  ›  �  
¾  ¡  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  9<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5740-5787" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="13" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4216-4320" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3606-3727" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4530-4665" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4322-4679" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3734-4189" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6116-6704" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2764-2766" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2767-2769" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2770-3483" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4714-5508" color="#ccffcc" type="standard" translated="1"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1988-2212" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2227-2749" color="#ffffff" type="standard"/></Feature><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1950" maxFusedRunOn="1950" detectionMode="exactProteinMatch"><Segment range="1882-1947" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="MACROD2" directionality="1" translationMW="47422.53" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1950" maxFusedRunOn="1950"><Segment range="601-1875" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  O<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-ACMSD</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2019.1.10</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  c     å  Ê        Ê’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³ßbÓ]EPˆEEÊšaúEÕ~Qf¿átÚæØF@õXaEYívýQT¨xUJ»¹‘vÝ£‘	æKXóV=.ºB `âkdM<?â£“…‹%øX8†x�U·baúøÕf-½ž$Y= öi`¯ÝAGèÕ£™[náNÈTU—oJ6¯ãn×Cj`êýq>8ÒÚ?µßiA`èõßaÚ®"ë¤R‡­VçUEXXJ«¼‘ÆYaEAŠ…EÑ„\/DMR QXMÔcFµÞ-â?ã­CJx•Qª5A…Y§U!Htm®#!õoÆQ×XVUhWE³Dí™�]^­µ}Eò M}†½¥ÑÔQU!U;ÐÄß�càHPïH~EYïBøc@7Q…1AuE`^UÌ‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  |  z  Ã  Å  
æ  É  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  9<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="0" name="MACROD2" directionality="1" translationMW="47422.53" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1990" maxFusedRunOn="1990"><Segment range="641-1915" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1990" maxFusedRunOn="1990" detectionMode="exactProteinMatch"><Segment range="1922-1987" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2267-2789" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2028-2252" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4754-5548" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2804-2806" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2807-2809" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2810-3523" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6156-6744" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3774-4229" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4362-4719" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4570-4705" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3646-3767" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4256-4360" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5780-5827" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  R<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-MACROD2</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.12.19</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  c	     æ  Ð        Ð’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³ßbÓ]EPˆEEÊšaúEÕ~Qf¿átÚæØF@õXaEYívýQT¨xUJ»¹‘vÝ£‘	æKXóV=.ºB `âkdM<?â£“…‹%øX8†x�U·baúøÕf-½ž$Y= öi`¯ÝAGèÕ£™[náNÈTU—oJ6¯ãn×Cj`êýq>8ÒÚ?µßiA`èõßaÚ®"ë¤R‡­VçUEXXJ«¼‘ÆYaEAŠ…EÑ„\/DMR QXMÔcFµÞ-â?ã­CJx•Qª5A…Y§U!Htm®#!õoÆQ×XVUhWE³Dí™�]^­µ}Eò M}†½¥ÑÔQU!U;ÐÄß�càHPïH~EYïBøc@7Q…1AuE`^UNœÈyÕaÂeFØvÇ�A‡u!ð?*Wó†Óìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      N  |  z  É  Ë  
ì  Ï  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  9<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="0" name="MACROD2" directionality="1" translationMW="47422.53" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1996" maxFusedRunOn="1996"><Segment range="641-1915" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1996" maxFusedRunOn="1996" detectionMode="exactProteinMatch"><Segment range="1928-1993" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2273-2795" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2034-2258" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4760-5554" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2810-2812" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2813-2815" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2816-3529" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6162-6750" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3780-4235" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4368-4725" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4576-4711" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3652-3773" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4262-4366" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5786-5833" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  R<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-MACROD2</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.12.19</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  bÞ     ç  Ó        Ó’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³ßbÓ]EPˆEEÊšaúEÕ~Qf¿átÚæØF@õXaEYívýQT¨xUJ»¹‘vÝ£‘	æKXóV=.ºB `âkdM<?â£“…‹%øX8†x�U·baúøÕf-½ž$Y= öi`¯ÝAGèÕ£™[náNÈTU—oJ6¯ãn×Cj`êýq>8ÒÚ?µßiA`èõßaÚ®"ë¤R‡­VçUEXXJ«¼‘ÆYaEAŠ…EÑ„\/DMR QXMÔcFµÞ-â?ã­CJx•Qª5A…Y§U!Htm®#!õoÆQ×XVUhWE³Dí™�]^­µ}Eò M}†½¥ÑÔQU!U;ÐÄß�càHPïH~EYïBøc@7Q…1AuE`^V:s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  |  }  Ì  Î  
ï  Ò  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  <?xml version="1.0"?><Features nextValidID="15"><Feature recentID="0" name="MACROD2" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="641-1918" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1999" maxFusedRunOn="1999" detectionMode="exactProteinMatch"><Segment range="1931-1996" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2276-2798" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2037-2261" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4763-5557" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2813-2815" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2816-2818" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2819-3532" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="6165-6753" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3783-4238" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4371-4728" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4579-4714" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3655-3776" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4265-4369" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5789-5836" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  R<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP-MACROD2</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.12.19</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  b�     x  ö        ö’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³ß`;O‰µK}Yêî¾ë^†ë©¾4†ø°�¾DÒ­»‹ãWï½;:A€˜ºÛ€-æ;`:ø6Ã<µÄ/8øà'¨êøï†ûhýpðî¹ë]€ÔáM`0Û!á;kç]4³tøÐcàr4;BŽ0à-:ç^G\á;alþ·çþ+ãµ A×O«ˆA@ëŒCÿtÑ ×ßáƒâ'Ð@ã`EÐÈ8ÐEø¶û€ÈƒÛlNø‚ø½¸è�ËÚñG�5ýIÔéÌ‡�Qö!¦Tm‡lyÔq‡Roò¥8m>Çˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  |    �     ï  ñ  	  õ  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  6<?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1522" maxFusedRunOn="1522" detectionMode="exactProteinMatch"><Segment range="1454-1519" color="#cc99b2" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1799-2321" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1560-1784" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4286-5080" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2336-2338" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2339-2341" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2342-3055" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5688-6276" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3306-3761" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3894-4251" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4102-4237" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3178-3299" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3788-3892" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5312-5359" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="CD82" directionality="1" translationMW="29626.35" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1522" maxFusedRunOn="1522"><Segment range="641-1441" color="#993366" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.11.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  bx     y  ù        ù’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³ß`;O‰µK}Yêî¾ë^†ë©¾4†ø°�¾DÒ­»‹ãWï½;:A€˜ºÛ€-æ;`:ø6Ã<µÄ/8øà'¨êøï†ûhýpðî¹ë]€ÔáM`0Û!á;kç]4³tøÐcàr4;BŽ0à-:ç^G\á;alþ·çþ+ãµ A×O«ˆA@ëŒCÿtÑ ×ßáƒâ'Ð@ã`EÐÈ8ÐEø¶û€ÈƒÛlNø‚ø½¸è�ËÚñG�5ýIáS§2uGØp†™Q¶±çPaÆHA¼Ê•üá´û#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      N  |    �  £  ò  ô  	  ø  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  <?xml version="1.0"?><Features nextValidID="15"><Feature recentID="14" name="CD82" directionality="1" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1444" maxFusedRunOn="1444"><Segment range="641-1441" color="#993366" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="13" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5315-5362" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3791-3895" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3181-3302" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4105-4240" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3897-4254" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3309-3764" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5691-6279" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="2339-2341" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="2342-2344" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="2345-3058" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="3" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="4289-5083" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="2" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1563-1787" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1802-2324" color="#ffffff" type="standard"/></Feature><Feature recentID="0" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="1525" maxFusedRunOn="1525" detectionMode="exactProteinMatch"><Segment range="1457-1522" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.11.14</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  `X     £  ã        ã’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ„Àü©_ÎO±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  Ü  Þ  ÿ  â  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ó<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4525-4572" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3001-3105" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2391-2512" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3315-3450" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3107-3464" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2519-2974" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4901-5489" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1549-1551" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1552-1554" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1555-2268" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="3" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3499-4293" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature><Feature recentID="2" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="773-997" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1012-1534" color="#ffffff" type="standard"/></Feature><Feature recentID="0" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.10.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  `m     ·  ñ        ñ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ„Àü©_ÎNP?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      N  Ü  Þ  ÿ          ð  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ô<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1026-1548" color="#ffffff" type="standard"/></Feature><Feature recentID="11" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="787-1011" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3513-4307" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1563-1565" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1566-1568" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1569-2282" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4915-5503" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2533-2988" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3121-3478" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3329-3464" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2405-2526" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3015-3119" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4539-4586" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.10.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  `[     §  Ñ        Ñ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:s!çT}‡i•aÛuaÔ†P?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      N  Ü  á  ç  ç  í  Ð  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ò<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="735" maxFusedRunOn="735" detectionMode="exactProteinMatch"><Segment range="667-732" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="994-1516" color="#ffffff" type="standard"/></Feature><Feature recentID="11" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="755-979" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3481-4275" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1531-1533" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1534-1536" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1537-2250" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4883-5471" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2501-2956" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3089-3446" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3297-3432" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2373-2494" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2983-3087" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4507-4554" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.10.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  `k     µ  	        	’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNñk1³�,pŸ5:©^”è'ÄìÞKÒ �ks!çT}‡i•aÛuaÔ†P?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      N          %    @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ô<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="791" maxFusedRunOn="791" detectionMode="exactProteinMatch"><Segment range="723-788" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1050-1572" color="#ffffff" type="standard"/></Feature><Feature recentID="11" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="811-1035" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3537-4331" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1587-1589" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1590-1592" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1593-2306" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4939-5527" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2557-3012" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3145-3502" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3353-3488" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2429-2550" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3039-3143" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4563-4610" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  J<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.10.11</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  `X     ¥  Ê        Ê’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ ZÜÈyÕaÂeFØvÇ�A‡u!”ÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  Õ  Ú  à  à  æ  É  @5      @,®ZTR

SMP4      ;øU\  xÁK¬­[zä÷÷ÿþÏ9×Z{ïsêœr¹SvÙ‰e;Ž¤b+Š‘8¡ÃEt@¤C„ +Dc zHôÓ@¢kÚt$8vä¸.{¯Û¼ý×1Æ÷ñ<ôñâß„ˆ�Æ‡à»áèkóø8ŽOC÷áÃWŸ¾~øö;ßùúëï}÷ÛÇïÿ…_øö/þðW¿Æ÷ñƒ_Ž-t4øÃø»øGñû`àãþ¯Xá�ÿïÿó�ÿñÿó'ÿï?ù'úÇúÓ?ùüçÏö³ŸÿüþÓóç—Ï·iº_/Ë:/iO¹D‹¿�ÿ6þ*„Á˜˜D±b�@DX B†0ˆbaf�!i"’"Å ‚((@1r•sEDB#ÐÅ±HAöÌ\ ´(€¥˜¬2Ú(áÝ°6bäÀ¢¬v*ˆ%-1È˜B¤´!ÿ6„¥è›ÚPµk¾Íè¦vN´Š��lJé¦s&Ë�–Ö×uEû”ïéàŒSZÇ_—�´7]e$MI¹1˜ $	"ªn¹]ÊÕÕ[EJ(þ$ƒa«ƒï°lóËÒøÎ‘f€8þ%È®™êªiö|Ÿ_¥œL1Ž¿ 	ŠÚÉUC�z¹/os©[ç$$Ràx€dãm_9LgAÓy£X	8§Âv8xZæëKBjGE‹Ç@HH²ïíðTó|½Þ²í»V!kÇAH²'Â8Zu>_.0í‡C½–iMÖë  Ž¿	²Î‚¾?Úûv}Ý8Ô! ŽB"�UÀ]sÒååü–]Ý;—Œ@8~‰ •e÷Ç¯�üò³ëEBs¨ Žß@ˆ	…¸˜öppeý’ÒÐ�F«¬‹çø$ÈÄ9£Çí|~ÝÕ8Ž�¶u�JÑU¥  âø]œ%Y}jÛ,Ÿ¯›T¡&+
"� ‰ä¡¦t[€Ã`Ý¦ÁÄ $‚ÅuÃ�¶é-%7ÖªBETí[CÛr›PUÇSÅÛË—7 ýx€·õm[†±ÑÂ ¡Œ�¶ãÇO²=¿ÿÙÕéÐû²i�0 !H*E5ceÖé²³?Ž ðV²íž¬Ì·õ6‹„Ú0qü!€*jGpã!Èt=¿éð±«¢R¦aè*óþ¾Ìµ>¶ŠE(éRLõ»¼?¿ÍºûøØÙ;½œïKxøðA¡Ü¯/‹Ñ]U %I’îNÇNÖû—gÆ©o…I -Þ)»º;ÁL—MÌá`4kfâè! TA.T}¨¬ú|['i|c‰xB_._Î;Õ£ó�p|€ $’s‘vx@:ß^oRãÑ%* áh  ‰ä¤Ü0žšr{ýrñíCo vH"ÑUS{¿Ïªîñàðþù'¯á0•ÞAÂ±‚ „¬’µþh’ºm¯ÈcW‹�p´ˆbl™Ãá¡Sæóå<ãÀ6iH´Q /¡ûæøÙ—üŒñÓƒUYAD¢+JÚ©ŸŽX.o¯³ëÇÊo.«(×„6§ËtÓôñãS…—÷çûÕŸZ[v�ˆÄ Á†µîÇQm·ëå¬ÜS]A@L a/ÉúÓX•ízK<t�"H8þW€DJÊª>žuûr¾¤æøñpÚïÏ¯Óe´�¡½_wÂ“¯ áø{ˆ’²%Úž†0ß®?MhêÎÐbb B¬ŠM%Ûv°½¼M%F•AÂñ·  !Ó²íÃ§·×Ÿ½ew|°X!Žÿ$‚=³Ãã‘ž_ž_õñiPHºxáø#±*z+ÅtÃa[n—]|][StñÂñ 	ŠÊ¬º¶	ØÎ÷Ž­Sbâ(ˆÿ	Äª€³ë³.ïÏÉ7MË:+Çß„€Xe½MËÓÇG³½¿üäšñÕ‡äýå|VAãwˆã¿ !&3±ª»Û|ËÅŽM#¢Âñ—!ÄNTØw=ùóý|u¨l¶áøŸAˆAH’NC/×÷—èÃÃS“è~~cÝT)0Î"ÕS×–××Ë„öÓÇGÚßoï_&Ssø
æýr^Š{zøºÁr9¿\ÕØIA  ðž¥T§§@·ËôŠ`êŠ �pt ªH–Ü>œÌ~¹M7v�Çv_Þ®×+êñØóv}_ÎÔUÁ¡€„ã·8K‘ªiº°_Ö»ë:ï3éâ9~¼ñ^šÓ¡’ëíy¦æÐš¢3„ãïB ¬˜ÜÃðØã~}»$Œcp› ÄÑ@ˆI�°ë~<>Ñôòò:ãC} °‚pü1!k[º¼í—$Åu^ºxŽß@ˆ	œh­ºê©±Ûô“iw§ƒÒYƒ‰ã+$(j'}ÆnN/—¥øS]¯ª ÄÑA B¡-éî|y¹Ï».­¯…
xO}?xÞ^×Tõ} dÂÑA UÌ–�ó]Ïi~]îŸM±é~ywÕcp" qüU1�s)ªzò�ì—ëÄA°G‰ ñ¾7Om�æ÷çë\ô±U(Z„8þ2 p.«„Ó!˜éþz½!|úx-—ùuÉÒ—�€3‡¡V|_ï¦¼ ¼��í\˜çó¶YýôpD:¿_ft�R»—»œ_óç÷?ßÑ=µ†ŠG	Š¾9©†ª•Ëí~MáÁ{�8ž $ÞºáúþÙ"˜&;qü1‰”²oM÷T…éå²n¨ëÊ�â!A1KÑ¦¸ß_ïâë®€8þ„D(é\(úòú“‹Ô­#"A¦”Ãø8œôåõgoÊŽ�J¬À¯eìÇG¼¾ÜsÛ^³@V0Uýa(ïo»˜¡.[A"ïú!èóûõæÐ4ÄF O� é¬ÂÐwÕ5_“�¢Îkhˆ*.ŽAÀ¹Özºîš@šâh!$à²Jjë‡f\ÓåvÝºšâG1�wÉäë'ïÖëûOg±}íÀ*þ„\2³Ómz›/I«§¡é{\çÏTa°FHÏñ?‡� ˜ÅÛ¡2ú~ß·Ü… M2ÅG	².EºnÐÍý|›9M­(Ûh}ï]ZVpÝéJŒ)™$ø!µÜö›ªôC­õ¼_/ëê]¥@¿��xé®%£Öi[¨zì»€<¿?ƒÐ¥™�U¦ÐÕ�év»‰ñM«²‚Çß‚«â
siÌ©ÖªœÓ´Ùã8¢—åzSÖTÎ ÀÑBHE@zôÝŽÛ¶Ì¥«ûÎÏË¢«^U$
ÈZàmS½Ïó™Û`kh-àè!Äª¸AíïÊzßÒÞôm]IÞïkNÎw�,Ó¼ËÖrEÇ_ï&„ÂûÕÜU9CDñ— 9ó:6Åx¿Ìâ][iRE	Å„ÀR Œ	ªÉzÝ2 ÛG¥ù|;Ÿ�r¶a21@HÀœ…uhlcä–
)e‘&æ•Œõ•ìSI^[§MRŽ'‰ ³Õc€šR*ÊõÞ%†)!$(vmMW[Ü÷mË]Ý�ÁÝ–‰ymkoDK†€ê0R�ëmŸfÝ;cÄÄ'‰€WéÚÆ”ÛvÎälÒ øÛà²+í�>¥´-®Æ†L
ÿ[p"¢Ê×µç<ífÎ•bUô¡¢�¾ã¥ÜV1u¨mC¼C;ŒA¾Ëâ¹w�²²–	Ô´][•’îË]ùntaÛÓ²Ü¦¾òZ	ÅïB ¨lvUu}_§ËeÍºíú£Ï<}¹&ûàP Ùw[õ‡!¬ëöºÂ4�… Äño@ ¾“¨‡S#óíù¶„æ±daÅB"àbú.XÙo3v×ô=0Ï—÷¹¢¶Ö¢ã?„�xgÖ}ßèõ|y¿Wh[aqtbIe¯êþ©Zï—×Õ„�Uµ(Ž¿
‰È‚ÜC^^·Rï‹* ŽG1‰leoêGÖùü¾ó³.n—R‡¡ÎévÛ§thj#ÐÅíÂh¯ÊºN[¦Ãátrér½\¥
¾NB ŽßB BÒÙøªïW:OÛjè«c�åõ}Þh¬[À†�ëî¤åºÜ6¶Õh|âøW! IÛR•.o÷eÝX©BÅ G‰ �Ð4Áë´mWh=ÀÅÿ²+ÑUã­Y×eQ­m´ÖIqüˆ¬	ÁöÖíû”²©Çc¯x}[~fT?�BñB(z-ì«¡ÍÛýz�šþ±3�×»ÜýP9ÇZqlQT¯ú6!O;6ÕCJË„lÆ&x³ïëò¦Ã¡í]‹Û´eÁI�Ç_„dÑª
!HN‰g±ŽŒ¦ødW)øú¨›ÛmÚt°ÖkÖñoBrÑÒVµ#Üv.uc�Š¤,ÄuÝø½¬W�MEÐñ„Å¬Ù9ßw&o÷-KqÎ(V"¿á�´3­q[º•Ý£ÉëõTS×–„â¿Îœ*W×}^§Ë™÷ÞE!ª¸!êë6Ó2ßv]wuWïyI»Ìªt¥îëfwk*§¡cÉ`muW%óTî^·‡¥,«’€ºVºPüÎL:¸Þº2Ï/‹ó]ßØé6¥RT´bŠ¿Þ)WUWwX×í¦Ýè+	™(þeHkÝ7&ˆÜK6uW7ÖKšQ×Œ¦Ãzß¯²;]�TüE�uÖªéGEï×·mëúÑˆâ�!$‚BÙ9×ºm—÷ìŽµsEIIoººÙè¾ÜIwmPŠ5Ç_„KÎ
‡êÁ»mºl,ÝX9"FñŠÂ`ÞUºñbö¼jè®÷ÁSY“e‚E+‰ß‡$ä¨©­Z÷mO0ucÝÎ¼ÙkÛè~3WÌ‹m½v¤I-R‰©šPmûö>gã;¯Sü· "@V»ó}wèõýeù¹òMÓCïšI(!’m2VyO¦ìÛ´Ö¡ÎÜöIUMÐ�•–²aïº6˜�ÏÓê„ZgD�9)Óµc‚m¨2Šâ÷Á¼ÙÝ)ŒN<M~ß;lëºCmµVPüŠgÙ4¬
5°ò¶ÌÉV_™$Y’7ÆkmPñ€h¥¬†*Û9[ò]¦¥®CÎ)ËÒ›¶ªÍ–&èÖx«�!’ø=ˆdÃÆÚViÅ{YJåÈÁ1Åád7«m£�’V›�î/ûe±0ME6ñ´ºÆ»Ö8¤y»¹ÞiOZ	@q„0C²‚q¦³aßÏÈÊU•Ïi¿óTÕ­ªŠm_ù�×}ÓƒÕÖ³ŠÿDÂ™Dy×9ÇËŒRU}Uë=mKhšª±Äó®«Êe5ˆ@ñ;�,•«=›û´ÝëP™PH±l¢¨o];Ïë}GÝ4ÁˆÅ_ƒ”R¹VÌ÷]¹ƒ¯ÄAâ#D
H{W9Jû¼Ü6_kOŠâwÁ�RöBÖ÷]ÀíM¶0øJ+Öâ,»7ý±ª×·ççŒVwbD â¿	aaI¦xTmåÊ|KÉÖuh ÿ:X,%K}ì}»ÝT:(VÞ4LÝT®ìmöÐ4&/«n¤qŠ%C`Ûáˆíöš‹§ÖVb  Šÿ<D„9ª©‡N§ëzÛMœ¥¢„€€I)jBcÝžÞ.*Œª"QŠãïCX™ˆê¦:ïËâ÷ž<Åÿ>„9["Ñ¬ˆHC)@².Ù&QÐñ¯¢˜]{�¶ÆkÍJ²Á�öäÄ¨ø-8“ÍN9¯!{¶¢l!c”ŽÿÙíÊ‰³Áp™—IÐŒj¹¯wÓ:ë ŽB"àURÝŒí‰Ë}*µ•3
d$þ"x'PUw•KÓ=•Ö»Úr.¤´Ê(ÒÂ;X×UoMZó:I±ÎB ŽG‰  {=4~7÷uy#gzM$ª¸M]×‘ÊÓr'%½6Šb ¢Š“²
lÕ·àëùýKîìPÜÒ:)Ã¡Ö ]<Ç‰ ;	Õm]/y™Åî!�-
œ2©±ý0nÓûÛ
©û 2”€ãw $"	l]ÛÊó-CÕÎª¢ÀeJ8ôO¼\Þ¦-º°C�‰ãB"ÀÎÙVÝñ€Ûù~ãêXwDE!kNm}Ü”_Þ&	O�U�/óëêø©v€8þ B"À^²vÇádÞ®ç7U?T6ì’‘¥ý“ß®¯ÓVÌÐáx„�°Ðv£Oû­Ì¦k½Ïš e-›j?8•æÛ²Y×¶ºX�pô�vômžoëfSçŒ€‰ã ±*zZŸšR~þüùÕúïÔ*‰.ž£ƒ€»*pu‹\¦ù³5£»ËŽß@ˆI„§¬éØÕœo¯—§æë–V¹ÞwöãP	ÉÎœ»±sS9ÏwM®6F@LG@àÄ)Tcgwž®7„ã¨TH8 Äªè¥(8†jº}ž—îØÕ9+�ðÌ÷®ûê#p~û<Ž½Ï¢‹ŽßBˆI$•’NCïèrYíÚŠAÂÑ@ I»YŽ>µ2ýÓ?�ò¡ï|.…˜8þs€’m†j(éþšØØññ­¯×çM·c£P@Âñ»bUô–©=tVnó”Ø;§6&Žÿ„˜PôÝ íO:ÝßÏÅÚÚŠÇo! YxÚS­qy¿r;ô–ŠG%'tãW}›_ÎÓ|x:˜T@ÂÑCD¼ð,ýÓ©ÎÓëœíØW6�p´€PÔ²ëÓcÝOŸŸÏKð}¥Q@ÂñoC@à²H©¿®¯×]ªPÃ áøCH›ìeèÕõúº"t£u…AÂñïCˆU±»ˆnÇ&í÷Ë¾±¶§¯Í6¿._„}å
ƒ„ã„ª {ß:æõRž=ŸFyŸÞÿé²Ž¿>`Ãõvƒ9Œ^©L"ÿe@(´Ûº}ÝíýõççÃÇZsºžßnY7§§Ûýú\0Œ�F!�”}wõpjõ´œWèº¯tÒ`âø]H$ac7ô¡|¹¿CÆº‡bˆH´Ñ,²nÉž†>ûérŸt>º_ž_^z·³fÈž �¾näùõ§ï¥ÎÄÄÑB IYùú8êm½ìYÚ®]<Ço! 	’ˆ„®w®Ì×s*�ã×­]øývGgzK 1q´€¯Ü�Ú|~{]ÔáØ[ˆ‰ã�  �wìm}ìš}=Ÿoªj?=Ôýó—+Ô0VšH8Z°‚ ©µnš~Ðòövžuõôah1}>?§Ðu�€âh! ¡H=[[–ëO6êû–™ÀÄñß€ $’%ûz¶¼N÷{
ÍãC¹¾þüVêñSc—õý~^äøÍ‡Ñ,ùö¶PóØÂ/šXJÎ85ÇFÏ_^/“=~uêÊåy›Ôééä�¾¼¼ßQ‡OÒt>Îxx|y™®/ú®×�ˆÄ# Fqn¬�çu_Q>>?ŸŸo Ç^«bâh! ‰¤Œ†
×çôÆæøéc‡ùz~-Ü�ž²Ço Ä$’‹pècÞß§…üáp:nùvþùýÜ}üêÃ0-/—èú@¢ÁÄñ_‡ $’¥¸jpf]¯Ëœ­;~õDëŸ¹­8tC’î«cðËÛû½ o5Q!�ìn<œZu¾½]çÐ?~rPï×ËålúOF»”—çUóÇP	²rªÛÃÛëe97ýXL  ‘$«4ãÑ¥óýóÛMžž²ß®ç+Zß(áx„€X•öàÚµ?ßž§UŸžŽÇÄ?™btÝPÑÅsü?  A3µ-h~¿-YÚJ‹ˆ£… ^sAûX7ó|½O¹ÃƒÕ…	’‘Ñõ'ÏëùuÖ®é6 Ž¿	2m›?=>),ï6ãð±ö âøB@‚D‰Ð}øÐ½]žo¨Æ!˜, q<@@"Xdëúc¨Ö×éÌª
¹M‹Ço  AVÛîû‡Jãõ’o!|h5	@ÿì:9“q[w+Ü…b3@¿…€ÀYJñÕA¥ûyÚ½1ÎZ!€8ZH�‘…û'ç·õýÏyêº’h@ÿBL(ú®sÛÊõõüf*c‰RŽ¿�s.ÔŽ£µæ}z…²Mí%iÇÎ,ºj½WeI°t ÑŽG‰ ° „>T_ïÊHUÁ0@ÿ„DP¤ºfº§Y™¶7ZH�ãoAH²QQUß„”–	›5�5Y«b÷dóqì¼º¿¬72'Õ¢Š‹?‚�²dýñ€õùå}ã±¯ªUsüw!$`N,¨º¶å|]ÎEu¡ö»U\ü!„˜P¨lbÇþ‘òëýâöC]Å?€�d¡«|µNËF€iŒRàx„�dC¡ºëÖå~Nm…uºq’äM Òñ@HED›¾Ò>§û4m×Z…í­œ5ŽC­yš/Š@ÁkÃ*~—�KÕŒuí÷ÏÚ9])6ñ÷ $Y±×®9X½>OK2mãBÑLñ¿†�x¡½­ÇzÀõrŸŒª 5E!A±{)ºêrËu¹N…joA:þ]	Š]!Îô-Öå~ŸsmÇ¶¡}]¶²øal½¥ë$Ê6Ú+›Tü}PÑuÓxÇ÷ûJ¨ý#öm½åR×ÁVÅ
(þ B`á­°õƒwÍår]”©[[±¦�j«Þ{¹_ž�ç«ø— $^‘CÝ¤å¶‰¢ÑY£Yƒâ¿Šl
Yç+‹eßîž­÷pLñ#$CÈ¹ª
¼.÷�tªkuÙnpVUäÉQü�Áeƒ,f™ge’k«ÖÞçË¹¸­)Ü7¾—ÖêªX(‰ß@Ì‰X¹PUÊœo…tpð°š@ñ¯A@¬²Þf„��ö¾¼]8?T#Ó¦„ãÿ!VÙÞ´:§–Þoo3*7V›N�ø $"9§ºîNª:ß.g©š‡ƒ’í6ßæäá¡rëôþrS¾nHÅñ $‚L%·Õƒðv¹ÏJmMš!{Y»fE¶ûÛÂZUõ.DOb’²d]ÇÚßnŸ i;Ò	ÿ:„ªPY½í�#O/?]Ñ˜ºÒ‰ ñ¿ƒä’­:¶Áo÷·�­«ƒ+Š•ÅÿRÀ…:@–ëÛ½4ÃPuÄërÖF¼sTE!ÞETºb¦´½bk«SoÕt›î°©ñ†ˆ Šÿ„Eq¶aÐý*éýf¨�� «ìœïê„yº.¹Âáñàè}=OºÎ[(€â¯A2œë«zÙ¦½ì­·N1Qü.3Œkëà×´\7¸¾±^öu9shíAx» g�a’0�m½Û×å‡¦í«÷}š’nBÐD øë�²fo«!dºî"!7Ai¦Ø¡¨”MÕŽ9ß®‰*´Á¨¬$þ�KN0U×TR¦•¸nŒõ¢ø÷ÀebT]=–ÛzË‚ºwŠ„â¯A\Ãë1°ìÓJºqº*–$6�¤re}Wi¬ë½�óÎÃ¨øKÈš•µ-ilóT’­ÃÐØõ¶ÎÊ$[ÒLñw 	‚ªn[à–ç�‡Æ[Å¿ ÎY¨j[âË2¿	†¶ÖÐñ$iRÎÔ�Vû�gtÞ—U÷.´!ðvÕ.Ø’RŠ‰(þŠYª+NT”³¤@ñ� ÉŠµSU–uçÝM×íz]ysUÎ�¦ø	²›¤�”ÕSZfp[yXÒEoœÛz½Ü^ò^ol&%Bñ\6RV÷NÑ¶NÈú¡Ô‚ÏÁˆ7Æ‰bÅ*~‘¬Îv^òížv_6ˆQÂ+
ª±îð~9_à¨n@’è "\2È©PJeVc1Æ‰Qü#'�ª*ßme¾
é¶rV=˜X’MºvFm’$µUhƒ•m^óJ–%ñ»à²�ò®·ûºœ%ÙÆ’’ø-„ŠÙÁ&ô¡É¼¾Ò†±qNHIÉJgˆ–”déÇ64sY÷»k�r¶è¸ðæÙê Á–”kB]9Üø&™M¬ÑÌûVD7­n�Ê×™`­ÑPH&¥½îŒQË²Î&Ô]€Z&™Iµ¡BÚ*£Ò>Ï‹÷•±Fÿ¸$­œ©œÏËb}uÕÌ7èºöÆ	‹Š?†”Màmç<Ý·T<jg‹Ao»
ÛtÛï¦«ƒ&%’+Ó·}™ïóó!T°I‹P<BPTa
õHþ~]ËÊ‡àŠ¿	Î¤TmWÔ}]]UUÚ‘(~ÒõàC9¿/™ûº6’è ,RÊjSÓxEó2›ëà´W€.>°ð¨¶m�ðº\'M�UP ˆ€â‹x×A×N3ïet«}6Lÿ{ˆïF¬µu6{N¼i§�c-Ø©À7­E¹Þ7„¾†Š‚ aQœÉæœ•r§[C]ï«¼^Å’­œ²Â€�BÉì•u­Ç’."¹«œÕEA(HAqE¹ªZ^Îçd]]]Tü,)¤,ÛÊbæ·‹)Íhm¹&¾±îð‡ø;PÝÿþ½Ö9Q`0"J B"€€‰‰ƒ˜ CX”0/B”P ÅŠAÄ
$*W\&)a*ž5«øW œ­)(EJ‘"N>ùä˜A†(0†‚iR ˜¬4sQÂ,0JÒ .ewÉæ@JSt.\J²ÉyÝNy[Ï.«®ÕZI*¹�·^kR ø]°pVš´mYç²+oŒQ$¥,§Ê¶ÎçëÅoÁI3Y=èzÝö[Ý9ë5ëø	Eg
dƒ%Í[É4À8!]\ü.„ÀÈŠKUµ0m×ë¥¢‡àE±p|„”�´µ®1YM«6ÙE˜WfÔcp�oû~Gp5(þDŠx?Bö}›ÊÎu½ m_©T½õ¤@IZ™à*íxÞÅ“óD
ÄñW!$‚ÂDuìeÕ&;H¤$°©»ºYË´"›Á´ÉÄñ‰@vbGƒ´,w6¨½VEÏñW $‚D¤«Ö[Ü·ùžÑ8ò… eg¡±
X¯Ó¼æ¶ ŽGœK1ö8v|ŸvØÛ h0q´�2¯¥yøè›—óóK	í±·BL„DP��i•Ãôöáä<«¬Šçè! AÒ¢CU+¤=_œ'¥tñ-„D€¤öÎ¶�Ðu^·útúTc=_>¿%]œ éâ9~ÁžQ×§£ÃÛ4¿ëðT;• Ž#–•÷¦}4aÝ®·™ÃØYÅ áøCœQ(T]»ð<_�#!‚ð&©kš€ûrÍ0‡Ú*�bÙy-ãá1”÷ëë}Õ�ïP Ž¿‰ÈBbGçsÞ.—âŽ�'RŽ¿‰`ÛUy|ÍÌ÷çeòõ)'‘è!Ä$’KÛ~ÛnÛšaO�Ç ÷ËÛýŠ¾«Cóš„ŸŽCsŸæŸ.Ò„6Q‘ø·  AÊ�k<MÓ	¾†	Äñ—! ‰¤²åêxpÛù~#óP%
"BLÈ¦ÀûÖš	7º6¦®E+ÇC oJ‚í�pÙïiKã‡–×óù�šÃhu)$"ÑA BÁ–ËpôjšßÖÝº¡Ö‘è! pÙÅøª3²¦É¦¡ª áè! ìe¯»ÃQöíúœ³i;eH8~‰`+¹jO#çë}.4¶=ë¬’­úã)¤åËùu
ãØR)ª„ì7�o¼V‰Ï˜Eô§ã‘æÏÏo‡V„Âñ[ ŠYx?6ƒÇu»<çYšÓ©NçËu¿ÆÇj™oSZ«j´JH8! ¬²”æCðù~Ý?ôY³Hü×  ¡ †£#µž¯gÛ<z˜$ ÁŽ-uCsR÷óõBÕC­!ºxáøÎ`©ê¡ÑiºÊv¨‚éâ9~dÃ|£ÍœS¶Ê[ËV �€PÊ:aüæäåí'oï8|:�H1§„0|ÕÔËËËeÁð8Bí &Ž?†«b’�õµöi_®ÜÙžHéâ9zˆ(*vMÊôŸì·Ÿ?“­Fï
ƒ„ã!&‘Ä%Tc?Ýf‡ÞºUƒ‰ão@ ‘{>›¯ŸÜþùùË+êêXÑÅG 
òîN�ÇJ½<_¯›<¶$�„ãQR¶Ä)|jh}~»ß«ªm(ƒ‰ã¿!&‘TöÆ!Ðöº.\õ­QÖyÓãá;Už~þ³7Ó}Eœ@Âñ_� „LKi†�µÏÓËT?V$ !†*æÎÒ¿}H—Ÿy�nýáÐ �7Ù’VµS Žd¥àC¨æíu}õõÇ'¼|þÙ{:ž>X³AÆª›þé{Íýgÿì}Æñ8 "Žÿ> ‘m»¢z:uûòåË+|jµ‚˜8þ¯@·–‚öô�äåþºîÕcÕ�Â›æ ¥·m™xe9jN¯Óe“al5D�‰ã  ¡È¶¦Ç‡€éùüº¢ùÐ+½$¿�
1Qß¡û-%EMÐ €8~±*ª,³>œ:ì—÷eÉC{€d&Ž@à2Uú–nóûëªm‰E %“8œð*k©œ1N„£‡«¢7¥CU±¢yÏ™«áðèðöÓ/ï©?|PÂBà%'søø±æŸ¾œ¯~xêj•5˜8þ§«¢§%ËéÁãv;ÿü�÷�ý)SÚ–)Ïª¿:MÓ´íªNËûy]Ž‡^»ûí¶î¦ýðØÒu~¹NÎv�. pJ<Ÿž<ßÿüåz-]õÔUiNóm*v8<~,ëyy]7~zøpDº¼Í¹„C¨7Ö ¬wµWÇOËÛûŸ¯hNOµà–ö‰ïÔ>»×ûõ¶Ó}¨êr^^¦†¶U…AÂÑA@‚Ýdêª&™¶÷›tí'_Ûiþ¼í&´½)V bBQIt5V¼/7ÞR]·[�p<@@¬ŠÞXÙÆÇÛåeâðíi¬¶õùò¶ct�ÁÖËº¯Š<ªtYÎ×—ºÇQ›}]n‹ààê¢Y(ÛY¡iC°S¾N@sìZð4Ý®»ÃèD´@8 ÄªØ-4Ç§J.÷ÛÛ¢ÕÓiyIkJki†¦Ii—«èªê,)qô¯Bª:·Üæ7£+ÍÐÅsü.›¨PU²­p¡ïTU ‹çè Äª˜ÌÊtºÆ>•wTOÇGl—//_Ø4Î-P"Äq€€E27õñ¡Õê|¹g;Á¢(0q´� ÐîLÿ0úœÎ·÷-O�Æ-ËzÎ¾9œ:•÷ù¾çlÛ'­ö�o áº"% q´bUlâ¢º¡q;ŸÏTF«“"HfÀ‡Î»´_®s®ÔøÐÐíúü¶©±îÉ­ZxáEºÃCµß/ççEª‡S7‚·r_¨ú8�Þ¦ù™ÃØ´LÇAH„²*{]F­xž–wåÇãXoÛ²ÌeUº±Vtü„DÀ™t¥›6l…•	Zk"H&2ÆŸ�—dX7Ú3)pükoU7…Îóºe­«VC” (Vh«ÎaÛ·»ÏÎjeâø;(z3ÚY'‚5èaì�Nåú¶ìöpÉ/´O“™KkƒÊZÀñß��¢ì|Ý·¸¦ëy§ý¡:¸:MyUÉØ®;PÙ.Ë„R¶VPñ{A‘¬Ñ·½ªÏóí®Ä×‰‰ßƒŠM¬MêŠÖ)A7Á(-àøc	Š¨ªª4aÝr>�íCÞ§ë+C�LËbâoCÌ™È›à@Yn
ºmû£j–ù>�Ù7§0rÞö[IJ�Í 9ßæå&Ü› Yƒ3gïêªQÛr_·œ×¦�Ç¿Î¢jãE¯2+ÒOýÐg=Í·;ÓÒ…D»‹òfPŽó²Ü¦ÑZ#–âïATqR5TcI|¿ï¤}×U&Ñff(JYM ’]�NC2’qª2Véø‘íª¬nŒÏ)•y	º1¡èø/‚s)Î¹±æmÞ'QeÁ*Q gQ&TÁmØ9Ñµö¬ãoCÌ¼ºœ3„Â«Ÿöªë=J¾í—Ü‡¾)ÂÛNhÐXãÅR�CÝÔý¢Ï÷u�øÐÕ�&ð,kNõÐuû¼3¤nDÅïC’*ÐC5³­e¥jo Uü>8¬ØÞø<ÍË¼×A{1�ðœ1N·.ç/74��µOy¾l	UÓ)Çß„�HAÉMÕ¶&ó]Þ‹jŸì0ß×û¶Þ\7<¢%Y·}Í¨¿ék»ç|á·lÚ‡¶ß÷åýgYmoK4à¹ }l›e¹½¬É†¡R\ ÈÆ¥®Aé¾¦¥¸ºeˆã! æe�ÝðttóûËóuÃ±N\²lœTu:-Óy‡ªÚDÿH¤”}ëN‡ ór~[%�½ÝÕ²•Õl¦öJ™ø!V…°û®?ð~¿ìN®kÇCH…
¼¼VË:—‹2_ëòùú³­¨u�Çß‚ó†bm];=çr[ŠO‡Jís^ÞJ
Ç‡^¯²ìwL¦ï[w“óš%ëbD�$ù~hÒù|KZûz£BŒAÕ4õ¶Ý—w®:ç`âø—!‰³«ºƒìe�qG=ÖU¥“ð–Ë¬J{êª�nËuv¹nÄ$Š‚¤³7]]¹t½e)míB²ÿDËka_µÝ.·-³¨Ê9Püˆó�Ð�Çº+Ï××©hÛ�“ÄÿÂ3rçº6`ÞîeVmoAbA¢ä}è[`>ß³mçuQ�ÿ¿ x[µuÍÎü¶öíÿ]ïc3×\«jU4BVec“BaˆGbŒ(ˆz"x&xàInÂ£ïB¼oC�$«ÖsŒÞÿþo¾Mk>Oþ%”DÎFör™}ãÇ—£Ð0Ïsc”‚jLˆa´VK?å–¦è’0åß‡’¢»bçe’í¼«Ú1ú GùßCQµFs¹lÇzÜ0^gï¤ÛòwP’ªÝØ§á©®åë—›/ƒïh?{çù:Ævnïw,!ÿwHS¢ÁÏpR÷M­‹éÏ÷õ±�˜ÝÙ4#”ÿŠf˜§at÷óã]û¢%€U)Ð~’»€j;B÷&ÀwÊÿ
m„Nq¸D=öõ83]FCÚzñ5Ø¼Wh?•Œ‰låŸ@‹ã£÷tÖý(ÐdÈhþ‡P)òÃ˜Ìc_ËYÝì2Pþ'ÐF®Œv°¦òÎ-r"kÀ"RŒçX´‰4ïàsþOèÜÉÍqî‡-ÞFÎ H…Â^†ÈG¿ï¿Ñ:M£s(Z†¼ºDŠ“6À2�(OPip5EÀ‡vŠÖßÚƒS²ýØ
yò†Á¤ù
‘®5‚]"èÖ8·ÌÂÇÚ4¶1oN9º²#2, Êª*ÔIa‡á‰UŽ·›º–ld%#”ÿª�d_­�³iuC0j”ÿ
Q©V¼I!Ji}¾8€òwPˆh3ÖRpb¶*÷Ó•z?J{8ãL £ù?@!*E{ËäIïï«DY’7'ŠaLùo èæTgÌ…|×}­@\¢i{)Ö3[‚*�óJÍïF‡˜æÚoUîygŒ0iþ+(´™ÝpH‰½ìå(i|Šor­w–‰TA”-Ð^¼FpiG¢æÇf€nJB´¦£(Ø«!€²ƒ’ô*À8Ï,ûcmM˜:‹J%kÌäPË
Ö­'CùŸBµ{Uh'?N‡ìÛæ
y¶^ÁÄÒ�'oÐ×rç´˜Å2õŠ»Iq2ÜåAÚ‡O†”•ò/ÑM£DÁÁŸ­Cl@¨,¤ÒØªñÆÔ½ú0N³­ºÞvÅÕ'L*�(Ø!zmGu!Eg:©3n">ë
Œ\8ÿ6¤2½pÝËÑÌ`¡²¨O—1}ÜÎ·Â×,+kŽí°”|T[ëa	ë�Þ]ô¡‡NÂB”
­l.Ÿß?ÿ7üO F%!!UR%U��B*JBù� Ú)Œ²R-j'¨’ª2À*�BX‰Œ�vil»«%c™	ÒK¨A €2�ó_A¥K5<¸H­¡˜Ù„ ¡S¾@ådã½�:*muÂxb¿Ý!Sœì|è®%v¶9få ‘Fðü(hýì~´aPÇùWPRts2É»‚zö³zÏAåß�4ã¹m«Þ¸Î&’€$%Uèá¸ÌVÏG±¼cåüPî®ªÈ´<ƒ¶;ŒYhr.tVî>ÿ(©]Ã0;ýúøèÀ«uÓƒäŸ@IHÑ¨â2|3Ùv|ÝÓf<E×�B*„Â4òYÎíç¿ñÁ(HHò/¡ E3½ŽÓë¢åþŽÍŸOÑ²   €U
%„D)ÏPR…\§x	¬çz/=>=›~¼ýíáÍoyU¨jþ](H¥!†§—É}¼ÿxÖùSª2T5?CAŠ®¨³y™�{ßnÚ¦i°j*ùgP€ U[
Ï£;ëzëÊËàEŒ¨æ_AÁÝõF6]�¯å®ç9R0Ý*$ÿ5 ÕÚ�Òók�Ç×ýÖýåõó¬rÜn…ñ¼X‹Æ=Hþ%¤ª‡ôt¹L…ëŠ2�ƒo0=H~†ÜÍÞì˜¾zûòCã%Žd„!$ù¿@IHµ©ê0ÍŠsÛ~Pž“©ä?„‚Tq²º9Es´UÖ~,@’¤Ú»´yº�<Þ?¶îíðy¸èûÛÛ†á%‚J¯•ÇéõÅÉßýí[p…ªæß…à.•ê§ëÒñÃÛZôiÂN
UÍ
RÅ!eœŸ½é?Ü~8Ìem7PÕüs(HUŽÊÓÓË‚ÛÇ—‡´p¶AšR—Ëò¬ýöhÐh§Î É%!4{z;¿Rzßý6ù;@*ù÷ $àÎ]yX¦nîûZû2ä*H%ÿ	 4Õ>N‹O·íÑÚø¤’
RÅÙÏ6>·õí~Ðå:TWÁÝQþ�P�ªî">^¸ô­l…Ï¯ß,úþø»>ž¾YÂññãmUw½8Ç¤’ÿ
:æËÕ±y¿=$ó`ª��d¸›½ãi¼¾ö¯_Ï¦nTwQhþ
:5g–'4­ïÛ¡4{#UÍ?‡‚Tåèl^ÒØÛ¶})n	Ž”*…àí… ça÷tµÞ
H%¿@BC3>=[9Þ×­cø­ožÔ<n·Ûšž.‰ÐáË4ÜÎwç+Y1=¨d]*O×7Ô�ßüæÑçñgÃ|<_7ãSdR¨jþ×P�*Jc¾>¿Žõí~ïtùäýÃªr
b¸[êÇ­3³kDª¤4ŒCB;öÐæë5øº}ýÀìÓ,ÚH1Ž£÷ÇþØ†ë·�Ë—·�‡¦×Ï)Ð¶¿µž¦Ü@*ù{(@ª¥W¹<ó¹Þ~è6-Q¹‚TòCAÂ� f¼zÇûc%ØÙÙf $ù
5c^§‹ÞÏ¿?w7¿üd¤ãþõëù¸¼&[�JvP�pNžfÄí£>ÎÁ,×Y¶í¾•à—DÚ@*ù{(HUË°˜½l+Ê%†ªšÿ
‚4�™FgpnåŒf&¯•ü= Å©�^§–Ûþõ&£‚v#B’¿‡„.èö2��[?q�+¬JÚÌf‚ŸH«¬âg»09…JöPpgi6Îòëvÿ¨=~þôS.ooûºLßD‚œ?Öî1Í$F¡’¤Š"JãËäûÛ�kâqD7’l¡ áífº,î¾i§‘iäb*ù§P�¢š.1M£â~¾[©ä	Aú!}¸Žó$Ûßo<ýƒ—¨To÷µûŸUÍOPDÏfä2?K-ëvØñi6hF„$ÿ
REUA\âþøØÕÍ×ç§ë}-=Ož»TúN&\Èi?Nã—Á[RháÎáB±®uû±ëe + I~�‚�z�ók0çûon-oŠU¨ä'(@�Ö™†,íçv¿÷”ÀLP)$|ñ3z}TØ8pF¡’-”„T{—6Å'3?ÞÖÿ{ÔÅNé<·w3¾LFíõi™¹¯GóÇ,Mš�á…ë¶});’}ëãx/|fÛ@JÍ—nC,ÎVZrQ-„$ÿ
JÂÝ¶fì¢=Ú*kâH�ä_@AŠÊ@Š“ã~¶Ê“�@’ù	JªÐ˜až<ê£4=Oæ²ï÷G³ñ%±í •ü_¡$Ü]…˜´cÝÊ¾²�½#0„$ÿ(©Rs0ÍÃ²Õmûf¸²/0=HöPR…ÖLó¥ó½¬ï‚% $ù÷ ¤
m�x˜¼³�ã×‹FB’):«±CJ]j©H³8v’ü”„ …Êì§™ëÇù»×1újIQYÃe8ÛVD÷eVµS²¾�+™+G£�ä %U4bN£M"gëÞµ¤�Ót—èÑöÓ�ÍÛ¤l’¿‡‚ ½t8¿Lëc›�`z¢Ë0_‡ùëÇûó5Û­*IvPR…œjœ½2÷­n7?\¼# $ùJªhè†áÌ­œ¬}V	’-”T©¹‡"ÍÓœÖûýkæóåÊº>Þ©˜iˆÎ4£J’ÿJªÐ¢ aF®Ûmmîéé9H¿Ýo�¸\ŸCoçñ@CHÉ³BòO¡¤ŠF‚–0¬Ç£PŸCb€$¿@IR”xž8jÙÖ¦åùòjpîëy÷ü<›I·ívÜ’M/�¤nû]Î98õ ÉÿJBhîÆ¥ÛóX›;ZÎ/PR…¢<,‹ïëm}`˜ë›HòÏ¡ H¯@´�U¶‚”¢Ä0Ýç'()º=Äzwqûv€&ŒQHþ}()º+@pK²í8Æ/ÉVÊŸ ¤h~gCšŽ²Ÿ�ì�¼�äÿ%Eó8ó¨º3Þ2(ÿÊÝKëÄqH£‘{}ß”—e¸DÔó0äiL0P‚ä¿†’*U[,—qßö[§tIåü” Úö…”Úý0a€åüJŠÎÚÉ¥)aÝîµi�.©ãü-š83zCýhí–RòLù×Ð~‚œ�‡€º¯çAnHK±û¶Vòá:Œ¶¶½<VrÑfÊŸ!ÄÁNœ ç�NÁðäÒy´ýt}Žcçü”Ò[7¼„ ³µíƒ˜¯Så,+N<-sŒ[?Ï¯-¥§ÁWîõðŽÌL&ÿ
JŠÎPãÝ8::Õµ)Àå¿„‚T»ÖèÆÑ¤÷õã8§˜,,Hò3”„»)Í½VÞoåÌb8ÿJBª'u^.q¸�§™fÃ I~…’*I[ü'–ãýCÖøê’v¥ü%Uè	ð%¶oçþ iŒl:Hò'(HUÏfÍåJ†�ÛÛ�Â?ù”â¶ïoçVGÿÍdðØ>ú{7þSPY÷µ�ñÓË_÷#ÅI¹±äŸCIHå�:/ËÛÇí‡£§ùuÚ£-n=„©Ûdœ†Xê¾ýøîÒ§o¢Óz|Èƒ¦Å‡j!$ùO ¤
9ºÚËÕ¤õvô=b±†:å(	©œç>]—ÎÿïËz$þ�*HòwPBç.fºÈy[7&0çOPREá²ÄefÝËý(éÉ§jA’ÿJªèø!­ßÅ8c:åÏPR­ÔÌ0¼Œµ­÷‚aš-q‡æÒqƒsg½·fèÓ°Ìî<Ê€ÇèÔåo¡¤ŠF¢iLÃÙ¶óífÜülmiû£Òü4FÇþØ8^—'˜³­f¸\-h/‡ X;Àqþ·PRÕªd†1:´½­úpÓ·—ˆ¯·mûü4’©ý:mrÞ€r€’*º
|˜RÓ~o…ÅLO¶—}»‡™ë`4ÿgh?¡)ŽlzÙ×�g‹j`ãhÃ¡‡ž¼õp’”TåD·sœ<êCš¸çéÙ¦½îçÛæº<S¡UV¶çâwÎ%UtÜæÆç¶ÎÛOéYjß¶/‡Ð0øÂÉ¿€¤×;<…q?·Õ˜)rBùJªRH½›ÀM¶¢~IÞ©É¿%UT4›Æ‰Ûãü‚SyŒ6[t{Ÿ’m²moÊËu#¶òPvÃè¬pþ#t®êÂ%Ð¹–[…,628/h¶³÷)riå°�i°I™ò¯!}gžÝlÜY‹]§`YÊÿÚ+‘³qP¢£v°ÌW7kY÷G7×4…”­“9g‰òŸBI�`}ŒáÔÒ´!ØÐmž Ò„œ&Hêc%ÓpíŽ×V S˜RtµôrtŠìÙ°æŸAI�Z°—å’¶�ýd�'âü-”¤p³)Í—ˆòþx¤:OÊ´1YÇÉZîUFÆÑú~ú`¢ñÂå•FLCtƒH+{+1Zo;å…ÈI0ã4Ärnûj'7&VÒü� M�B„m²ê}°ó4KoÇÇÝø)F%ÒFLÁÇdPÏóqòb¼!Òüï ý �>–ê¾8ëMT£¤ ü=T«íì8³—ZGX�
�òÝWƒ	�\—£:±ÁXß‰ò¯¡9‰�!ìrèCœ\T«ùÿ@:»Ñ9ûfqIžCãü¿ �áÈ{k[ë…­bDÛËhˆ“ÇyNÒ’ïçÖ°p°Ækþ"Æ›9àÔRìQ'ò†XóïC¥Ápò~èRnjÒužõìÛ~¤]P&Q¾@QYÙ…87:öµÛî ÚìéÕ» È
*v\¢•£m¡$çÄä¿€ªJ#6Þ…äµžéÁ¦Á9³×Bûhƒ7`•^“ƒÔjxvì‰¡Z­ŠÑAÐ4Ì‹O¥¬½Èä\€áü	
j¶Õi˜®Wz»|uøä–n4ÿ6´©�¹Ž÷Û½º9o:åW¨Rs;ñ8Žñq¾‚çáÅ™³õ]½³Ö‘T+Ž†z)c÷pÎ0(ipeˆ.hÓ³‹P4ÆPþ-t9Ÿý<7o�eE'˜SÙ¨pˆ°6ÿo(D+\]ü Ô·*Çè¬gbÍŸÑ™È›�ÔZ‚åÄ– Ê?Áÿ°äÙBASE      '¸  xÁA  ƒ°YãúÀ þµ,¹™b£pˆK+LØlH›çbSÖ�ÖÄµ	5'Íå°É46®˜3Y��dšÒHF“Å@I&ÉÀDiS·YÛ\Òpk²Ì­–n´,+·­m›¹ÕV²-Í�µ�e[µ$
”£9Ê–š�ZÔRÕTSÊp *J© ƒpèÈ¥JNS×"m!±ÄF¡²jƒÔ*·aŒ@„jBƒ¡€m£70Æ„Êª�R«Ü†1 mª&6H­jEé˜1mª‰�R«Úpƒ

`nd¬ÚÆFÉl�º(�9˜ÉVÓXµ�pIA*`lÖš¸AŒÙ L@n 3›Û¦UÛ–µ¥cŽZ”.q9k1S#�“gÓØÄ
ÐBPOS      
¾  xÁAŽVD±ƒˆ�ëµ„²"&l‹¥Çþó÷÷?___?>ïW{ß?Û¯÷ßû÷›ñ¦°�ÛV/ÍËØÕÞÒY€Éš°v†Œ3ajÆrŠåæµ±T,5+3rlM5fÊfšUiÌr ¨µ-YÄe,Ba@¢hL²  ÊÈ&ƒ«	3À,
aÆÂ4C�2C0€Ô$Ú¤µ"Ø²�1„df	„�,…å°Í™Ô„	"¦h ³µ5	KÑÀFC‘Q@�ZT²Ö¾CrKd7ÞƒÕëÆZ×äÐë]§Z½Ëu­ÝN*r»}FUårÚÚj?©$Wtï³óù—
-DCNF4       ºý   xÁKJÄ@…Ñ¯ªów°Z|cOÇŽÜ‚¸·ã]„4â@!£ †$…¹ž“N §D˜œ¶2oÙ¤�ÿöo·×jøà.Áû=ðËAÁ@¯3z=3ÐËÈèOY÷¬„™JJ’‚2+ìÙjd5,­Z<9Æ›¬†%²‚M-5*•2*P�¨y)1Î]ŒP¢Ö�?�ß?p¾\~]ÑŒsG 5€W=òO9O…TEXT       î%  xÁKnÂ0 Ð9Ê [ó³GÊÂù”V$!J(”ËUÏß÷`Êc.5º
®¤ûv<»7�c° Q|&ñ×h$0ä©Ž°~ì'Èu*Ò®­™“îö5S Ý©f�uÎ-pðf]>õ0nOÃõñBÒÊ¸RC!.ñwÃq{¢®�’U!V¢(Ä%,ŸSB\Ró¤ÆjèPˆKJbž,DQè®ý‡æ¦…Òm>ÎÅ­éNê¶;Œ¹}-”¾ÇÆêHŒÇn -” ió ‡Æß¿_pîõç~84È^ þ¤c?¸CLIP       	            „<AlignableSequences><Sequence name="W1836-W1505-8095-1.CMV-F.YP06545262.A02" ID="0" isTrace="1" sortOrder="0"/></AlignableSequences>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ò<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="13" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="728" maxFusedRunOn="728" detectionMode="exactProteinMatch"><Segment range="660-725" color="#cc99b2" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="12" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="987-1509" color="#ffffff" type="standard"/></Feature><Feature recentID="11" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="748-972" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3474-4268" color="#ccffcc" type="standard" translated="1"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1524-1526" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1527-1529" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1530-2243" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="transl_table"><V int="1"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4876-5464" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="RIGHT"/></Q></Feature><Feature recentID="7" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2494-2949" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="direction"><V text="LEFT"/></Q></Feature><Feature recentID="6" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3082-3439" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3290-3425" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2366-2487" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2976-3080" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4500-4547" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  I<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FH-GFP</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ˆ     ›  Ä        Ä’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ ZÜÈyÕaÂeFØvÇ�A‡u üfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      N  Ú  Ú  à  Ã  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ò<?xml version="1.0"?><Features nextValidID="14"><Feature recentID="1" name="3xFLAG" directionality="1" translationMW="2730.72" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" maxRunOn="833" maxFusedRunOn="833" detectionMode="exactProteinMatch"><Segment range="660-725" color="#cc99b2" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;three tandem FLAGÂ® epitope tags, followed by an enterokinase cleavage site&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="981-1503" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="742-966" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3468-4262" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1518-1520" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1521-1523" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1524-2237" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4870-5458" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2488-2943" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3076-3433" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3284-3419" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2360-2481" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2970-3074" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4494-4541" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  q     �  ’        ’’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ ZÜËMÒ.DÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  ¨  ¨  ®  ‘  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="931-1453" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="692-916" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3418-4212" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1468-1470" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1471-1473" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1474-2187" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4820-5408" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2438-2893" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3026-3383" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3234-3369" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2310-2431" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2920-3024" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4444-4491" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  r     �  –        –’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ Zã\ËMÒ.DÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      N  ¬  ¬  ²  •  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="935-1457" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="696-920" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3422-4216" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1472-1474" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1475-1477" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1478-2191" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4824-5412" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2442-2897" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3030-3387" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3238-3373" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2314-2435" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2924-3028" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4448-4495" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  u     “  £        £’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ Zã\ËMÒ<ìK‘ñ›±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  ¹  ¹  ¿  ¢  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="948-1470" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="709-933" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3435-4229" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1485-1487" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1488-1490" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1491-2204" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4837-5425" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2455-2910" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3043-3400" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3251-3386" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2327-2448" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2937-3041" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4461-4508" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  u     “  £        £’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“*W¥:	ñ;÷’ôˆ ZãFoMÒ<ìK‘ñ›±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      N  ¹  ¹  ¿  ¢  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="948-1470" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="709-933" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3435-4229" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1485-1487" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1488-1490" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1491-2204" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4837-5425" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2455-2910" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3043-3400" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3251-3386" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2327-2448" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2937-3041" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4461-4508" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  �     Ÿ  ”        ”’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg¿¬±Û¸Ç2ÅÏN¥:Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      S  n  p  �  �  š  ª  °  “  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="933-1455" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="694-918" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3420-4214" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1470-1472" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1473-1475" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1476-2189" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4822-5410" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2440-2895" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3028-3385" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3236-3371" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2312-2433" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2922-3026" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4446-4493" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  …     £  ¡        ¡’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg¿¬±Û¸Ç2Å²C3Ó©N‡0?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      S  n  p  �  “  §  ·  ½     !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="946-1468" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="707-931" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3433-4227" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1483-1485" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1486-1488" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1489-2202" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4835-5423" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2453-2908" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3041-3398" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3249-3384" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2325-2446" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2935-3039" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4459-4506" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  �     ­  «        «’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg¿¬±Û¸Ç2Å²Ï¹ä3=:”èsñ›±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      S  n  p  �  ”  ˜  �  ±  Á  Ç  ª  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="956-1478" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="717-941" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3443-4237" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1493-1495" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1496-1498" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1499-2212" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4845-5433" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2463-2918" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3051-3408" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3259-3394" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2335-2456" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2945-3049" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4469-4516" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ‘     ¯  ±        ±’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg±;ðZË»Œs,[,û‘C3Ó©N‡0?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      S  t  v  •  š  ž  £  ·  Ç  Í  °  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="962-1484" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="723-947" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3449-4243" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1499-1501" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1502-1504" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1505-2218" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4851-5439" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2469-2924" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3057-3414" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3265-3400" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2341-2462" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2951-3055" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4475-4522" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ’     °  ·        ·’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg±;ðZË»Œs,[,û‘C3Ó©N‡	óñ›±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      S  t  v  •  š  ž  £  ·  Í  Ó  ¶  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="968-1490" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="729-953" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3455-4249" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1505-1507" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1508-1510" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1511-2224" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4857-5445" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2475-2930" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3063-3420" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3271-3406" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2347-2468" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2957-3061" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4481-4528" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ”   
  ²  ½        ½’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“ð|üg±;ðZË»Œs,[,û‘	ðä3=:”èpŸ0?»#ë’�On(¨ÿ¿ò>¾‡ø#Þýâú¾YVV�³h¸I¶¹®  ÐtÔ A u“Cc€Â¹‚äFg„¶�¯X
£ô�”-d×ARý ORw„µ�¯h
£ô�T-d „µ€ª¿i Ü�”-dÚªôö¥¥\ö'«÷Úµ€æ…yc\‡êW	êý“†–R|®Äõ�ËX!P4õ\—|ÿ
¯ø¯fƒ{kšŒ®reÌ}2Â|³K¬.|‘sFß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      S  t  v  •  š  ž  ©  ½  Ó  Ù  ¼  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="974-1496" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="735-959" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3461-4255" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1511-1513" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1514-1516" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1517-2230" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4863-5451" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2481-2936" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3069-3426" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3277-3412" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2353-2474" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2963-3067" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4487-4534" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ’   	  °  ¸        ¸’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFóÁðñœ~ÄïÁk,vî1Ì±l³îD'Ã�ÌôêS¡Â|Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      N  o  q  �  •  ™  ¤  ¸  Î  Ô  ·  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="969-1491" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="730-954" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3456-4250" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1506-1508" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1509-1511" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1512-2225" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4858-5446" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2476-2931" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3064-3421" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3272-3407" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2348-2469" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2958-3062" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4482-4529" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ’     °  ¸        ¸’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ97Áðñœ~ÄïÁk,vî1Ì±l³îD'Ã�ÌôêS¡Â|Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      >  o  q  �  •  ™  ¤  ¸  Î  Ô  ·  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="969-1491" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="730-954" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3456-4250" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1506-1508" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1509-1511" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1512-2225" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4858-5446" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2476-2931" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3064-3421" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3272-3407" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2348-2469" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2958-3062" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4482-4529" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ‘     ¯  ²        ²’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²ÇnãËË>äB|9ÏN¥:'ÌÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      >  i  k  Š  �  “  ž  ²  È  Î  ±  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="963-1485" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="724-948" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3450-4244" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1500-1502" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1503-1505" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1506-2219" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4852-5440" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2470-2925" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3058-3415" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3266-3401" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2342-2463" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2952-3056" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4476-4523" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ’     °  ¸        ¸’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²ÇnãËË93îD'Ã�ÌôêS¡Â|Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      >  i  k  Š  �  ™  ¤  ¸  Î  Ô  ·  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="969-1491" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="730-954" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3456-4250" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1506-1508" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1509-1511" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1512-2225" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4858-5446" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2476-2931" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3064-3421" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3272-3407" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2348-2469" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2958-3062" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4482-4529" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ”     ²  À        À’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²Ç0ónãËË93îD'Ã�ÌôêS¡Â|Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      >  i  k  ’  —  ¡  ¬  À  Ö  Ü  ¿  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="977-1499" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="738-962" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3464-4258" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1514-1516" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1517-1519" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1520-2233" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4866-5454" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2484-2939" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3072-3429" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3280-3415" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2356-2477" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2966-3070" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4490-4537" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ž     ¼  Æ        Æ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²Ç0ónãËË93îD'Áð¹ÏN¥:'ÌÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      >  i  k  ’  —  ¡  ¬  ¯  ´  Æ  Ü  â  Å  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="983-1505" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="744-968" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3470-4264" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1520-1522" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1523-1525" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1526-2239" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4872-5460" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2490-2945" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3078-3435" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3286-3421" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2362-2483" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2972-3076" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4496-4543" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  °     Ì          ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²Ç0ónãËË93îD'Áð¹ÏN¥:…òÑ¼äÎ|Ñ»µ:Å®4±Â|Àüfìx�®J==¸¢£þÿÈúúàP�{÷‹êùeXAZ6Í¢á$"Úæ¸  AÓP€QÖMŽ cæ‘žÚ@z½`*�ÒvPµ�[]Kö�=IÞÖ@z½ *�ÒuPµ�Öªý¦ƒrvPµ�Kh
«ÓÚ–•sØž¯ßhrÖšå�r©\'«öNXIò»Öw-`…@ÓÕr]óü*¿àV½ší®h8N2¹È	”C1ôË	òÍ.°¸}òEÍ|,÷Ø!5N+|ý¾�Ã•ÃÝJÓ"ðÄ@Æ=ùÃS‡øR¶ã}ðÔãò?ƒ÷û!÷ø~pÈÒ:ÓÎÇÝ…4ÜzëRóØüPç/A3}ºëPqÃ^uÌñR±þ_6Äá@Ûµ5ÛàÔàI×�t÷\¹›`ñÔÑEÃmB­FóÝvÄ4ÈÓ³ÇÞ}4]ÿÛpÿ#Ž?}çá7ô¼þT×LÆÝ‚øàJÈ|óÀmîÃ`q8�IS1îFÙm=Ÿv¢D*žŽ¥Uû÷~ÿá~ÙV5¢Š)z*hÓ¦X)Õ•5“mÕ«ueMª«xÚä¢
‹Õíµ‰ºPÉZ%2–jŠU¬ÊVª)[NÚª_Y°Õoé•µQd|F@¡"Šô¨Q/y¥EÈõËTU|¹´`ýç!}·ùmJª ±òTÞVÁ•?ñ©¡À<1rEA@QSÀÎ@ÎH“sŒÉ}÷<Î–3ÎtËBê°b3ÿšŠš«•�­Y‰¼í„u—øec­ešPQ/„0T_N Xˆ´¤�RÿC¿ÓCE&5M�»ZKM}�RÿC¿ÓCE&5M�»ZKM}’üÿ—¼ý¿?åï?Jóö»ÏöZª¦¦4CÄ<û¸NkÑI!:ª>Cª5FÆÔGA„*Í†…Ô`hÜÐ®ðó  D9¬9‡€Ýtu°ã¸cÏ"¼8´Í ÏÂº¨µ‹Â?……ãQÄ4Ì9²qÀÊú3N#±Ê-áLàãš� Ðnø¶íú;ãÄT›Û`á�c8ÙÎ†ðçãö±÷ÔÅvÍ±17'°`SÂè±´nM´³=<^+=Ô16?1ì²Ø1�Ž�m‚X<ê¸Û ðà"9´“(9ü†háDè0Å€áó¯²:œ&Ï;ñ¬Ó6Ï®lúèq+®î ¬VSý~=·«÷Ï>¹…B€ë²«ÀsÃ�†ûÓ0íŽ®³÷ù åá]ÁAgÁA3˜pÖUGE•spŠÊŠÙ\À+ôî,gýñö€=g?2®¾«ýÿýJÀ…Ð;4õË ÃCøöO´)í™ž¤hjUëj¥©T�…ê¡–í‡Õoér«+Þ-òEQµAºèFúª¸Ì–ãŽ�]U_|çÓ**<Q9õîªñB^´Ñ3F}Yâúä‰<’�÷Þµ¸“|ùÙû;Ž[âŸH8ãÒe,‹§À {QÆJ|C4ÂÀáp ¬�Ý?N�1qùß„gçL„æS=Î¿T0t&ð”Ã@°]LÜ@N½ Ï‚n¦KâÀ«=û‡¡2Æª!ŽË@ù�UÏMsªœ+àú£ƒêŽÝŠêøÊoøkˆ|š|ö6      >  i  k  ’  —  ¡  ¬  ¯  ´  Æ    $    !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  É<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1049-1571" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="810-1034" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3536-4330" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1586-1588" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1589-1591" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1592-2305" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4938-5526" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2556-3011" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3144-3501" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3352-3487" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2428-2549" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3038-3142" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4562-4609" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  ¯     Ë          ’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
�ØÌ|¿ÇìNü²Ç0ónãËË93îD'Áð¹ÏN¨_-ÎLçÁí±;S¬ZãK'ÌÆnÇˆúä£ÓÛŠ*?ïü�¯¡þ÷¿x¾¯–U„£lÚ.B-®k€ €45 hdÐØà0€î`¹™á-¤«Ö¨ý'eY …µÐT¿hÔ�á-d«Ú¨ý'UY !-`*¯Úh7'eY „¶€ª½=©iW=‰êýö‡-`9¡^X×!ú•Âz¿dá¥€TŸ+±=grÖHT=W%ß?Â«þkÙ ÞÚæƒ„ã+œ€™D3L°Ÿ,Òë‡ß$\Ñ·ÂÏ}‚P1â·À �Ûà±81É\=Ô­2/@Äcßœ58…+n7ßN?#ø?²‡ç�#­<çü}ØSMÇ®µ/=�Årô7Û®µ5çQüÏ…+1ßà…ólN±ëPAÃ]¾ ÝN�y×OuË™¶M\6Ô!zÔo=×lAÃL�;<}çÓEßý°Çò8ãñ×Þ~KÏá5GýqÌmØ/Ž¬‡Ï<Þì6‰Ô•0óäm–ÓÙ÷j$B©èêU_¿wïþá]•acZ(¢—¢¦�:e‚�YSY6ÝZ·VTÚª·�®J ¨½^ÛX›¥•¢S)f¨¥ZÌ¥j¢•´íª¥õ�ñ[Vþ™[UGÄd
(¯J�u÷šT\�ï\µ@ÅWË›@ÆÞrÛ–Ôª �%MålùPÿ‘:SÃ ÄT1PLäàÔ‰0·8Ì—ßwóÌéc<ç@Ì´ Þ« V#0_ù¨©ª¹YÚÕ˜›ÎØGY†V:ÖY¡UøCEôâˆ‹J@ˆ/ô;ý44RcTØÛµ¤´×Ðˆ/ô;ý44RcTØÛµ¤´×Ù/Ïù{ÏÛóþ^óô¯?k¼ÿ`áåªªjcD<CÏ°û„æ½’Cª Cä:£TlmDtA²¬Øh]F�Í
ï:CšÃ˜x×G[;†<ò+Ã‹LÐü+ª‹Qñø¼#øX^5CLÃ› à÷¯£4â;¢ÞÀP9 1Hðï‹nß£¾<EI½¶Ö0Ã�œèo~?k}LWlÛr{<.‹A†àqDÛ@;3ÓÅâ³ÐíCcñÃnË!ýƒøèñfØ UƒÎ«�­±â Áó›AÙ2ƒŸÈfŽNƒX:û#©Âló¿Í3lúæÏ®‡ºá0à
Åañõ1Ï×ãÛq±¯|óë˜T(°[*¼<8o½3 nØàJë?�^ÜÖ|ó9‡eTtYW7 ,¨­•Ì°¿@àÞâÆßÿhÖsó*ëê¿ß÷ÿÔ¬Pý³O\°4?�dûBžÙ™êF†¥^¶ªZ•A¹Q¾ªnØ}Vþ—!*²½á2Ñÿ$UT®„oª«ŒÉn8èÕÕU÷Î}0‚¢£ÁµŸ^ê¯%àëM4gÕž/®H“É)}ëQ{‰7Ï�Ÿ³¸å¾)ôƒŽ= ÆRÈº|
µd§Á”3L, 
ÈÝÓôè�ñxF~tÈNa3Üëñ@ECBo	L4ÐDÍÄëÐ\ø&êd¾,
³ß¸z,j¢ì´ 0O˜\ô×0ú©Â¾ª8>¨íØ®¯Œ¦ÿ†¸�—É§Ïc      >  i  k  ’  —  ¡  ¬  ¯  ´  Æ        !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  É<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1043-1565" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="804-1028" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3530-4324" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1580-1582" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1583-1585" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1586-2299" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4932-5520" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2550-3005" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3138-3495" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3346-3481" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2422-2543" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3032-3136" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4556-4603" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  c     �  {        {’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNÔë¸ÒÇ	óñ›±â>¹(ôöâŠ�ûÿ#ëè�B=ïÞ/«å•ahÛ6‹„�‹kšà € M@GY468Œ ;˜.DfxKiêõ€ª?IÙBÖ@!mt/Úõ'xKYêö€ª?IÕBÖ@KX
«öšÉÙBÖ@!- *¯OjZUÏbz¿}¡ËXhW–5È~¥pž¯Ù8i`'ÊìOYÜµ€ROUÉwÏðªÿ�Zöh7¶¹ á8Êç &QÇÓ,'Ë4ºÂá÷É4mð³ß`„ÔA8­ð#öø,NrWu+L‹Ã1÷çNáJÛ�÷ÃS�Èþßì‡ßáùÃ#HëO9ÿvÓqë­KÏcñCœ½Íöë­AÇyÔ3Ä!JÄwø!|Û…lzÔp×o€7S�'^uÓÝræmƒÇSEµ^µÏuÛpÓ#NÏyôÑwÿl1ÃüŽ8üu÷Ÿ„ßÒóøMQÿ\E3vã�+!óÏ·»�Äâu%L<Ç¹e´ö}Ú‰ªz:•WïÝûÿ…øWeXXÖŠ(¥è©£N™`§VTÖM·V­Õ•6ª­ãk’ˆ*/W¶Ö&éC%h”ÊYª)V³)Z¨¥m;j©}d<VÃU¿¦VÕE‘ñ„Š+Ò ]D½æ• {×-P1UòæÐ1ƒ÷œ…ößåµ*¨Ä#ÉSy[þTÿÆ¤N‡ TðÅÈ1ELT985"L-Î3%÷Ýüó:XÏ9Ð3-7ªÀˆÌþj*j®Vvµf&ó¶Ö_á•Žµ–hUAD¾ÁQ}8�b"Ò�"KýÿM˜Õ66íi-5ô"KýÿM˜Õ66íi-5öKóþ^óöüÿ—¼ý+ÏÚï?Ø8yjªš˜Ñóì>á9¯E$„ê¨ù¨ÕQl«6Q�£sB»ÃÎ€�æ°æuÑÖÃŽá�<ŠðâÓ4?
ê¢Ô|~/þ�GÓ0æÈ8=Ç+èÍ8ŽÇ(·…0ƒŽhR<A»âÛ·èï�Romƒ†5Œ0ãg:ÃŸ�ÚÇßSÛ6ÄÄÜžÁ�O¢ÆÐa¸Q6ÐÌôñx¬ô;PÄØüpÄ²È`Æ>:<Y¶`óªàklxƒÃ€ˆ0|æÐvL çò£… Ã‡Î¾Èêp›<ïÆ³LÛ>¹³ë¡Ä®¸L¸±X|}LsõøöÜF¬kß<úæ
¬Ê¯ÏïLÀ¶8ºÏßä C—…wuŸüÎaÃYUUÍÂ(*+es ¬/Ð87¸±Ÿ÷ÄÚ õœüÊºú¯÷ýÿõ+?@ìÓ×,ãÙ>Ð§¶fz‘¡©W­ª–¥PnBoª†[¶U¿¥ÈJ¬¯xL´ÉFÕë¡êªã2[Ž:5uU}óŸL ¨¨ðmDç×º«Å	x:ÓDÍõg‹ë’$òJCßzÔ^âMóçgìî9oŠ} ã�H1”².Ÿ�íG)ðeÓ…À²7tý:ÅÇç|^Ÿ�2˜EL÷:üPPÁÐ›ÂSÁt3q:ô W>	º™/‹¬÷î„Ë¨†;- æW=5Ì>ªp¯ƒêŽª;v+«ã)¿á® eòióØ6      ‘  —  z  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ç<?xml version="1.0"?><Features recycledIDs="1" nextValidID="14"><Feature recentID="13" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="908-1430" color="#ffffff" type="standard"/></Feature><Feature recentID="12" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="669-893" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3395-4189" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1445-1447" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1448-1450" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1451-2164" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4797-5385" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2415-2870" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3003-3360" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3211-3346" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2287-2408" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2897-3001" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4421-4468" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  «      º  }        }’šY%µ§ ¶’¶OÙ˜¼Êv^œ%`üø8|ýqÿÏÚµ–˜¯Ù%ÏYêö‡-` I©ÂW�ÞƒIÛR&Ù�Rsÿšµ‡	X?>¦?IØ~˜«ç Òvç&’Û9§Ø!Œ*ƒIÛX�“
‡· jõ.÷ý¡ËX¨ªõ[\«ÕbÉuï?ÚÕ€ÂC"p€Bæe4N
’ËFó“9ð{FìNÔë¸ÒÇ	óðß=öM@ÄŠß ‚?o‚ÄàpÇ%p÷R´È¼11�~pÔáþ­¸ß|58ü�àýþÈ}þœ24Ž´óŸñ÷aM7ºÔ¼ö?9ËÐLßnºÔp×�Gó<B¬@Ç‚Í±8P6Ç­Avøu8uç]=×.fØ<u4QpÛP…ëQ¼÷]±24ìñ÷ŸMöÃ?Èã�Ç_yøMý/?„ÕõÄS1·`¾8²<ð{°ØN'RTÃÌ{‘¶[OgÝ¨‘
§£©U~ýß¿ø_…vU…�h¢Š^Šš4é–
ueMdÛujÝYSjªÞ6¹(‚¢õ{mbn”2V‰L¥š¢•k2•ªŠVÓ¶ª—ÖCÅl5[úemTY�(H¢½*ÔKÞiQr½rÕ_.m?yÈ_mþ[Rª€,B<•7•°_å@OüjDèpO\ƒPPTÅA03�3ƒR$ÂÜã2_}ßÏ3¥Œó�2Ðƒz¬XŒÁæ¢¦ªågkVbo;aeþXëYf…TKáÓˆ"-) T¿ÐïôÐÑI�ScnÖ’Ó_B T¿ÐïôÐÑI�ScnÖ’Ó_d¿?åï?oÏù{ÏÒ¼ý®óýƒ‡–ª©©�ñ>ÃîšôRHAª��ê�Q±µÐaÊ³a¡u74+¼<èkaà7]l8îóÈ¯-3@3ð®ª-GÇâð�áaxÔq3lƒƒÜp2¾ŒÓˆìr‹xS@x8æ€Å#À4¾-»~Žøñ&öØ8cXÃ6s¡¼9øý¬}õ1]³lLMÉìðº,m�Åm ìÏOŠÏCµM�ÇA»,‡öcã£Å›`�V:®¶Çˆ<8ƒÎmdÊ!š8Q:1`8|ëìŽ§	³Îük4Í³ë›>ºJë„À{€+‡ÇÔÇ?_�mÄjÆ½óÏ®aP :Álªððàa¾ôÌ»c�+¬ýþ@9xWpPGYðP_Ìæ5•QÑe\Ü"€²¢¶W0
Âýƒ{‹ÿ|Gý YÏÌ«¯ªÿßÿR°!CôÍ=rÀ0Ðþ=“í
{fg©•zÚ©jUä!Fú¨e»aõ[ú\„ªÊ÷„ËGü‘TmPnº¾ª®3%¸ã£WUWß9ôÂ
Š�ÔN}{ª¼P—ƒ­4LÑŸVx¾¹"O$¤=÷­Eî$ß>v~Îã–ø§Ò8ôƒK"éð(Ôq’ŸPÍ0°8\ +#wOÓ L\~wÅáùÓ!9„TÏs¯Å	¼%0Ð,A7¯@sà›©’ø°*Ï~áèL±ªˆc²Ð Á>`UsÓ\Ãê§
ø>¨àú£·bº¾2›þâ_&Ÿ=�      |  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  Ö<?xml version="1.0"?><Features nextValidID="12"><Feature recentID="11" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="2629-3423" color="#ccffcc" type="standard" translated="1"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="679-681" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="682-684" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="685-1398" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="codon_start"><V int="1"/></Q><Q name="transl_table"><V int="1"/></Q></Feature><Feature recentID="9" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4031-4619" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1649-2104" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2237-2594" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2445-2580" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1521-1642" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="2" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2131-2235" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="1" name="MCS" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="591-671" color="#99ccff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;multiple cloning site&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="0" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3655-3702" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  F<Notes>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pEGFP-N1</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created>2018.5.31</Created>
<LastModified>2018.5.31</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  #Œý7zXZ  æÖ´F !   t/å£ä c#L] Ë‡ØÎf‘ƒÊý{3Ôé·Ú(1v%f M*	mj÷)p80çÌ*iÚ	´NY]Qó“�úF7î&ƒÕ!Ò÷ÀnÉ;_xˆÓëöQ/r¢o²{�$³“Î)zÅäpÝîf
‰æT°ô~Ïp[i›˜@åyd‹±+x¦ï9ÎêÔ}G¥vÍ^ñjŠxù¬—ý{^°Ïpªt'ïVK×¸ ŸRë¾˜S"A—£ÌI¼º°¿›ìt/øjŠZö™®èœV1é°ÔGC:’(92ôí‰²=ul¸×/§šÿ=qG/’ã5ÜHrÁ‘q«MþÌ®¨Jœ�l@:Å©n$8üY<±€þÆäcQVª@t±”–1š©ûÞxý6Óž5M­¸ENP?Í|oû“²Cì2Kb=ü†(Èµ²e••v\¹@âWÃf÷øÊB,¬�>�e•‘²$0¶¥òrfí…?¸ª`õJÖ€x}Uøþ}™NÒó“rg×ªgÀpÍù·"{-z�ì‡ËRn¤ÿÏDlÔëø÷aÊp¤>Íë#µT‘E¶„o�¨¥ˆê ÝCÔ+(žž[/IÙðïq~8-×M·y¨2Y…p^ô™8ûi¹âKÛF£Ùƒ©”¤f™‚z3}zª‡Ì>…¬¨¨–\¢AÉùqÊñx €Ë‰Œj²ÖðŠz9�À0`6«‚BÃ~­vË
§È¤ÓR�ÇL:+l¬aSU¸'^n¢[zØó�Ák¡k
Eqú`:”uò‹„m ÄïÅQêÎ`Ägžó­9…ºn?hö�ÿ�Çµ´À9~Ê¿WÙˆlfŒ´¼¢IØ—ñ'j•Þ»ë­ÃK!æ—õD/»°†¹Ÿw€óO­ÝSÝ†Ç˜k8Š—0]I�ðíôƒÄ�ˆ"ˆÏÌ8Àó~ñ­ÕJ‹ «‰óH´fIºÔV€PÞÀgP$�|B{-›B¡(º+%¦‹{!wn‚X�}ý��®gžÜÀƒ4éPRç®Ö^æ6muœwä…ù=€	Gïj’Ò¨ø!a*Ø¼# ¥”ýî¡TôòôZ—ƒ6JX¾ÏÀM¿°kÔ³D÷JŠZ˜òAS9oÛð¢€…È”|™øÁÚqsœ“2Z%u!‘¯Š°Ó€®`¥¹ÌãØw &Ñ†t‚å>‹Ã$v`µŸ8èY{áJ¯ŠüœYV¶äÖ•\¡n£�›+çh(à`¾ò<Dám¤íR5
:ð°½\ËZCÝ<ïg¯¾F<rá"Ù´µ¹(ù¶ ±éµ,Ø�Ô_Ã°²ÿ*Çõ˜t`W çÂD(†¤zRÚÒjÓ›Ð8«Ít:½ïü·ïhpÖâ€Êj»)@à:1h»³7üaa½òÚ”½Y¯ænèU»!p‹ÜØ´T‚IÇj±	�ïûðš0¡…«{#f‘ÐJüXu¸}»&æçòì²…f�V4gÚÐË1‚i›PÎÑ–Ó@«…˜¢:xƒBT�‡,¬`A ßE‚kJ®ŸšYB~[÷"Ýþk7Ñ:Öþœ¯B�"±Â¡�µÁàHSHkëô‰�òïŽÊ bR«ŽWXÍòwmÏU�)&#'Âù‹{ÿœ#\.ÕŽë¾Ì&M�rŽ6[Þ6ÆG�ä1œÝ’÷÷Ùö”')öÒXKâÃ�ª©c“®*³f…Æ`©h È»+N¤T†O/z#¬ÀŒ·` Ö‡³-çµš{7ú™Ä^d2µ‘µJµ{ë­ì$RIÞO2jâšÐ{sÚ¸þ;7ÚÎ²„uãåï`F`½ÆZ+zƒµ´QŽ®•T°„È<½,òò'"QÒòÁTúø¨òéÎ\‘mi#f%³xžgk�zTk‰k=;­+VPdJÛµ”…þ�œmH–¤˜Ï*Ï¾ »e•±©#X¥Y
RaxŒÛåÖ#œÑI<`õX˜{UÑ¬wûÅá`œˆ²Âú.-ts¤8i7˜¾ˆŸ�,WÒÆ¿ï`>j;L!Hú¬i³¦¿ÜhD“ß´ÉpºÑB¬~‡°�XÏë­tø,�µõvåw “=jZß@x4Íî´+t¨±Oo‡A€Öz³U2³Ùµ&þCJÀhÈ1FfpŒ1ÿh<f7Ðaé”pZXov®8 W{«I åðY™VÃ´›Âñ¤Ö€h.E{pŠì¥”äMAZ’TÜíÃÓ®Êô7…méw³ˆ�4}Y·Ò|ý �¶�øÁtn•æã®V²|çSBúÐ»ÚÅ@$èq´j‚N`]´‡Ò�˜V¥ÿ¡Wüès#ù�l\WðË@ÐšCµ‰[ëÖ¬ÎŽ_~ü„ŸžÝÍY�‘¡Í2Ž±Ûx]cÀXCwÃ¾N¶.‡êÖ/¡4ÿØðú¦£Ô‹K°©25£ I¿v;þ	æPÆÁÌ/1~\q³Dk‘ÖdA`V)C«÷‹)=Ô(Œï6Ä×>ÜaGýybpLt±ÙAvdàÇVu~�·ée_2ü›�•®‡rÝ£›G�íCb>8Öî¢îÐÌ5vØú?¢4äËIYYÜ"Ÿ# ÙQ|K–ú«ñR!Ù§-ý¼ÿ™%ÆÅ]€Ò¡ë­rˆ”ÌÇï½Ü z¾Øbˆ xÊÕ)†2²  P¾t¬öÙ˜Ãó}™Eºûï6x‹êÝßmï=Â·$Ï«�[‘õoé¶á±…SÏRþh¶êÒZÛE¬ƒ!ù’‘[XX�¦­I™'ŸÑØÖaYq	¶¢–wãs†üÃÂwêØ
©éà| †Ýì!ZV5,Ó˜7í9ïÌ�Ê¯Æ‚W‘•ñÒ˜š^Ò”½�`Ó†æŠ˜bÿ®¤©ÏäºŠÜ(¨[yS�–F¾‰š¨âzà`krÖ&—=ŒÝ=� vHu8ªd`åÞ~‰YíØ»R/ò;lU¶eh­´Ýdo›Žl%¼e\ê ÃášìŽ6�óçç‘]Q±D1é•¦yïk÷ÛK9Bºå\s ¥$ .?
´òúYÑ)´ga^í‰a~Ž�úåXÅc¯6C�ç|Ò…®· üÉÉï¶G{»kÝˆ¨¯^,²ÐB´ûŸg¤o�¬$Û�Iæžj‚‘ðiçfÑYxŠM¡á™¤)–Þªu|_Íràú;ëì·oz�Hz¦gÝfƒšB½ksý¬j–UÅºXâY'ïÀV…/l'úêµló=[^ª]Øì ˆŸñnn‹ÄcÊõ©°=¼©•1 ÅÊGW8T	uX±m(`2k:«zYçK×£C‡+LÝõJ/g$uUËÕ(JÊ%¤bþAG'V(÷s1iHKŠ�ÌÏ96¡©�û¬ºLÅ"PQÞy¦º  åÍ6÷W�ãÃµá;×DÐ!Ä%æå·ò œif¯#¢Æcg¨*‚ÁAò�È·]ÝhÅg7D"M½¢ÈÅ]%<°_'tvÑSãEN½ž÷M<3ëÈñoÞ#ðY©©¿ í&Ï¹,¦9Š0~À³Xí©y2ÓÛñk¶O^º	[Ñf/HÞö§øfÙ1{H#=nQùNôÊÜJ5ë‚€ÄÊöûní3Õä¼¶|BtÇ Ù¿à•Cã›YN®L/n…ÖNç;ÿºªK¿hC<ìÑý	š‹™_¡:ZéKBÔaL­,jËSäk+>Fƒ×ÊÂ@÷Ÿ×g¨"í³Ú°OƒŠÙ÷9È?š¾Ó·“¡HÐ%š•¿B~úä™û¢Ø'�2£º’ó¶°ƒK¼ž—xà×$Œw•Jzš‚sodÍ�.û~ðÉ¨|-ÀP¬aé|—fúÜeBZù3�SpYc©…4Z?¢‰‚DÒ}ýc—�å—±¹tÉ
1ÞŸH°ÐÏG_Â¶�3¿˜~~PD="gŠ'†]–Šy™Â¼éWxÎ~"#_e‰‰ÄÖàXä‡p²ä&½èÜÚ®\É¼uÍ„ì,1—³g%êd¢w»D“²ÅAÕÑ–«[…-ãû×R8]]èÄÐ´«æa§_ÊëŠr$<+	&•T"­VÑÎŽ“+3FÐ`ˆ†ðÃ=¢Ó`Xù¥¯ÅfiºéC¤J4|Ò¼�˜[ì	�K<
Œ0 ˆvÄ·0v~Ò\ç˜ÑÙÜ”’aC8‚¼ÈêKó+ö^V¡jÙ‘‡XGç3‘6tœ2}`ø˜È€Óê�úiÅÖùbÄ€‹ã\YÞ}ß´R©öü¼‘ÖüÒ¤.ª^×aG`sîöGxâÛŒèß§6ÿAÑ{Ù8¨‡råîØü*DÎ%~˜°Tÿ•üÔS'`‰?’ï¥ÑÊ4çe1‘|øxè\Šú.ûpç­Å§îÙû¤0Ud€i¹á<�#5SŽ�‹vnØC±8¨òfñÉžúiŠ1ÈTMñ*/œaðÔ"þn¯BÛÍYºICPEhß³ìÊ.öïî8/Yâð±;B‚@Âšª¹!`‹Z`…-ï5Î~Ñç¿Ý=VMƒ¥'ŠzÅÓÁ[OçèG$–Fúp¿At€¹¸~+ú+È[ª±HÆÀB3¢Æ7“6Ö\|+›q÷1*-D‘ö7ûÍNü$LÊ«ÝâTVÍ¦ÊVû³Ú»ºN�4ùÂúþŒöËgÔ¿9Þjop¦�F×¯nþ/UÜÔÔ×WGJÖ!Ê*zækoâÀu�÷iØÖ—’h>)Va±ÑÐÔ»r_zZx#Ã)ß2úŸa]wÔûöª!"¸�°ÙƒeÃ©ž¶´TYƒ³ºìË,L…Û§ÀoábJ4™sRv¿ÎPQw1ñ.é¹-Xfœ¤qyÀ{““ï¢w¹¡áþ�¼¤û]t<ƒ£”ƒ·ôôgrg(èhí�Bj¥Èy«åªÌ]wDiyÞµ“íÃ¡¹2ÝÐX�=5Áˆ™i=l=û“?	ÛSšK!2ù ²ŽÌøíÜë88X#yË¾™ŒœùÛKÒØœö‡%‚“'8‰Ó\w`¢TæD¢ÍÁÉ³Kyëa‰ËWsóûÛ–˜˜F»ˆäÀð§i„»�¯«{AÏÌµ?€ÿø}`ÜvUÈ?Ò¾"4ö†Çé{ó>`/Úþ·‰	>8Jó.^ÈÜŸýIˆcÞ}àŒóŒE6ðÈ]Pé+’Ü‡|RHhÒ‹Ü	”ŽH/ƒÑŸ\1!¹KÓ¦Ì€k‘gºì¥5††H¬w*z=�‡¯Œ�ÙÆ¸)y}�Ìk±™Í©‡l‡ûú½æú’îtaæiyåQ³OV$+Â5=«Y Ý7ƒ…"E�ïù$<u®ÁÞ�Ž¸þèÖ3"N^ùñ¼È½¾âë+¯j1æ:J=Ðç¨1¶¥.ºˆ÷?<r —ÂÏñ]äÐˆ¿d}Ç=ÈõhèggB�d~y^;©Ï‹Èô…w¸$Ùèâûo¸º†Ær<Å”¹Oã£ëžVê,ê]/ÓÝ]ë[ËÁÌªÓ±Ï³¡yZ!ôjN“×ÿw:giI0�¼K-„å~n‘ÅÁ¬Q¤EÆ¯Dq0KÞ>m˜ŒHî	¨z3>ŸÞƒ€£…|ÈÑuœk%ŠXºS$šeN¡]`L/Yˆ•fú×K‡‚Q/u<ZšÛ Ò.©¸M”*@ìÝ4{�s}M)i;r!~ÞßS �-¸ªr›Xý¡Ã'›Ýf3Uƒ973£æ¿1?‰pÁdû;¬ÛŒï�øk>8Œ®2€x9Yê7öÁ…ò1�Ó^¤îù„‘Û¹es†^ÑÔ(þ4…sXIS!b8ÜŒÛ²œ¨FB¦¸·â`ªT+^´#ÙmöÉ/úxK’‡§oo]Ü¨®ìÌâ7`yä-weŠù+`ƒ”÷§Œ3Ñ{"ºÑL2ëvƒzÊ,{Õ!vc¬#}}þ§ÊSŸ‡‰8¡ÝSAªª’"±Ù'ýUóãLòÐnÞ$Y+›‚ ¸žaÛiPùó øBÂ/ô‘^¿œËÐà{5$.N=…+4¨ÓÅ8kÔÚ¦L„,+9”`Ûôª¥§?ýE¢¸�»ƒKÕåˆ•?•:^V6ZÀ<Bî!ð›Žîì©.HøhZ((#Ò+™x¡Â`µA¯l»:»*]P¯EØcŠYW9kF9[j~bóù„yÖ’H2!K@"Qà’w$	M&½ˆê²pOA-,ß¬•	U%VMG¹q§y–àÄ<¬p_jò¯®8IÎF§3”ÔìoËE·ŸÊcÍ¶üCƒ*¿…-³)#0˜á.|dh^m|Uþ»ƒI¨‹’DŽ¸ÏÅyþt¤/IZ²¥§žÀ…Ÿ-ŸìÀ¨�*;Eˆ«}©Æ{!}ÿ³Yw{…+9Ä|];‘M„�ŽÂšð–Š•{úÄg&ÅÍ'LL°Ï-‘xM'V|nÂzàªi-Éá‡è,JÇ€Ñ¯ó)„ã!FcF‘S³öŽé¨Ô•Úlë7:&“÷ÇÊ+vXRöà$¦©Ê˜¹(Å ómXÓ7Â}¬ÇÌ�‘þ>ó½›8Q]Z•¥õ]
eÒ
xq.“¤	DYjSì¼¾ö�þzÜcµ8Æ3çûÆ‘zù‡õ…Ñi_ªÏðÎß¯„Éƒçw“^yóŽ�õi¤¢¬æp²VabÐ’„¦ æã›AMf]®¥l°h("¼Á-,Ù^úRiò›:¬¤Ê;)r�?™±z…=ƒFlec’6Ÿ*¥eØ³î.ùÙÔ÷z–Ø$N",L}óÞ…Jk3x¢T(za™_J·'êÚÔ
'Ÿ-vyPø|*m˜'eJã-ÂFŒ‚A.Uõû![on ÄsŸê¹‡Ó¨Æ+9T_�`ªÐÒª™r¢ö¶¦à†{iœ„2¿˜bà”ÐÎËIÆï]µÌ	v’öQê‚C}¥éÇ0[�YÆ(.$ú†œ¶¿>÷0–¶ý°ÍÓ
3‰¯i"d¹¯Ÿþ×nªÁµ©¼<™ýü‚ îÎ0'ISH³ë#A-ˆ\Ò‡n�4a¾!ÚS^èÑM·¦-Æ‚ëñ—¯X;»È8Q³ª5˜g…Âù¾ðæûb]WDú©vAkà×	Ù-1¹„�3kfÇ­§@sˆº-qÁ9•_±*ãÒ”‰IaV¹0~Ÿvú(£¶2hµµïã›ˆæ‡¸�,×WÍâÕä˜Í1Z;³eñ¯µQ©þ.-ƒœó§FÙq
²|÷7ÞEýlsíê¸ý3˜ÈÎ³Ð.íÆNó
_~IXÌ%òVúÇÔ¨xáëüèë”8úBd!ü?�~òÚ[A#�ÅÕ.»õ8žèÊì0zé.?@ók°iÑ&ÐiV$Á^ôe¾I=1lÜW,UÉå}ô«üŒGIûfM0:¿‹:îyˆÅC‰øEÈüË�Ð£HÉ*q¬-z�Ý€¿ÚªA±|<»LãÌÎ±iRÜ7ÄÅ2·8Ùó,7…W¥ñÎEhu¦� 2«Koj‡#Õôl\žU†ËPZÊ@Å¤‰p5Q¬h˜ãoëíª�&ž²Ä	Òïõ�ÍÔê M”ôìÑ¬ïôÇBµñueG!Ô
ô:+aï;¹LÄÙæ2['Q*òjÈZîRãÍêM�amMFë/L§p…M»;‡%ñ J+`³Srm_¾o~Æß—ùÁ‡Ý/GßDV´ô¿e­Ð,»,9E-ŒƒyB|wfV%æÿfëùåÒ˜Ú³hzLL+qý6Gdmz¥Ýnhÿ$À	ÿév#ˆ”Ë
™¯Åßƒ0™‹ƒC�»r‚O³«k}ÉA1õlCšœ=±“6 ,T‹’V´¯W FŒÉ�ËànŸÅÚKcnTŒ5œ˜óa@t˜„Ÿ¢Á&qÐ¹CRÜÞ.ÈÄæTRo¢¶‹Ã4’uº€Ù8eåóÝÙSåsSIßÓˆkÜ‹|/…¡#æTÔV°Q§à#ŠaÆ¨H}õUäø=‘A¦4Ú›˜èEºå”¢@}÷[ÉÑ.S›Û+LF¤'“Åè;G�ÉW6we-Ö”š=«
M©¾�{Ö°Êû¾[Ò9|ÝzÇÇ´(¹4{¸¿?é"+®Ø#j¡Ä‚ »#s³‡ÄþÍ-!@î·üNÈ.VH?ÿf)\éÐ?vû©]™[ÈŠ|Î¡°#ªÂœ„¨Ü.Êìçî²±£ÑZðxÒÙùâaÍÃ–¦ï7dFì`™èyVsä3wãäãä×QƒÈ(2öDÐ<u!£ï;¸a“Œ].Ç¯ÄQàŽz0}4Žx>m:0öœ3{Àã±óHuÕ±ò¢ìÊÃO[1þvÞ?—¯ãÅ…±HËkr£(˜³Ê¼ŠÃ¥d(ðo:Uw9Î2rÆÀ‰Û“¹»€Õ|L…r «ç‰*ÄIÃ6²Ÿ™Uû†¨º7Ï×1ú5û*§Ö ùÄw�q!6W…ÿ‘¯¤{	‡j‚­±Å‡æ®e7öb[uçjfDÒ�?²
ŠËE«FÇGs��x›ò�+ŠÞµ_Ío¡ªÒ¡ÕãW‘)›qdisÅ×ß ¨uW-D©)/Ÿ¢bý�ªLh‹ät®hì?Oª“Iu½õ¹Ï}×¦Ð“-`·Rë@*Çç$bGô’¡›æd¤~!*Ú#Í×åO°x§kË½ÖP�4”Èq­Å(#_L«Ó$›Ç=eÜ±õ1¢¦ï:êBÿú¦c‰y\v÷ ¹ß<-n°üÄ¡‘³�+ŠCä¾¡îÉžÊaÇ3ÿ[ÍË
-}G_[ÜPúvÿj"ê=«TÓC^j™%-ûÕ}ZœJëŸ#ÁäÓp_Ú4@•ø‡Á'OÂî9ÛÌ‡�ËœJ’þ·Íoâb¦K´<ÕN.há1Óï�·fø€5Ä7aÂC¡ÔÔºñŽÓg’Z#Ú ÃàQ^¤ù»ºèSÜía)bÏ½1xJ
YlÚï"gq‘ªtâ´1–:Ê9&ëj_j€i.ù§¼XÐŒÙÂi³š–Õÿ×50÷¼ýHFES��#Bq–"ü+]fK{ÿh¹4Ø>PS&“9rC^Î‹™fü5RŒ¥�¶^µI‡ƒ@Í�ø3WÝc:`š€xçkýíú‰ÄuHN'z(ÇášÜkaô(ï�ÅªéCÉÌ2ÛTgZÀè˜¬“µçàÒkWªØ_òU]8/Â�ð"8´„rîÆI6"±‹ÁœT·íXqf}ú±§Ú
ìq'¬ÌÅ“k?Š?_³Ì4à·~ãZïdóÁæa!\ÌÔß4“ÛÀ/z /YÚ'å‰r0æåd€6a]Titwb}�\øPÀlÇÔžú'1’ðà5¾X$ët[ßŒÇõeE÷H˜B3ÀÖÃêz-H—óÿ¡wK�€²R¤éÀzåjO÷�”“ô ‚’ý'GÕkëWPïûE’Ÿî ýÜÔFAIiêžGº­úú¤ìcÉ¨±šN¢ u´6˜g^vü/²iüŒf&¶õ¨:…ˆ'³øqÝkí`<L³É™l: ¥Ú%fÛ×6²óIo�¯¨0{OÖäžJ™j„Œ™NsA8«dN
Ò=1Rkµ¤ÂiÈ¯9[š�½^�•¡Š6Äb\¨C`6ÞŸ/K@�¬eõÄ”€r56:Mð=Zwº£éÎÚ>&'×ºƒYíYº\ÐÂ X”wƒ·sÁ+ÕB7Í–íúù	é÷~»)ÄNkÏ#fï�Rî‡l·Sz;.’x
�²~çìÿp1éO‹t,™ñqxõ`¹xê%Ù„TÙ÷Oõ¾mçÌŒ=dñú_‡;ØÖÌîÜ7¤aÝ<Éú ÿiç‹5Sç0ÁÃ"oq§ ˆ.ŠZ�˜Z,_ A4ò=þƒƒDC}kCÔ4«56Ü‰ñÿ$îÇV�ß5t©ójéä v=×móŒ¯G¬{~ù /×([<Ú«V‹Fe¤sÛÄû;.ì.*¥e%GÜ¶»Ð˜€V±HNõ¹¦ÿ°™²Ry€æJK¬§˜©ID}µýâF|žÞ¿„­:™R3
•K£ò<ª�y…âÖf·ìàY³)š†$`}/ºîdOÃ%[ÃÝN+,ÎH«
s´�H&S¿km`FlÝA¡~+´¶´óAß$Ú÷ðwÎlI¸ß=¾œêÌŽÅÿa"!YúÃO‡õbln5û—4ß§³I©Ìo•{à�7õu¿í#·t…¹’Û\YÛ
Œ†ðÂ&+*RÈ£
K#nˆUx«t{ÕbÜ:7×ù¡ú‚pådBaÑ['Úº˜pËkG÷Yòƒ¨äZ7QÎfÔ8Üæ“ÌÒHê `“JYU×â[ÀÏŠk­¦�˜?�û§_ËøÛ¥U
ðž�èà«Ù(éBàûmÌ^„9E¢Å€IÿP‚G�>$Öey`LgƒÀÜ0Fúv”b»79•Óý‹r’Àr¢þÖ�‰ã:¾¨Žœñ®ZÑþ
l²ÿ{1š’ô_J¿DG)’\ïg=‡*?*€£øªÏö³À@žšmOä?Vw!aÜ˜ˆþq]eI«·QŽbÏâ«^ßSYÒ‡@ù0qt×ý%èè9q~ôïâÞž§©Ê:ÃŠâM£;¤Õ†O*´Ô%§pFA|ÙìîDJn¯ðkNÁÞÒÉÄ%‡!3Ó]žð3?kR¾qQÇ	xbôlÝJtþšõ‚=T%Ëè‰j�ðÞ5ªé„ü¾TRàƒº‰øÏïI@ûs=ÚÏ�OÂ6Ìj9!4:Tyv\¿X{ú'¯øÂDq 9rD»Ð«Ñ¼ÔyÎ	‹z%:‘1p@¿÷îüÏTÆ]ú ±r$OCeîB®ä#�~p�ÑÚÅ%dë,Gˆ'WeÖ\ÙpdZØØ¡ÃP7ý‚ñºGY{¬¦Ýwþ¼?¸/ÃT†`Õ×/;©yÉ~©†BÎœ9«c’›ÔÈ¡I.!N7·ÿð–“{8UT©—5ÇÈÙ$/¯;j(nõ_ìÝ{]2à~ÄYM¨ª]öÀP$ØØ¡ ˜xK’NËw=$!¢µ¨ÌºÉ¶ˆV˜60qåá-wY¿€?)âc>éŽÑ¼¦/ÁñB>rø`?r¼sZd’ô_ô@ÿ›¿ÏçÅWÈ@òY�)–GA8ç{<Tn¥ˆ_kR°ÜZ�ÓÕÓ\9ð±»s±t²â?mN(ÔžÀmåÅ«hàšN&o™�:¾J9Â‡éäð`zb[UsH¿öádÀ¬Í{ˆaNrá
‚ˆÀx�àý¾©Á7‚û†^æt²ð£aXŒ”–XÝW¯÷ñ=¿“™`wú	¦‘Çr?…._T‚„ƒ99/É0¼Úç3,çU÷“£C(]Ò¾”TïGÚºHSêN3¤g,ó§8éÕ Ô²ÕÛžùgýé‰”YR™?l{¬¨ŠJ™£ÅA¬èæŽµÑráwmÄY­@Õˆÿ‹Ë®âÏâôê?É.J2CÑŒÍÜA÷íx"U|è�½ uj33ãâÊÏ³…‘ê¸A_¶6„r%×>±¤dz þÔßiŠÇ¸•|Û;ñä”"ü`èúùVSbàsY5«HÒ–‰ö½dMO|FùØ�Ÿ¦xþ!‰LBb£ÇãbýÖ«ÒŽÞ£˜(*ÅÅ¨éÄ*Ö¹$Óò/å¤–TÁ�ßÕ?oeÙbR_ãQTã›¥ÓVmYŠj§'yŸî‰Ú¬úT¢óÇ|ré�˜x¥ùŽõ§ŒÄÏoÔÿxOk¨d_AÖú†”)ñMqà_†‚¢è74Ÿ(´žÚïwÆÞ�´Òãy¤:D™çGc/³ËÆœú�Z6ÉBCãP9ƒ)­îâÕk3žDÀCsfC¼Ý5Àô²Œ‰�´U²UEæ>É? ¥LJcÙ|×*#¾+ÄûMJ|Í=Ú_:{‡7™¥;-C¼Z·b|º×…¶E¿/ÒK3~²íåi1»­ÏVî»²”ãëÜÉ×xÉØ|ù¨p©ê/¸,¹Gèb^ÔhÅ�9vë
ROÆi/êdsNmý`ZMÿH @Eûº?ö™7Ð,rƒ@jßqVªO«ØÖa	ÛCûwo½[~XÛÆ\
eÇh¥€©ïvFäµÖ¯3>kæ÷'õ   
á‰—ÅWbJ èFäÀ ¥²�l±Ägû    YZ   -<AlignableSequences trimStringency="Medium"/>  !<AdditionalSequenceProperties><UpstreamStickiness>0</UpstreamStickiness><DownstreamStickiness>0</DownstreamStickiness><UpstreamModification>FivePrimePhosphorylated</UpstreamModification><DownstreamModification>FivePrimePhosphorylated</DownstreamModification></AdditionalSequenceProperties>
  a<?xml version="1.0"?><Features nextValidID="16"><Feature recentID="0" name="å��å�‘çŽ¯åŒ–ä»‹å¯¼åº�åˆ—" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="969-980" color="#a6acb3" type="standard"/></Feature><Feature recentID="1" name="æ­£å�‘çŽ¯åŒ–ä»‹å¯¼åº�åˆ—" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="661-672" color="#a6acb3" type="standard"/></Feature><Feature recentID="2" name="HSV TK poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="4771-4818" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;herpes simplex virus thymidine kinase polyadenylation signal&amp;nbsp;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot; title=&quot;http://www.ncbi.nlm.nih.gov/pubmed/3018551&quot;&gt;(Cole and Stacy, 1985)&lt;/a&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="3" name="AmpR promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3247-3351" color="#ffffff" type="standard"/><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;bla&lt;/i&gt;&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="4" name="SV40 poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2637-2758" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="5" name="SV40 ori" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3561-3696" color="#ffff00" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="6" name="CMV promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="365-568" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus (CMV) immediate early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="7" name="CMV enhancer" type="enhancer" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="61-364" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;human cytomegalovirus immediate early enhancer&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="8" name="SV40 promoter" directionality="1" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="3353-3710" color="#ffffff" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;SV40 enhancer and early promoter&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="9" name="f1 ori" directionality="2" type="rep_origin" swappedSegmentNumbering="1" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="2765-3220" color="#ffff00" type="standard"/><Q name="direction"><V text="LEFT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="10" name="ori" directionality="1" type="rep_origin" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="5147-5735" color="#ffff00" type="standard"/><Q name="direction"><V text="RIGHT"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;high-copy-number ColE1/pMB1/pBR322/pUC origin of replication&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="11" name="EGFP" directionality="1" translationMW="26942.08" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="0" hitsStopCodon="1"><Segment range="1795-1797" color="#05fd14" type="standard" translated="1"/><Segment name="1a" range="1798-1800" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="0"/><Segment range="1801-2514" color="#05fd14" type="standard" translated="1" translationNumberingStartsFrom="2"/><Q name="codon_start"><V int="1"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;mammalian codon-optimized&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;enhanced GFP&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="M,V,SKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYK*"/></Q></Feature><Feature recentID="12" name="NeoR/KanR" directionality="1" translationMW="28979.67" type="CDS" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1" hitsStopCodon="1"><Segment range="3745-4539" color="#ccffcc" type="standard" translated="1"/><Q name="codon_start"><V int="1"/></Q><Q name="gene"><V text="&lt;html&gt;&lt;body&gt;&lt;i&gt;aph(3')-II&lt;/i&gt; (or &lt;i&gt;nptII&lt;/i&gt;)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="note"><V text="&lt;html&gt;&lt;body&gt;confers resistance to neomycin, kanamycin, and G418 (GeneticinÂ®)&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="product"><V text="&lt;html&gt;&lt;body&gt;aminoglycoside phosphotransferase from Tn5&lt;/body&gt;&lt;/html&gt;"/></Q><Q name="transl_table"><V int="1"/></Q><Q name="translation"><V text="MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKASMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF*"/></Q></Feature><Feature recentID="13" name="bGH poly(A) signal" type="polyA_signal" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1018-1242" color="#a6acb3" type="standard"/><Q name="note"><V text="&lt;html&gt;&lt;body&gt;bovine growth hormone polyadenylation signal&lt;/body&gt;&lt;/html&gt;"/></Q></Feature><Feature recentID="14" name="MCMV" type="promoter" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="1257-1780" color="#ffffff" type="standard"/></Feature><Feature recentID="15" name="FAM64A(human)-circRNA" type="misc_feature" allowSegmentOverlaps="0" consecutiveTranslationNumbering="1"><Segment range="673-968" color="#a6acb3" type="standard"/></Feature></Features>
   —<?xml version="1.0"?><Primers nextValidID="0"><HybridizationParams minContinuousMatchLen="10" allowMismatch="1" minMeltingTemperature="40"/></Primers>
  ³<Notes>
<UUID>02537702-210a-4747-99aa-f42abd87fa35</UUID>
<Type>Synthetic</Type>
<ConfirmedExperimentally>0</ConfirmedExperimentally>
<CustomMapLabel>pCMV-FAM64A(human)-circRNA-mCMV-EGFP-Neo</CustomMapLabel>
<UseCustomMapLabel>1</UseCustomMapLabel>
<Created UTC="16:0:0">2018.5.29</Created>
<LastModified UTC="22:16:22">2026.5.7</LastModified>
<SequenceClass>UNA</SequenceClass>
<TransformedInto>Unspecified</TransformedInto>
</Notes>
  Y     K         
?????                                                                                                       ÿ d      DO  d              E              ÿÿÿÿYô? P                                                                                                                                                             s<StrandColors><TopStrand><ColorRange range="660..668" colors="light blue"/><ColorRange range="669..671" colors="black"/><ColorRange range="968..979" colors="light blue"/></TopStrand><BottomStrand><ColorRange range="660..668" colors="light blue"/><ColorRange range="669..671" colors="black"/><ColorRange range="968..979" colors="light blue"/></BottomStrand></StrandColors>   3<?xml version="1.0"?><EnzymeVisibilities vals=""/>
   )<?xml version="1.0"?><CustomEnzymeSets/>
